• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    COMBINATION OF ACTIVE COMPOUND, COMPOSITION FOR CONTROL OF PHYTOPATHOGENIC HARMFUL FUNGI, METHOD FOR CONTROL OF PHYTOPATHOGENIC HARMFUL FUNGI, PROCESS FOR PRODUCTION OF COMPOSITIONS FOR CONTROL OF PHYTOPATHOGENIC HARMFUL FUNGI AND COMBINATION OF COMBINATIONS active, particularly within a fungicidal composition, comprising (A) N-cyclopropyl-N- [benzyl-substituted] -3- (difluoromethyl) -5-fluoro-1-methyl-1H-pyrazole-4-carboxamide of thiocarboxamide and another active compound (B) with fungicidal action. In addition, the invention relates to a method for curative, preventive or eradicative control of phytopathogenic fungi from crop plants, to the use of a combination according to the invention for the treatment of seed, to a method of protecting seed and especially to the treated seed.
    公开号:BR112013027091B1
    申请号:R112013027091-8
    申请日:2012-04-18
    公开日:2020-12-01
    发明作者:Peter Dahmen；Frank Göhlich；Hendrik Helmke；Ingo Wetcholowsky；Thomas Seitz；Ulrike Wachendorff-Neumann；Christophe Dubost；Philippe Desbordes；Stéphanie Gary
    申请人:Bayer Cropscience Aktiengesellschaft；
    IPC主号:
    专利说明:

    [001] The present invention relates to combinations of active compound, particularly within a fungicidal composition, which comprises (A) a derivative of N-cyclopropyl-N- [benzyl-substituted] -3- (difluoromethyl) -5- fluoro-1-methyl-1H-pyrazol-4-carboxamide or thiocarboxamide derivative and another fungicidal action compound (B). In addition, the invention relates to a method for curative or preventive or eradicative control of phytopathogenic fungi from plants or crops, to the use of a combination according to the invention for seed treatment, to a method for protecting a seed and not at least to the treated seed.
    [002] N-cyclopropyl-N- [benzyl-substituted] -carboxamides or thiocarboxamides, their preparation from commercially available materials and their use as fungicides are described in patent documents WO2007 / 087906, WO2009 / 016220 and WO2010 / 130767.
    [003] Since the environmental and economic requirements imposed on modern crop protection compositions are increasingly increasing, with respect, for example, to the spectrum of action, toxicity, selectivity, application rate, waste formation and capacity to favorable preparation, and since, in addition, there are problems, for example, with resistance, a constant task to develop new compositions, particularly fungicidal agents, which in some areas help at least to fulfill the requirements mentioned above.
    [004] The present invention provides compound combinations / compositions that in some respects achieve at least the stated objectives.
    [005] It has now been found, surprisingly, that the combinations according to the invention not only enable the additive increase of the spectrum of action in relation to the phytopathogen to be controlled, which at first was expected, but obtains a synergistic effect that extends the field action of component (A) and component (B) in two ways. First, the application rates for component (A) and component (B) are lowered although the action remains good as well. Second, the combination still achieves a high degree of phytopathogen control even where the two individual compounds become ineffective in such a low application rate range. This allows, on the one hand, a substantial expansion of the spectrum of phytopathogens that can be controlled and, on the other hand, increased safety in use.
    [006] In addition to the fungicidal synergistic activity, the active compound combinations according to the invention also have surprising properties that, in a broader sense, can also be called synergistic such as, for example: broadening the spectrum of activity to other phytopathogens , for example, resistant strains of plant diseases; lower application rates of active compounds; sufficient pest control with the aid of the active compound combinations according to the invention even at application rates, where the individual compounds show or virtually show no activity; advantageous behavior during formulation or during use use, for example during crushing, sifting, emulsifying, dissolving or dispensing; storage and improved light stability; formation of advantageous waste; improved toxicological or ecotoxicological behavior; improved plant properties, for example better growth, increased crop yields, a better developed root system, a large leaf area, greener leaves, stronger shoots, less seed needed, lower phytotoxicity, mobilization of the plant's defense system , good compatibility with plants. In this way, the use of combinations of active compound or compositions according to the invention contributes considerably to maintaining health of young cereal, which increases, for example, the winter survival of the treated cereal seed and also protects the quality and yield. In addition, combinations of active compounds according to the invention can contribute to increased systemic action. Even if the individual compounds in the combination do not have sufficient systemic properties, the active compound combinations according to the invention can still have this property. Similarly, combinations of active compound according to the invention can result in a higher persistence of fungicidal action.
    [007] Correspondingly, the present invention provides a combination comprising: (A) at least one derivative of formula (I)
    where T represents an oxygen atom or a sulfur atom and X is selected from the list of 2-isopropyl, 2-cyclopropyl, 2-tert-butyl, 5-chloro-2-ethyl, 5-chloro-2-isopropyl, 2-ethyl-5-fluoro, 5-fluoro-2-isopropyl, 2-cyclopropyl-5-fluoro, 2-cyclopentyl-5-fluoro, 2-fluoro-6-isopropyl, 2-ethyl-5-methyl, 2- isopropyl-5-methyl, 2-cyclopropyl-5-methyl, 2-tert-butyl-5-methyl, 5-chloro-2- (trifluoromethyl), 5-methyl-2- (trifluoromethyl), 2-chloro-6- (trifluoromethyl), 3-chloro-2-fluoro-6- (trifluoromethyl) and 2-ethyl-4,5-dimethyl, or an agrochemically acceptable salt thereof, and (B) at least one other active fungicidal compound B.
    [008] Combinations comprising at least one compound of the formula (I selected from the group consisting of: N-cyclopropyl-3- (difluoromethyl) -5-fluoro-N- (2-isopropylbenzyl) -1-methyl- 1 H- pyrazole-4-carboxamide (compound A1), N-cyclopropyl-N- (2-cyclopropylbenzyl) -3- (difluoromethyl) -5-fluoro-1-methyl-1 H-pyrazole-4-carboxamide (compound A2), N - (2-tert-butylbenzyl) -N-cyclopropyl-3- (difluoromethyl) -5-fluoro- 1-methyl-1 H-pyrazol-4-carboxamide (compound A3), N- (5-chloro-2-ethylben2yl ) -N-cyclopropyl-3- (difluoromethyl) -5-fluoro-1-methyl-1H-pyrazol-4-carboxamide (compound A4), N- (5-chloro-2-isopropylbenzyl) -N-cyclopropyl-3- (difluoromethyl) -5-fluoro-1-methyl-1 H-pyrazol-4-carboxamide (compound A5), N-cyclopropyl-3- (difluoromethyl) -N- (2-ethyl-5-fluorobenzyl) -5-fluoro -1-methyl-1H-pyrazol-4-carboxamide (compound A6), N-cyclopropyl-3- (difluoromethyl) -5-fluoro-N- (5-fluoro-2-isopropylben2yl) -1-methyl- 1 H- pyrazol-4-carboxamide (compound A7), N-cyclopropyl-N- (2-cyclopropyl-5-fluorobenzyl) -3- (d ifluoromethyl) -5-fluoro-1-methyl-1 H-pyrazol-4-carboxamide (compound A8), N- (2-cyclopentyl-5-fluorobenzyl) -N-cyclopropyl-3- (difluoromethyl) -5-fluoro- 1-methyl- 1 H-pyrazol-4-carboxamide (compound A9), N-cyclopropyl-3- (difluoromethyl) -5-fluoro-N- (2-fluoro-6-isopropylbenzyl) - 1-methyl- 1 H- pyrazol-4-carboxamide (compound A 10), N-cyclopropyl-3- (difluoromethyl) -N- (2-ethyl-5-methylbenzyl) -5-fluoro-1-methyl-1H-pyrazol-4-carboxamide A 11), N-cyclopropyl-3- (difluoromethyl) -5-fluoro-N- (2-isopropyl-5-methylbenzyl) -1-methyl-1 H-pyrazol-4-carboxamide (compound A 12), N- cyclopropyl-N- (2-cyclopropyl-5-methylbenzyl) -3- (difluoromethyl) -5-fluoro-1-methyl-1 H-pyrazol-4-carboxamide (compound A13), N- (2-tert-butyl- 5-methylbenzyl) -N-cyclopropyl-3- (difluoromethyl) -5-fluoro-1-methyl-1 H-pyrazol-4-carboxamide (compound A 14), N- [5-chloro-2- (trifluoromethyl) benzyl ] -N-cyclopropyl-3- (difluoromethyl) -5-fluoro-1-methyl-1 H-pyrazol-4-carboxamide (compound A 15), N-cyclopropyl-3- (difluoromethyl) -5-fluoro-1 -methyl-N- [5-methyl-2- (trifluoromethyl) benzyl] - 1 H-pyrazol-4-carboxamide (compound A 16), N- [2-chloro-6- (trifluoromethyl) benzyl] -N-cyclopropyl -3- (difluoromethyl) -5-fluoro-1-methyl-1 H-pyrazol-4-carboxamide (compound A 17), N- [3-chloro-2-fluoro-6- (trifluoromethyl) benzyl] -N- cyclopropyl-3- (difluoromethyl) -5- fluoro-1-methyl-1 H-pyrazol-4-carboxamide (compound A 18), N-cyclopropyl-3- (difluoromethyl) -N- (2-ethyl-4,5 -dimethylbenzyl) -5-fluoro- 1 -methyl-1 H-pyrazol-4-carboxamide (compound A 19), and N-cyclopropyl-3- (difluoromethyl) -5-fluoro-N- (2-isopropylbenzyl) -1 -methyl-1H-pyrazol-4-carbothioamide (compound A 20).
    [009] In a particular embodiment of the invention, fungicidal compound B of the invention is selected from the following groups: (1) inhibitors of ergosterol synthesis, (2) respiratory chain inhibitors in the I or n complex, (3) chain inhibitors respiratory system in the ni complex, (4) mitosis and cell division inhibitors, (5) compounds capable of multi-site action, (6) compounds capable of inducing a host defense, (7) inhibitors of amino acid biosynthesis and / or protein, (8) inhibitors of ATP production, (9) inhibitors of cell wall synthesis or glucan synthesis, (10) inhibitors of lipid and membrane synthesis, (11) inhibitors of melanin biosynthesis, (12 ) inhibitors of nucleic acid synthesis, (13) inhibitors of signal transduction, (14) compounds that can act as decouplers, (15) other fungicides (16) additional fungicides.
    [010] Combinations comprising an ergosterol synthesis inhibitor selected from the group consisting of [Group (1)]: (1.1) aldimorph (1704-28-5), (1.2) azaconazole (60207-31-0), ( 1.3) bitertanol (55179-31-2), (1.4) bromuconazole (116255-48-2), (1.5) cyproconazole (1 1309699-4), (1.6) diclobutrazol (75736-33-3), (1.7) diphenoconazole (1 19446-68-3), (1.8) diniconazole (83657-24-3), (1.9) diniconazole-M (83657-18-5), (1.10) dodemorph (1593-77-7), (1.11) dodemorph acetate (3 1717-87-0), (1.12) epoxiconazole (106325-08-0), (1.13) etaconazole (60207-93-4), (1.14) fenarimol (60168-88-9), (1.15) fenbuconazole (114369-43-6), (1.16) fenhexamid (12683317-8), (1.17) fenpropidin (67306-00-7), (1.18) fenpropimorph (67306-03-0), (1.19) fluquinconazole (136426- 54-5), (1.20) flurprimidol (56425-91-3), (1.21) flusilazole (85509-19-9), (1.22) flutriafol (76674-21-0), (1.23) furconazole (1 12839-33 -5), (1.24) furconazole-cis (1 12839-32-4), (1.25) hexaconazole (7998371-4), (1.26) imazalil (60534-80-7), (1.27) imazalyl sulfate (58594-72-2), (1.28) imibenconazole (86598-92-7), (1.29) ipconazole (125225-28-7), (1.30) metconazole (1251 16-23-6), (1.31) miclobutanil (88671-89-0), (1.32) naphthifine (65472-88-0), (1.33) nuarimol (63284-71-9), (1.34) oxpoconazole (174212-12-5), (1.35) paclobutrazol (76738-62-0), (1.36) pefurazoate (101903-30-4), (1.37) penconazole (66246-88-6), (1.38) piperalin (3478-94-2), (1.39) prochloraz (67747-095), (1.40) propiconazole (60207-90-1), (1.41) protioconazole (178928-70-6), (1.42) pyributicarb (88678-67-5), (1.43) pyrifenox (88283-41 -4), (1.44) quinconazole (103970-75-8), (1.45) simeconazole (149508-90-7), (1.46) spiroxamine (1 18134-30-8), (1.47) tebuconazole ( 107534-96-3), (1.48) terbinafine (91 161 -71-6), (1.49) tetraconazole (1 12281 -77-3), (1.50) triadimefon (43121-43-3), (1.51) triadimenol ( 89482-17-7), (1.52) tridemorph (81412-43-3), (1.53) triflumizole (68694-11-1), (1.54) triforin (26644-46-2), (1.55) triticonazole (131983- 72-7), (1.56) uniconazole (8365) 7-22-1), (1.57) uniconazole-p (83657-17-4), (1.58) viniconazole (77174-66- 4), (1.59) voriconazole (137234-62-9), (1.60) l- (4-chlorophenyl) -2- (1 H- 1,2,4-triazol-1-yl) cycloheptanol (129586-32-9), (1.61) methyl 1 - (2,2-dimethyl-2,3- dihydro-1 H-inden- 1 -yl) - 1 H-imidazole-5-carboxylate (110323-950), (1.62) N '- {5- (difluoromethyl) -2-methyl-4- [3- (trimethylsilyl ) propoxy] phenyl} -N-ethyl-N-methylimidoformamide, (1.63) N-ethyl-N-methyl-N '- {2-methyl-5- (trifluoromethyl) -4- [3- (trimethylsilyl) propoxy] phenyl } imidoformamide and (1.64) O- [1- (4-methoxyphenoxy) -3,3-dimethylbutan-2-yl] 1H-imidazol-1-carbothioate (11 1226-71 -2), and salts thereof.
    [011] Combinations comprising an ergosterol synthesis inhibitor selected from the group consisting of cyproconazole (113096-99-4), diphenoconazole (119446-68-3), epoxiconazole (106325-08-0), fenhexamid (126833-17) are preferred -8), fenpropidin (67306-00-7), fenpropimorf (67306-030), fluquinoconazole (136426-54-5), hexaconazole (79983-71-4), ipconazole (125225-28-7), metconazole (125116-23-6), miclobutanil (88671-89-0), prochloraz (67747-09-5), propiconazole (60207-90-1), protioconazole (178928-70-6), spiroxamine (118134-30- 8), tebuconazole (107534-96-3), tetraconazole (11228177-3) and triadimenol (89482-17-7), and salts thereof. More particularly preferred are combinations comprising an ergosterol synthesis inhibitor selected from the group consisting of cyproconazole (1 13096-99-4), epoxiconazole (106325-08-0), fenhexamid (126833-17-8), metconazole (12511623-6 ), propiconazole (60207-90-1), protioconazole (178928-70-6), spiroxamine (1 18134-30-8) and tebuconazole (107534-96-3), and salts thereof.
    [012] In addition, combinations comprising a respiratory chain inhibitor in complex I or II selected from the group consisting of [Group (2)]: (2.1) bixafen (581809-46-3), (2.2) boscalid (18842585- 6), (2.3) carboxin (5234-68-4), (2.4) diflumetorim (130339-07-0), (2.5) fenfuram (24691-80-3), (2.6) fluopyram (658066-35-4) , (2.7) flutolanil (66332-965), (2.8) fluxpyroxad (907204-31-3), (2.9) furametpir (123572-88-3), (2.10) furmeciclox (60568-05-0), (2.11) isopirazam (mixture of 1 RS, 4SR, 9RS syn-epimeric racemate and 1 RS, 4SR, 9SR anti-epimeric racemate) (881685-58-1), (2.12) isopirazam (1 RS, 4SR, 9SR anti-epimeric racemate) , (2.13) isopyrazam (anti-epimeric enantiomer 1 R, 4S, 9S), (2.14) isopyrazam (anti-epimeric enantiomer 1 S, 4R, 9R), (2.15) isopirazam (syn-epimeric racemate 1 RS, 4SR, 9RS ), (2.16) isopyrazam (1 R, 4S, 9R syn-epimeric enantiomer), (2.17) isopyrazam (1 S, 4R, 9S sin-epimeric enantiomer), (2.18) mepronil (55814-410), (2.19) oxycarboxin (5259-88-1), (2.20) penflufen (494793-67-8), (2.21) pentiopi-rad (183675-82-3), (2.22) silkxane (874967-67-6), (2.23) tifluzamide (130000-40-7), (2.24) 1-methyl-N- [2- (1,1,2,2-tetrafluoroethoxy) phenyl] -3- (trifluoromethyl) -1H-pyrazol-4-carboxamide, (2.25) 3- (difluoromethyl) -1 -methyl-N- [2- (1,1,2,2-tetrafluoroethoxy) phenyl] -1H-pyrazol-4 carboxamide, (2.26) 3- (difluoromethyl) - N- [4-fluoro-2- (1, 1,2,3,3,3-hexafluoropropoxy) phenyl] -1-methyl- 1 H-pyrazol-4-carboxamide, (2.27) N- [1 - (2,4-dichlorophenyl) -1-methoxypropan-2- yl] -3- (difluoromethyl) -1-methyl-1 H-pyrazol-4-carboxamide (1092400-95-7), (2.28) 5,8-difluoro-N- [2- (2-fluoro-4- {[4- (trifluoromethyl) pyridin-2-yl] oxy} phenyl) ethyl] quinazolin-4-amine (1210070-84-0), (2.29) benzovindiflupir, (2.30) N - [(1S, 4R) -9 - (dichloromethylene) -1,2,3,4 etrahydro-1,4-methanonaphthalen-5-yl] -3- (difluoromethyl pyrazol-4-carboxamide, (2.31) N - [(1R, 4S) -9- ( dichloromethylene) -1,2,3,4-tetrahydro- 1,4-methanonaphthalen-5-yl] -3- (difluoromethyl) -1-methyl-1 H-pyrazol-4-carboxamide, (2.32) 3- (Difluormethyl ) - 1-methyl-N- (1, 1,3-trimethyl-2,3-dihydro-1 H-inden-4-yl) - 1 H-pyrazol-4-carboxamide, (2.33) 1,3,5 -Trimethyl-N- (1, 1,3-trimethyl-2,3-dihydro-1 H- inden-4-yl) -1 H-pyrazol-4-carboxamide, (2.34) 1 - Metii-3- (trifluormethyl ) -N- (1,3,3- (2.35) 1 - ethyl-3- (trifluoromethyl) -N - [(1 S) - 1,3,3-trimethyl-2,3-dihydro- 1 H-inden -4-yl] - 1 H-pyrazol-4-carboxamide, (2.36) 1-Methyl-3- (trifluormethyl) -N - [(1 R) -1,3,3-trimethyl-2,3-dihydro- 1H-inden-4-yl] -1 H-pyrazol-4-carboxamide, (2.37) 3- (Difluormethyl) -1 - methyl-N - [(3S) -1, 1,3-trimethyl-2,3- dihydro-1 H-inderi-4-yl] -1 H-pyrazol-4-carboxamide, (2.38) 3- (Difluormethyl) -1-methyl-N - [(3R) -1,1,3-trimethyl-2 , 3-dihydro-1H- inden-4-yl] -1H-pyrazol-4-carboxamide, (2.39) 1,3,5-Trimethyl-N - [(3R) -1, 1,3-trimethyl-2, 3-dihydro-1 H- inden-4-yl] - 1 H-pyrazol-4-carboxamide, (2.40) 1,3,5- Trimethyl-N - [(3 S) - 1, 1,3-trimethyl- 2,3-dihydro-1 H-inden-4-yl] -1 H-pyrazol-4-carboxamide and (2.41) benodanyl (15310-01-7), and salts thereof.
    [013] Combinations comprising a respiratory chain inhibitor in complex I or II selected from the group consisting of bixafen (581809-46-03), boscalid (188425-85-6), fluopyram (658066-35-4), flutolanil are preferred (66332-96-5), isopirazam (mixture of 1 RS, 4SR, 9RS syn-epimeric racemate and 1RS, 4SR, 9SR anti-epimeric racemate) (88165-58-1), isopirazam (1 RS syn-epimeric racemate, 4SR, 9RS), isopirazam (1R, 4S, 9R sin-epimeric enantiomer), isopirazam (1S, 4R, 9S sin-epimeric enantiomer), isopyrazam (1-RS, 4SR, 9SR anti-epimeric racemate), isopirazam (enantiomer anti-epimeric 1R, 4S, 9S), isopirazam (anti-epimeric enantiomer 1 S, 4R, 9R), penflufen (494793-67-8), pentiopirad (183675-82-3), silkxane (874967-67- 6) , 3- (difluoromethyl) - 1-methyl-N- [2- (1,1,2,2-tetrafluoroethoxy) phenyl] -1H-pyrazol-4-carboxamide, 3- (difluoromethyl) -N- [4-fluoro -2- (1,1,2,3,3,3-hexafluoropropoxy) phenyl] - 1-methyl-1 H-pyrazol -4-carboxamide, fluxpyroxad (907204-31-3), benzovindiflupir and N- [1 - (2,4-dichlorophenyl) - 1 - methoxypropan-2-yl] -3- (difluoromethyl) - 1-methyl-1H-pyrazol-4-carboxamide, and salts thereof. More particularly preferred are combinations comprising a respiratory chain inhibitor in complex I or II selected from the group consisting of bixafen (581809-4603), fluopyram (658066-35-4), isopyrazam (1 RS, 4SR syn-epimeric racemate mixture, 9RS and anti-epimeric racemate 1RS, 4SR, 9SR) (88165-58-1), isopyrazam (syn epimeric racemate 1 RS, 4SR, 9RS), isopyrazam (1R, 4S, 9R syn-epimeric enantiomer), isopyrazam (enantiomer syn-epimeric 1 S, 4R, 9S), isopirazam (anti-epimeric racemate 1RS, 4SR, 9SR), isopirazam (anti-epimeric enantiomer 1 R, 4S, 9S), isopirazam (anti-epimeric enantiomer 1 S, 4R, 9R ), penflufen (494793-67- 8), pentiopirad (183675-82-3), silkxane (874967-67-6), fluxpyroxad (907204-31-3), benzovindiflupir and N- [1 - (2,4- dichlorophenyl) - 1-methoxypropan-2-yl] -3- (difluoromethyl) - 1-methyl-1H-pyrazol-4-carboxamide, and salts thereof.
    [014] Combinations comprising a respiratory chain inhibitor in complex III selected from the group consisting of [Group (3)]: (3.1) ametoctradin (865318-97-4), (3.2) amisulbrom (348635-87-0) are preferred , (3.3) azoxystrobin (131860-33-8), (3.4) ciazofamid (1201 16-88-3), (3.5) coumetoxystrobin (850881-30-0), (3.6) coumoxystrobin (850881-70-8), (3.7) dimoxystrobin (14160052-4), (3.8) enestroburin (238410-1 1 -2), (3.9) famoxadone (131807-57-3), (3.10) phenamidone (161326-34-7), (3.1 1 ) phenoxystrobin (918162-02-4), (3.12) fluoxastrobin (361377-29-9), (3.13) kresoxim-methyl (143390-89-0), (3.14) metominostrobin (133408-50-1), (3.15 ) orisastrobin (189892-69-1), (3.16) picoxystrobin (1 17428-22-5), (3.17) pyraclostrobin (175013-18-0), (3.18) pyrametestrobin (915410-70-7), ( 3.19) piraoxystrobin (862588-11-2), (3.20) pyribencarb (799247-52-2), (3.21) triclopyricarb (902760-40-1), (3.22) trifloxystrobin (141517-21 - 7), (3.23) (2E) -2- (2 - {[6- (3-chloro-2-methylphenoxy) -5-fluid ropyrimidin-4-yl] oxy} phenyl) -2- (methoxyimino) -N-methylethylamide, (3.24) (2E) - 2- (methoxyimino) -N-methyl-2- (2 - {[({(l E ) -l- [3- (1rifluoromethyl) phenyl] ethylidene} amino) oxy] methyl} - phenyl) ethanamide, (3.25) (2E) -2- (methoxyimino) -N-methyl-2- {2 - [(E ) - ({1- [3- (trifluoromethyl) phenyl] -ethoxy} imino) methyl] phenyl} ethanamide (158169-73-4), (3.26) (2E) -2- {2 - [({[(1 E) - 1 - (3- {[(E) -1- fluoro-2-phenylethyl] oxy} phenyl) ethylidene] amino} oxy) methyl] phenyl} -2 (methoxyimino) -N- methylethylamide (326896-28- 0), (3.27) (2E) -2- {2 - [({[(2E, 3E) -4- (2,6-dichlorophenyl) but-3-en-2-ylidene] amino} oxy) methyl] - phenyl} -2- (methoxyimino) -N-methylethylamide, (3.28) 2-chloro- N- (1,1,3-trimethyl-2,3-dihydro-1 H-inden- 4-yl) pyridine-3 -carboxamide (119899-14-8), (3.29) 5-methoxy-2-methyl-4- (2 - {[({(1 E) -l- [3- (trifluoromethyl) phenyl] ethylidene} amino) oxy ] methyl} phenyl) -2,4-dihydro-3H-1,2,4-triazole-3-one, (3.30) methyl (2E) -2- {2 - [({cyclopropyl [(4 methoxyphenyl) imino] methyl} sulfanyl) methyl] phenyl} -3- methoxyprop-2-enoate (149601-03-6), (3.31) N- (3-ethyl-3,5,5-trimethylcyclohexyl) -3- (formylamino) -2-hydroxybenzamide (226551-21-9), (3.32) 2- {2 - [(2,5-dimethylphenoxy) methyl] phenyl} -2-methoxy-N-methylacetamide (173662-97 -0) and (3.33) (2R) -2- {2 - [(2,5-dimethylphenoxy) methyl] phenyl} -2-methoxy-N-methylacetamide (394657-24-0), and salts thereof.
    [015] Combinations comprising a respiratory chain inhibitor in complex III selected from the group consisting of ametoctradine (865318-97-4), amisulbrom (34863587-0), azoxystrobin (131860-33-8), ciazofamid (1201 16) are particularly preferred -88-3), dimoxystrobin (141600-52-4), enestroburin (238410-1 1-2), phenamidone (161326-34-7), fluoxastrobin (361377-29-9), kresoxim-methyl (143390-89 -0), metominostrobin (133408-50-1), orisastrobin (189892-69-1), picoxystrobin (117428-22-5), pyraclostrobin (175013-18-0) and trifloxystrobin (141517-21 -7), and salts of these.
    [016] Combinations comprising a respiratory chain inhibitor in complex III selected from the group consisting of ametoctradine (865318-97-4), azoxystrobin (13186033-8), fluoxastrobin (361377-29-9), pyraclostrobin (175013) are more particularly preferred. -18-0) and trifloxystrobin (141517-21-7), and salts thereof.
    [017] Combinations comprising a mitosis inhibitor and cell division selected from the group consisting of [Group (4)]: (4.1) benomyl (17804-35-2), (4.2) carbendazim (10605-21 -7) are still preferred , (4.3) chlorphenazole (3574-96-7), (4.4) dieto-fencarb (87130-20-9), (4.5) etaboxam (162650-77-3), (4.6) fluopicolide (2391 10-15-7 ), (4.7) fuberidazole (3878-19-1), (4.8) pencicuron (66063-05-6), (4.9) thiabendazole (148-79-8), (4.10) thiophanate-methyl (23564-05-8 ), (4.1 1) thiophanate (23564-06-9), (4.12) zoxamide (156052-68-5), (4.13) 5-chloro-7- (4-methylpiperidin-1-yl) -6- (2 , 4,6-trifluorophenyl) [1,2,4] triazolo [1,5-a] pyrimidine (214706-53-3) and (4.14) 3-chloro-5- (6-chloropyridin-3-yl) - 6-methyl-4- (2,4,6-trifluorophenyl) pyridazine (1002756-87-7), and salts thereof.
    [018] Combinations comprising a mitosis inhibitor and cell division selected from the group consisting of pencicuron (66063-05-6), thiophanate-methyl (23564-05-8), fluopicolid (2391 10-15-7) and thiophanate (23564-06-9), and salts thereof.
    [019] Combinations comprising a mitosis inhibitor and cell division selected from the group consisting of fluopicolid (2391 10-15-7) and salts thereof are more particularly preferred.
    [020] Combinations comprising a compound that may have a multi-site action selected from the group consisting of [Group (5)]: (5.1) Bordeaux blend (8011 -63-0), (5.2) captafol (2425- 06-1), (5.3) captan (133-06-2), (5.4) chlorothalonil (1897-45-6), (5.5) copper hydroxide (20427-59-2), (5.6) copper naphthenate ( 1338-02-9), (5.7) copper oxide (1317-39-1), (5.8) copper oxychloride (1332-40-7), (5.9) copper sulfate (2+) (7758-98- 7), (5.10) di-clofluanid (1085-98-9), (5.1 1) dithianon (3347-22-6), (5.12) dodine (2439-103), (5.13) dodine free base, (5.14 ) ferbam (14484-64-1), (5.15) fluorofolpet (719-96-0), (5.16) folpet (133-07-3), (5.17) guazatin (108173-90-6), (5.18) acetate guazatin, (5.19) iminoctadine (13516-27-3), (5.20) iminoctadine albesylate (169202-06-6), (5.21) iminoctadine triacetate (57520-17-9), (5.22) mancobre (53988- 93-5), (5.23) man-cozeb (8018-01 -7), (5.24) maneb (12427-38-2), (5.25) they met (9006-42-2), (5.26) they met zinc (9006-42-2), (5.27) oxine-copper (10380-28-6), (5.28) propamidine (104-32-5), (5.29) propineb (12071 -83-9), (5.30) sulfur and sulfur preparations including calcium polysulfide (7704-34-9), (5.31) extract (137-26-8), (5.32) tolylfluanid (731 -27-1), (5.33) zineb (12122-67-7 ), (5.34) ziram (137-30-4) and (5.35) anilazine (101-05-3), and salts thereof.
    [021] Combinations comprising a compound that may have a multi-site action selected from the group consisting of a mixture of Bordeaux (801 1-63-0), chlorothalonil (1897-45-6), dithianon (3347-22-6) are particularly preferred. ), dodine (2439-10-3), folpet (13307-3), guazatin (108173-90-6), copper oxide (1317-39-1), copper oxychloride (1332-40-7), hydroxide copper (20427-59-2), copper sulfate (7758-987), mancozeb (8018-01-7), maneb (12427-38-2), copper oxin (10380-28-6), propineb ( 12071-83-9), sulfur and sulfur preparations including calcium polysulfide (7704-34-9), tiram (137-26-8) and copper naphthenate (1338-02-9), and salts thereof. Most particularly preferred are combinations comprising a compound that can exhibit multi-site action selected from the group consisting of chlorothalonil (1897-45-6), folpet (133-07-3), mancozeb (8018-017) and propineb (12071-83 -9), and salts thereof.
    [022] Combinations comprising a compound that may have a defense for the host selected from the group consisting of [Group (6)]: (6.1) acibenzolar-S-methyl (135158-54-2), (6.2) isothianyl (224049) are preferred -04-1), (6.3) probenazole (27605-76-1), (6.4) thiadinyl (223580-51 -6) and (6.5) laminarin (900822-4), and salts thereof.
    [023] Most particularly preferred are combinations comprising a compound that can have a defense for the host selected from the group consisting of isothianyl (224049-04-1) and salts thereof.
    [024] Combinations comprising an amino acid inhibitor and / or protein biosynthesis selected from the group consisting of [Group (7)]: (7.1) andoprim (23951-85-1), (7.2) blasticidin-S (2079- 00-7), (7.3) cyprodinil (121552-61-2), (7.4) kasugamycin (6980-18-3), (7.5) kasugamycin hydrochloride (19408-46-9), (7.6) mepanipirim ( 1 10235- 47-7), (7.7) pyrimethanil (531 12-28-0), (7.8) 3- (5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-iquinoline (861647-32-7), (7.9) oxytetracycline (79-57-2) and (7.10) streptomycin (57-92-1), and salts thereof.
    [025] Combinations comprising an amino acid inhibitor and / or protein biosynthesis selected from the group consisting of cyprodinil (121552-61 -2) and pyrimethanil (531 12-28-0), and salts thereof are particularly preferred. More particularly preferred are combinations comprising an amino acid inhibitor and / or protein biosynthesis selected from the group consisting of pyrimethanil (531 12-28-0) and salts thereof.
    [026] Combinations comprising an ATP production inhibitor selected from the group consisting of [Group (8)]: (8.1) fentin acetate (900-95-8), (8.2) fentin chloride (639-58- 7), (8.3) fentine hydroxide (76-87-9) and (8.4) siltiofam (175217-20-6), and salts thereof.
    [027] Also preferred are combinations comprising an inhibitor of cell wall synthesis or glucan synthesis selected from the group consisting of [Group (9)] :( 9.1) bentiavalicarb (177406-68-7), (9.2) dimetomorf ( 1 10488-70-5), (9.3) flumorf (21 1867-47-9), (9.4) iprovalicarb (14092317-7), (9.5) mandipro-pamid (374726-62-2), (9.6) polyoxins ( 1 1 1 13-80-7), (9.7) polyoxorin (22976-86-9), (9.8) validamycin A (37248-47-8), (9.9) valiphenalate (283159-94-4; 283159-90- 0) and (9.10) polyoxin B (19396-06-6), and salts thereof. Particularly preferred combinations comprising an inhibitor of cell wall synthesis or glucan synthesis selected from the group consisting of benthiavalicarb (177406-68-7), dimetomorf (1 10488-705), iprovalicarb (140923-17-7) and mandipropamid (374726 -62-2), and salts thereof. More particularly preferred are combinations comprising an inhibitor of cell wall synthesis or glucan synthesis selected from the group consisting of iprovalicarb (140923-17-7) and salts thereof.
    [028] Combinations comprising a lipid and membrane synthesis inhibitor selected from the group consisting of [Group (10)]: (10.1) biphenyl (92-52-4), (10.2) chloroneb (2675-77-6) are also preferred. ), (10.3) dichloran (99-30-9), (10.4) edifenfos (17109-49-8), (10.5) etridiazole (2593-15-9), (10.6) iodocarb (55406-53-6), (10.7) iprobenfos (26087-47-8), (10.8) isoprothiolane (50512-35-1), (10.9) propamocarb (25606-41 -1), (10.10) propamocarb-hydrochloride (2560641-1), (10.1 1) protiocarb (19622-08-3), (10.12) pyrazophos (13457-18-6), (10.13) quintozene (82- 68-8), (10.14) technazene (1 17-18-0) and (10.15 ) tolclofos-methyl (57018-04-9), and salts thereof.
    [029] Combinations comprising a lipid and membrane synthesis inhibitor selected from the group consisting of propamocarb (25606-41 -1) and propamocarb-hydrochloride (25606-41 - 1), and salts thereof are particularly preferred.
    [030] More particularly, combinations comprising a lipid and membrane synthesis inhibitor selected from the group consisting of propamocarb (25606-41 -1) and salts thereof are preferred.
    [031] Combinations comprising a melanin biosynthesis inhibitor selected from the group consisting of [Group (1 1)]: (1 1.1) carpropamid (104030-54-8), (1 1.2) diclocimet (139920-32- 4), (1 1.3) phenoxanil (1 15852-48-7), (11.4) phthalide (27355-22-2), (1 1.5) piroquilon (5736932-1), (1 1.6) tricyclazole (41814-78- 2) and (1 1.7) 2,2,2-trifluoroethyl {3-methyl-1 - [(4-methylbenzoyl) amino] butan-2-yl} carbamate (851524-22-6, and salts thereof.
    [032] Combinations comprising a melanin biosynthesis inhibitor selected from the group consisting of tricyclazole (41814-78-2), and salts thereof are particularly preferred. Also preferred are combinations comprising an inhibitor of nucleic acid synthesis selected from the group consisting of [Group (12)]: (12.1) benalaxyl (71626-1 1-4), (12.2) benalaxyl-M (kiralaxil) (98243-83 -5), (12.3) bupirimate (41483-43- 6), (12.4) clozilacon (67932-85-8), (12.5) dimethyrimol (522153-4), (12.6) ethirimol (23947-60-6), (12.7) furalaxil (57646-30-7), (12.8) himexazole (10004-44-1), (12.9) metalaxyl (57837-19-1), (12.10) metalaxyl-M (mefenoxam) (70630-17- 0), (12.11) ofurace (58810-48-3), (12.12) oxadixyl (77732-09-3) and (12.13) oxolinic acid (14698-29-4), and salts thereof.
    [033] Combinations comprising a nucleic acid synthesis inhibitor selected from the group consisting of benalaxyl (71626-1 1-4), benalaxyl-M (kiralaxil) (98243-83-5), metalaxyl (57837-19- 1) and metalaxyl-M (mefenoxam) (70630-17-0), and salts thereof.
    [034] Most particularly preferred are combinations comprising a nucleic acid synthesis inhibitor selected from the group consisting of metalaxyl (57837-19-1) and metalaxyl-M (mefenoxam) (70630-17-0), and salts thereof.
    [035] Combinations comprising a signal transduction inhibitor selected from the group consisting of [Group (13)]: (13.1) chiozolinate (84332-86-5), (13.2) fenpiclonil (74738-17-3), (13.3) fludioxonil (131341-86-1), (13.4) iprodione (36734-19-7), (13.5) procymidone (32809-16-8), (13.6) quinoxifen (124495-18-7) and (13.7 ) vinclozolin (50471 44-8), and salts thereof.
    [036] Combinations comprising a signal transduction inhibitor selected from the group consisting of fludioxonil (131341 -86-1), iprodione (36734-19-7) and vinclozolin (50471 -44- 8), and salts thereof are particularly preferred. More particularly preferred are combinations comprising a signal transduction inhibitor selected from the group consisting of fludioxonil (131341-86-1), and salts thereof.
    [037] Combinations comprising a compound that can act as an uncoupler selected from the group consisting of [Group (14)]: (14.1) binapacril (485-31 -4), (14.2) dinocap (131-72-6) are also preferred , (14.3) ferinzone (89269-64-7), (14.4) fluazinam (79622-59-6) and (14.5) meptildinocap (131-72-6), and salts thereof.
    [038] Combinations comprising a compound that can act as a decoupler selected from the group consisting of fluazinam (79622-59-6) and meptildinocap (131-72-6), and salts thereof are particularly preferred.
    [039] Combinations comprising a fungicide selected from the group consisting of [Group (15)]: (15.1) bentiazole (21564-17-0), (15.2) betoxazin (163269-30-5), (15.3) capsimicin are also preferred. (70694-08-5), (15.4) carvona (99-49-0), (15.5) cinometionat (243901-2), (15.6) pyrophenone (clazafenone) (688046-61 -9), (15.7) cufraneb ( 1109618-7), (15.8) ciflufenamid (180409-60-3), (15.9) cymoxanil (57966-95-7), (15.10) cyprosulfamide (221667-31-8), (15.11) dazomet (533-74- 4), (15.12) debacarb (62732-91 -6), (15.13) dichlorophene (97-23-4), (15.14) dichlorine (62865-36-5), (15.15) difenzoquat (49866-87-7) , (15.16) diphenyl methyl sulfate (43222-486), (15.17) diphenylamine (122-39-4), (15.18) ecomato, (15.19) phenpyrazamine (473798-59-3), (15.20) flumetover (154025-04- 4), (15.21) fluoroimide (4120521-4), (15.22) flusulfamide (106917-52-6), (15.23) flutyanil (304900-25-2), (15.24) fosetyl aluminum (39148-24-8) , (15.25) fosetyl-calcium, (15.26) fosetyl-sodium (39148-16-8), (15.27) hexachlorobe nzene (1 18-74-1), (15.28) irumamycin (81604-73-1), (15.29) metasulfocarb (66952-49-6), (15.30) methyl isothiocyanate (556-61-6), (15.31 ) methafenone (220899-03-6), (15.32) mildiomycin (67527-71-3), (15.33) natamycin (7681 -93-8), (15.34) nickel dimethyldithiocarbamate (15521-65-0), (15.35) nitrotal-isopropyl (10552-74-6), (15.36) octylinone (26530-20-1), (15.37) oxamocarb (917242-12-7), (15.38) oxyphenol (34407-879), (15.39) ) pentachlorophenol and salts (87-86-5), (15.40) phenothrin, (15.41) phosphonic acid and its salts (13598-36-2), (15.42) propamocarb-phosethylate, (15.43) propanosine-sodium (88498 -02-6), (15.44) proquinazid (189278-12-4), (15.45) pyrimorf (868390-90-3), (15.45e) (2E) -3- (4-tert-butylphenyl) -3- (2-chloropyridin-4-yl) -l - (morpholin-4-yl) prop-2-en-1-one (1231776-28-5), (15.45z) (2Z) -3- (4-tert -butylphenyl) - 3- (2-chloropyridin-4-yl) -1- (morpholin-4-yl) prop-2-en-1-one (1231776-29-6), (15.46) pyrrolnitrine (1018-71 -9), (15.47) tebufloquin (376645-78-2), (15.48) keyboard software (7628 0-91-6), (15.49) tolnifanide (30491 1-98-6), (15.50) triazoxide (72459-586), (15.51) triclamide (70193-21-4), (15.52) zarylamid (84527-51) -5), (15.53) 2-methylpropanoate (3S, 6S, 7R, 8R) -8-benzyl-3 - [({3 - [(isobutyryloxy) methoxy] -4-methoxypyridin-2-yl} carbonyl) amino] -6- methyl-4,9-dioxo-1,5-dioxonan-7-yl (51787534-2), (15.54) 1- (4- {4 - [(5R) -5- (2,6- difluorophenyl ) -4,5-dihydro-1,2-oxazol-3-yl] -1,3-thiazol-2-yl} piperidin-1-yl) -2- [5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl] ethanone (1003319-79-6), (15.55) 1 - (4- {4 - [(5S) -5- (2,6-difluorophenyl) - 4,5-dihydro-1 , 2-oxazol-3-yl] - 1,3-thiazol-2-yl} piperidin-1-yl) -2- [5-methyl-3- (trifluoromethyl) -1 H-piyl] ethanone (1003319- 80-9), (15.56) 1 - (4- {4- [5- (2,6-difluorophenyl) -4,5-dihydro-1,2-oxazol-3-yl] - 1,3-thiazole- 2-yl} piperidin-1-yl) -2- [5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl] ethanone (1003318-67-9), (15.57) 1H-imidazole-l 1- (4-methoxyphenoxy) -3,3-dimethylbutan-2-yl (111227-17-9), (15.58) 2,3,5,6-tetrachloro-4- (methylsulfonyl) pyridine-carboxylate (13108-52-6), (15.59) 2,3-dibutyl-6-chlorothieno [2,3- d] pyrimidin-4 (3H) -one (221451-58-7), (15.60) 2,6- dimethyl-1 H, 5H- [1,4] dithino [2,3- c: 5,6-c '] dipyrrol- 1,3,5,7 (2H, 6H) -tetrone, (15.61) 2- [ 5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl] - 1 - (4- {4 - [(5R) -5-pheni 1- 4,5-dihydro-1,2-oxazole- 3-yl] -1,3-thiazol-2-yl} piperidin-1-yl) ethanone (1003316-53-7), (15.62) 2- [5-methyl- 3- (trifluoromethyl) -1 H-pyrazole -l-yl] -1- (4- {4 - [(5S) -5-phenyl-4,5-dihydro-1,2-oxazoI-3-yl] -1,3-thiazol-2-yl} piperidin-1-yl) ethanone (1003316-54-8), (15.63) 2- [5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl] - 1 - {4- [4- ( 5-phenyl-4,5-dihydro-1,2-oxazol-3-yl) - 1,3-thiazol-2-yl] piperidin-1-yljetanone (1003316-51 -5), (15.64) 2-butoxy -6-iodo-3-propyl-4H-chromen-4-one, (15.65) 2-chloro-5- [2-chloro-1- (2,6-difluoro-4-methoxyphenyl) -4-methyl-1 H-imidazol-5-yl] pyridine, (15.66) 2-phenylphenol and salts (90-43-7), (15.67) 3- (4,4,5-trifluoro-3,3-dimethyl-3,4- dihydroisoquinolin-1-yl) quinoline (861647-85-0), (15.68) 3,4,5-trichloropyridine -2,6-dicarbonitrile (17824-85-0), (15.69) 3- [5- (4-chlorophenyl) -2,3-dimethyl-1,2-oxazolidin-3-yl] pyridine, (15.70) 3 -chloro-5- (4-chlorophenyl) -4- (2,6-difluorophenyl) -6-methylpyridazine, (15.71) 4- (4-chlorophenyl) -5- (2,6-difluorophenyl) -3,6- dimethylpyridazine, (15.72) 5-amino-1,3,4-thiadiazol-2-thiol, (15.73) 5-chloro-N'-phenyl-N '- (prop-2-in-1-yl) thiophene-2 - sulfonohydrazide (134-31 - 6), (15.74) 5-fluoro-2 - [(4-fluorobenzyl) oxy] pyrimidin-4-amine (1174376-1 1-4), (15.75) 5-fluoro-2- [(4-methylbenzyl) oxy] pyrimidin-4-amine (1174376-25-0), (15.76) 5-methyl-6-octyl [1,2,4] triazolo [1,5- a] pyrimidin-7- ethyl amine, (15.77) (2Z) -3-amino-2-cyano-3-phenylprop-2-enoate, (15.78) N '- (4 - {[3- (4-chlorobenzyl) -1, 2, 4-thiadiazol-5-yl] oxy} -2,5-dimethylphenyl) -N-ethyl-N-methylimidoformamide (15.79) N- (4-chlorobenzyl) -3- [3-methoxy-4- (prop-2- in-1-yloxy) phenyl] propanamide, (15.80) N - [(4-chlorophenyl (cyano) methyl] -3- [3-methoxy-4- (prop-2-in-1-yloxy) phenyl] propanamide, (15.81) N - [(5-bromo-3-chloropyridin-2-yl) methyl] -2,4-dichloropyridine-3 -carboxamide, (15.82) N- [1 - (5-bromo-3-chloropyridin-2-yl) ethyl] - 2,4-dichloropyridine-3-carboxamide, (15.83) N- [l- (5-bromo- 3-chloropyridin-2-yl) ethyl] - 2-fluoro-4-iodopyridine-3-carboxamide, (15.84) N - {(E) - [(cyclopropylmethoxy) imino] [6- (difluoromethoxy) -2,3- difluorophenyl] methyl} - phenylacetamide (221201-92-9), (15.85) N - {(Z) - [(cyclopropylmethoxy) imino] [6- (difluoromethoxy) -2,3-difluorophenyl] methyl} -2-phenylacetamide ( 221201 -92-9), (15.86) N'- {4 - [(3-tert-butyl-4-cyano-1,2-thiazol-5-yl) oxy] -2-chloro-5-methylphenyl} - N-ethyl-N-methylimidoformamide, (15.87) N-methyl-2- (1 - {[5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1 - yl] acetyl} piperidin-4-yl) - N- (1,2,3,4- tetrahydronaphthalen-1-yl) -1,3-thiazol-4-carboxamide (922514-49-6), (15.88) N-methyl- 2- (1 - {[5 -methyl-3- (trifluoromethyl) -1 H-pyrazol-1-yl] acetyl} piperidin-4-yl) -N - [(1 R) - 1,2,3,4-tetrahydronaphthalen-1-yl] - 1,3-thiazol-4-carboxamide (922514-07-6), (15.89) N-methyl-2- (1 - {[5-methyl-3- (trifluoromethyl) - 1 H-pyrazole-1-yl] aceti 1} piperidin-4-yl) - N - [(1 S) - 1,2,3,4-tetrahydronaphthalen-1-yl] -1,3-thiazol-4-carboxamide (922514-485), (15.90) pentyl {6 - [({[(l-methyl-1H -tetrazol-5-yl) (phenyl) methylidene] amino} oxy) methyl] pyridin-2-yl} carbamate, (15.91) phenazine-1-carboxylic acid, (15.92) quinolin-8-ol (134-31 -6 ), (15.93) quinolin-8-ol sulfate (2: 1) (134-31-6) and (15.94) tert-butyl {6- [({[(1-methyl-1 H-tetrazol-5-yl ) (phenyl) methylene] amino} oxy) methyl] pyridin-2-yl} carbamate, and salts thereof.
    [040] Combinations comprising a fungicide selected from the group consisting of fosetyl-Al (39148-24-8), metrafenone (220899-03-6), propamocarb-phosethylate, proquinazid (189278-12-4), N- are particularly preferred methyl-2- (1 - {[5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl] acetyl} piperidin-4-yl) -N - [(1 R) - 1,2,3 , 4-tetrahydronaphthalen-1-yl] - 1,3-thiazol-4-carboxamide (922514-07-6), N-methyl-2- (1 - {[5-methyl-3- (trifluoromethyl) - 1 H - pyrazol- 1-yl] acetyl} piperidin-4-yl) -N- (1,2,3,4-tetrahydronaphthalen-1-yl) - 1,3-thiazole-4-carboxamide (922514-49-6) , 1 - (4- {4- [5- (2,6-difluorophenyl) -4! 5-dihydro-1,2-oxazol-3-yl] - 1,3-thiazol-2-yl} piperidin- 1 -yl) -2- [5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl] ethanone (1003318-67-9) and 2-butoxy-6-iodo-3-propyl-4H-chromen -4- one, and salts of these.
    [041] More particularly, combinations comprising a fungicide selected from the group consisting of fosetyl-A1 (39148-24-8), and salts thereof are preferred.
    [042] Also preferred are combinations comprising a fungicide selected from the group consisting of [Group (16)]: (16.1) 1-methyl-3- (trifluoromethyl) -N- [2 '- (trifluoromethyl) biphenyl-2-yl] - 1 H-pyrazol-4-carboxamide, (16.2) N- (4'-chlorobiphenyl-2-yl) -3- (difluoromethyl) -1-methyl-1 H-pyrazol-4-carboxamide, (16.3) N- (2 ', 4'- dichlorobiphenyl-2-yl) -3- (difluoromethyl) - 1-methyl-1 H-pyrazol-4-carboxamide, (16.4) 3- (difluoromethyl) - 1-methyl-N- [4 '- (trifluoromethyl) biphenyl-2-yl] -1H-pyrazol-4-carboxamide, (16.5) N- (2', 5'- difluorobiphenyl-2-yl) - 1-methyl-3- (trifluoromethyl) -1 H-pyrazol-4-carboxamide, (16.6) 3- (difluoromethyl) - 1-methyl-N- [4 '- (prop- 1 -in- 1-yl) biphenyl-2-yl] - 1 H-pyrazole- 4-carboxamide, (16.7) 5-fluoro-1,3-dimethyl-N- [4 '- (prop- 1 -in-1-yl) biphenyl-2-yl] - 1 H-pyrazol-4-carboxamide, (16.8) 2-chloro-N- [4 '- (prop-1-in-1 - yl) biphenyl-2-yl] pyridine-3-carboxamide, (16.9) 3- (difluoromethyl) -N- [4' - (3,3-dimethylbut- 1 -in- 1-yl) biphenyl-2-yl] - 1-methyl- 1 H-pyrazol-4-carboxamide, (16.10) N- [4 '- (3 , 3-dimethylbut-1-in-1-yl) biphenyl-2-yl] -5-fluoro-1,3-dimethyl-1H-pyrazol-4-carboxamide, (16.11) 3- (difluoromethyl) -N- (4'-ethynylbiphenyl-2-yl) - 1-methyl- 1 H-pyrazole-4-carboxamide, (16.12) N- (4'-ethynylbiphenyl-2-yl) -5-fluoro- 1,3-dimethyl- 1 H-pyrazol-4-carboxamide, (16.13) 2-chloro-N- (4'-ethynylbiphenyl-2-yl) pyridine-3-carboxamide, (16.14) 2-chloro-N- [4 '- (3, 3-dimethylbut- 1 -in-1-yl) biphenyl-2-yl] pyridine-3-carboxamide, (16.15) 4- (difluoromethyl) -2-methyl-N- [4 '- (trifluoromethyl) biphenyl-2- yl] -1,3-thiazol-5-carboxamide, (16.16) 5-fluoro-N- [4 '- (3-hydroxy-3-methylbut- 1 -in-1-yl) biphenyl-2-yl] - 1,3-dimethyl-1 H-pyrazol-4-carboxamide, (16.17) 2-chloro-N- [4 '- (3-hydroxy-3-methylbut- 1 -in-1-yl) biphenyl-2-yl ] pyridine-3-carboxamide, (16.18) 3- (difluoromethyl) - N- [4 '- (3-methoxy-3 - methylbut- 1 -in-1-yl) bipheni 1-2-yl] - 1-methyl - 1 H-pyrazol-4-carboxamide, (16.19) 5-fluoro-N- [4 '- (3-methoxy-3-methylbut-1-in-1-yl) biphenyl-2-yl] -1,3 -dimethyl-1H-pyrazol-4-carboxamide, (16.20) 2-chloro-N- [4 '- (3-methoxy-3 -methylbut- 1-in- 1-yl) biphenyl-2-yl] pyridine-3-carboxamide, (16.21) (5-bromo-2-methoxy-4-methylpyridin-3-yl) (2,3,4- trimethoxy-6-methylphenyl) methanone, (16.22) N- [2- (4- {[3- (4-chlorophenyl) prop-2-in-1-yl] oxy} -3-methoxyphenyl) ethyl] -N2- (methylsulfonyl) valinamide (220706 93-4), (16.23) 4-oxo-4 - [(2-phenylethyl) amino] butanoic acid, (16.24) but-3-in-1 -il {6 - [({[ (Z) - (1 - methyl-1H-tetrazol-5-yl) (phenyl) methylene] amino} oxy) methyl] pyridin-2-yl} carbamate, (16.25) 4-Amino-5-fluopyrimidin-2-ol (mesomer form: 6-Amino-5-fluid irimidin-2 (1 H) -on), (16.26) propyl 3,4,5-trihydroxybenzoate, (16.27) 1,3-dimethyl- N- (1, 1 , 3-trimethyl-2,3-dihydro-1 H-inden-4-yl) - 1 H-pyrazol-4-carboxamide (1051 13-56-2), (16.28) 1,3-dimethyl-N- [ (3R) -1, 1,3-trimethyl-2,3-dihydro-1 H-inden-4-yl] -1 H-pyrazole-4-carboxamide, (16.29) 1,3-dimethyl 1N - [(3 S) - 1,1,3-trimethyl-2,3-dihydro-1 H-inden-4-yl] - 1 H-pyrazol-4-carboxamide, (16.30) [3- (4-chloro-2-fluorophenyl ) -5- (2,4-difluorophenyl) - 1,2-oxazol-4-yl] (pyridin-3-yl) methanol (12296059 6-2), (16.31) (S) - [3- (4-chloro-2-fluorophenyl) -5- (2,4-difluorophenyl) -1,2-oxazol-4-yl] (pyridin-3- il) methanol (1229606-46-5), (16.32) (R) - [3- (4-chloro-2-fluorophenyl) -5- (2,4-difluorophenyl) - 1,2-oxazol-4-yl ] (pyridin-3-yl) methanol (1229606-02-3), (16.33) 2- {[3- (2-chlorophenyl) -2- (2,4-difluorophenyl) oxiran-2-yl] meti} - 2,4-d ihydro-3 H- 1,2,4-triazole-3-thione (1342260-19-8), (16.34) 1 - {[3- (2-chlorophenyl) -2- (2,4 - difluorophenyl) oxiran-2-yl] methyl} -1H-1,2,4-triazol-5-yl thiocyanate (1342260-26-7), (16.35) 5- (allysulfanyl) -l - {[3- ( 2-chlorophenyl) -2- (2,4-difluorophenyl) oxiran-2-yl] methyl} - 1H-1,2,4-triazole (1342260- 41 -6), (16.36) 2-fluoro-6- ( trifluoromethyl) -N- (1, 1,3-trimethyl-2,3-dihydro-1 H-inden-4-yl) benzamide, (16.37) 2-fluoro-6- (trifluoromethyl) - N - [(3R) - 1, 1,3-trimethyl-2,3-dihydro-1 H-inden-4-yl] benzamide and (16.38) 2-fluoro- 6- (trifluoromethyl) -N - [(3S) -1,1, 3-trimethyl-2,3-dihydro-1H-inden-4-yl] benzamide, and salts thereof.
    [043] All indicated mixing pairs of classes (1) to (16) may, if their functional groups so permit, optionally form salts with suitable bases or acids.
    [044] In general component (B) is selected from the compounds mentioned in the L1 list: (1.1) aldimorf (1704-28-5), (1.2) azaconazole (6020731-0), (1.3) bitertanol (55179-31- 2), (1.4) bromuconazole (1 16255-48-2), (1.5) cyproconazole (113096-99-4), (1.6) diclobutrazol (75736-33-3), (1.7) diphenoconazole (119446-68-3 ), (1.8) diniconazole (83657-24-3), (1.9) diniconazole- M (83657-18-5), (1.10) dodemorf (1593-77-7), (1.1 1) dodemorf acetate (3171787-0 ), (1.12) epoxiconazole (106325-08-0), (1.13) etaconazole (60207-93-4), (1.14) fenarimol (60168-88-9), (1.15) fenbuconazole (1 14369-43-6) , (1.16) fenhexamid (126833-17-8), (1.17) fenpropidin (67306-00-7), (1.18) fenpropimorf (67306-03-0), (1.19) fluquinconazole (136426-54-5), ( 1.20) flurprimidol (56425- 91-3), (1.21) flusilazole (85509-19-9), (1.22) flutriafol (76674-21 -0), (1.23) ftirconazole (112839-33-5), (1.24) furconazol-cis (112839-32-4), (1.25) hexaconazole (79983-71 -4), (1.26) imazalyl (60534-80-7), (1.27) imazalyl sulfate (58594-72-2), (1.28 ) im ibenconazole (86598-92-7), (1.29) ipconazole (125225-287), (1.30) metconazole (1251 16-23-6), (1.31) miclobutanil (88671 -89-0), (1.32) naphthifine (65472 -88-0), (1.33) nuarimol (63284-71 -9), (1.34) oxpoconazole (174212-12-5), (1.35) paclobutrazol (76738-62-0), (1.36) pefurazoate (10190330 -4), (1.37) penconazole (66246-88-6), (1.38) piperalin (3478-94-2), (1.39) prochloraz (67747-09-5), (1.40) propiconazole (60207-90-1 ), (1.41) protioconazole (178928-70-6), (1.42) pyributicarb (88678-67-5), (1.43) pyrifenox (88283-41-4), (1.44) quinconazole (103970-75-8), (1.45) simeconazole (149508-90-7), (1.46) spiroxamine (1 18134-30-8), (1.47) tebuconazole (107534-96-3), (1.48) terbinafine (91 161-71-6), (1.49) tetraconazole (112281 -77-3), (1.50) triadimefon (43121-43-3), (1.51) triadimenol (89482-17-7), (1.52) tridemorf (81412-43-3), (1.53 ) triflumizole (68694-1 1 -1), (1.54) triforin (26644-46-2), (1.55) triticonazole (131983- 72-7), (1.56) uniconazole (83657-22-1), (1.57) uniconazole-p (83657-174), (1.58) v initonazole (77174-66- 4), (1.59) voriconazole (137234-62-9), (1.60) 1 - (4-chlorophenyl) -2- (1 H-1,2,4-triazole-1-yl) cycloheptanol (129586-32-9), (1.61) methyl 1 - (2,2-dimethyl-2,3-dihydro-1 H-inden- 1 -yl) -1 H-imidazole-5-carboxylate (11032395-0 ), (1.62) N '- {5- (difluoromethyl) -2-methyl-4- [3- (trimethylsilyl) propoxy] phenyl} -N-ethyl-N-methylimidoformamide, (1.63) N-ethyl-N-methyl -N '- {2-methyl-5- (trifluoromethyl) -4- [3- (trimethylsilyl) - propoxy] phenyl} imidoformed (1.64) 0- [l- (4-methoxyphenoxy) -3,3-dimethylbutan-2 -yl] 1H-imidazole-1-carbothioate (1 1 1226-71-2), (2.1) bixafen (581809-46-3), (2.2) boscalid (188425-85-6), (2.3) carboxin (5234 -68-4), (2.4) diflumetorim (130339-07-0), (2.5) fenfuram (24691-80-3), (2.6) fluopiram (658066-35- 4), (2.7) flutolanil (66332-96 -5), (2.8) fluxpyroxad (907204-31-3), (2.9) ftirametpir (123572-88-3), (2.10) furmeciclox (60568-05-0), (2.11) isopyrazam (mix of racemate syn- epimeric 1 RS, 4SR, 9RS and anti-epimeric racemate 1 RS, 4SR, 9SR) (881685-58-1), (2.12) isopyraz am (anti-epimeric racemate 1 RS, 4SR, 9SR), (2.13) isopirazam (anti-epimeric enantiomer 1 R, 4S, 9S), (2.14) isopirazam (anti-epimeric enantiomer 1 S, 4R, 9R), (2.15 ) isopyrazam (syn-epimeric racemate 1 RS, 4SR, 9RS), (2.16) isopirazam (syn-epimeric enantiomer 1R, 4S, 9R), (2.17) isopirazam (syn-epimeric enantiomer 1 S, 4R, 9S), (2.18 ) mepronil (55814-41-0), (2.19) oxycarboxin (525988-1), (2.20) penflufen (494793-67-8), (2.21) pentiopirad (183675-82-3), (2.22) silkxane (874967 -67-6), (2.23) tifluzamide (130000-40-7), (2.24) 1-methyl-N- [2- (1,1,2,2-tetrafluoroethoxy) phenyl] -3- (trifluoromethyl) - 1 H-pyrazol-4-carboxamide, (2.25) 3- (difluoromethyl) -1-methyl-N- [2- (1, 1,2,2-tetrafluoroethoxy) phenyl] -1 H-pyrazol-4-carboxamide, (2.26) 3- (difluoromethyl) -N- [4-fluoro-2- (1,1,2,3,3,3-hexafluoropropoxy) phenyl] - 1-methyl-1H-pyrazol-4-carboxamide, (2.27 ) N- [1 - (2,4-dichlorophenyl) - 1-methoxypropan-2-yl] -3- (difluoromethyl 1) - 1-methyl-1 H-pyrazole-4-carboxamide (1092400-95-7), (2.28) 5,8-difluoro-N- [2- (2-f luoro-4 - {[4- (trifluoromethyl) pyridin-2-yl] oxy} phenyl) ethyl] quinazolin-4-amine (1210070-84-0), (2.29) benzovindiflupir, (2.30) N - [(l S , 4R) -9- (dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl] -3- (difluoromethyl) -1- metypyrazol-4-carboxamide, (2.31) N- [(1 R, 4S) -9- (dichloromethane) - 1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl] -3- (difluoronnetyl) - 1-methyl- 1 H-pyrazole- 4-carboxamide, (2.32) 3- (Difluormethyl) - 1 - methyl-N- (1, 1,3-trimethyl-2,3-dihydro-1 H-inden-4-yl) -1 H-pyrazol-4 -carboxamide, (2.33) 1,3,5-Trimethyl-N- (1, 1,3-trimethyl-2,3-dihydro-1 H-inden-4-yl) - 1 H-pyrazol-4-carboxamide, (2.34) 1 - Methyl-3- (trifluoromethyl) -N- (1,3,3-trimethyl-2,3-dihydro-1 H-inden-4-yl) -1 H-pyrazol-4-carboxamide, ( 2.35) 1-Methyl-3- (trifluoromethyl) -N - [(1 S) - 1,3,3-trimethyl-2,3-dihydro-1 H-inden-4-yl] - 1 H-pyrazole-4 - carboxamide, (2.36) 1- Methyl-3- (trifluormethyl) -N - [(1R) -1,3,3-trimethyl-2,3-dihydro-1H-inden-4-yl] -1 H-pyrazole -4-carboxamide, (2.37) 3- (Difluormethyl) -1-methyl-N - [(3S) -1, 1,3-trimethyl-2,3- dihydro-1 H-inden-4- i]] - 1 H-pyrazol-4-carboxamide, (2.38) 3- (Difluormethyl) - 1 - methyl-N - [(3R) - 1, 1,3-trimethyl- 2,3-dihydro- 1 H- inden-4-yl] -1 H-pyrazol-4-carboxamide, (2.39) 1,3,5-Trimethyl-N - [(3R) - 1, 1,3-trimethyl -2,3-dihydro- 1 H- inden-4-yl] -1 H-pyrazol-4-carboxamide, (2.40) 1,3,5-Trimethyl-N - [(3S) -1,1,3- trimethyl-2,3-dihydro-1 H-inden-4-yl] -1 H-pyrazol-4-carboxamide, (2.41) benodanil (15310-01-7), (3.1) ametoctradine (865318-97-4) , (3.2) amisulbrom (348635-870), (3.3) azoxystrobin (131860-33-8), (3.4) ciazofamid (1201 16-88-3), (3.5) coumetoxistrobin (850881-30-0), (3.6 ) coumoxystrobin (850881-70-8), (3.7) dimoxystrobin (141600-52- 4), (3.8) enestroburin (238410-1 1-2), (3.9) famoxadone (131807-57-3), (3.10) fenamidone (161326-34-7), (3.1 1) phenoxystrobin (918162-02-4), (3.12) fluoxastrobin (361377-29-9), (3.13) kresoxim-methyl (143390- 89-0), (3.14 ) metominostrobin (133408-50-1), (3.15) orisastrobin (189892-69-1), (3.16) picoxystrobin (117428-22-5), (3.17) pyraclostrobin (17 5013-18-0), (3.18) pirametostrobin (915410-70-7), (3.19) pirao-xistrobin (862588-1 1 -2), (3.20) piribencarb (799247-52-2), (3.21) triclopiricarb (902760-40-1), (3.22) trifloxystrobin (141517-21-7), (3.23) (2E) -2- (2 - {[6- (3-chloro-2-methylphenoxy) -5- fluoropyrimidin-4-yl] oxy} phenyl) -2- (methoxyimino) -N- methylethylamide, (3.24) (2E) -2- (methoxyimino) -N-methyl-2- (2- {[({(l E ) -l- [3- (trifluoromethyl) phenyl] -ethylidene} amino) oxy] methyl} -phenyl) ethanamide, (3.25) (2E) -2- (methoxyimino) -N-methyl-2- {2 - [( E) - ({l - [3- (trifluoromethyl) phenyl] - ethoxy} imino) methyl] phenyl} ethanamide (158169-73-4), (3.26) (2E) -2- {2 - [({[( 1E) - 1 - (3- {[(E) - 1-fluoro-2-phenylethyl] oxy} phenyl) ethylidene] amino} oxy) methyl] phenyl} -2- (methoxyimino) -N- metiletanamide (326896-28 -0), (3.27) (2E) -2- {2 - [({[(2E, 3E) -4- (2,6-dichlorophenyl) but-3-en-2-ylidene] amino} oxy) methyl ] - phenyl} -2- (methoxyimino) -N- methylethylamide, (3.28) 2-chloro-N- (1,1,3-trimethyl-2,3-dihydro-1 H-indent-4-yl) pyridine- 3-carboxamide (119899-14-8), (3.29) 5-methoxy-2-methyl-4- (2 - {[({(1 E) - 1 - [3- (trifluoromethyl) phenyl] ethylidene} amino) oxy] methyl} -phenyl) -2,4-dihydro-3H-1,2,4-triazole-3-one, (3.30) methyl (2E) - 2- {2 - [({cyclopropyl [(4-methoxyphenyl) imino] methyl} sulfanyl) methyl] phenyl} -3-methoxyprop-2-enoate (149601-036), (3.31) N- (3-ethyl-3 , 5,5-trimethylcyclohexyl) -3- (formylamino) -2-hydroxybenzamide (226551-21 -9), (3.32) 2- {2 - [(2,5-dimethylphenoxy) methyl] phenyl} -2-methoxy- N-methylacetamide (173662-97-0), (3.33) (2R) -2- {2 - [(2,5-dimethylphenoxy) methyl] phenyl} -2-methoxy-N-methylacetamide (394657-24-0) , (4.1) benomyl (17804-35-2), (4.2) carbendazim (10605-21 -7), (4.3) chlorphenazole (3574-96-7), (4.4) dietofencarb (87130-20-9), ( 4.5) etaboxam (162650-77-3), (4.6) fluopicolide (2391 10-15-7), (4.7) fuberidazole (3878-19-1), (4.8) pencicuron (66063-05-6), (4.9 ) thiabendazole (148-79-8), (4.10) thiophanate-methyl (23564-05-8), (4.1 1) thiophanate (23564-06-9), (4.12) zoxamide (156052-68-5), ( 4.13) 5-chloro-7- (4-methylpiperidin-1-yl) -6- (2,4,6-trifluorophenyl) [1,2,4] triazolo [1,5-a] pyrimidine (214706- 53-3), (4. 14) 3-chloro-5- (6-chloropyridin-3-yl) -6-methyl-4- (2,4,6-trifluorophenyl) pyridazine (1002756-87-7), (5.1) Bordeaux mixture (8011 -63-0), (5.2) captafol (2425-06-1), (5.3) captan (133-06-2), (5.4) chlorothalonil (1897-45-6), (5.5) copper hydroxide (20427- 592), (5.6) copper naphthenate (1338-02-9), (5.7) copper oxide (1317-39-1), (5.8) copper oxychloride (1332-40-7), (5.9 ) copper sulfate (2+) (7758-98-7), (5.10) diclofluanid (1085-98-9), (5.11) dithianon (3347- 22-6), (5.12) dodine (2439-103), (5.13) dodine-free base, (5.14) ferbam (14484-64-1), (5.15) fluorofolpet (719-96-0), (5.16) folpet (133-07-3), (5.17) guazatin (108173 -90-6), (5.18) guazatin acetate, (5.19) iminoctadine (13516-27-3), (5.20) iminoctadine albesylate (169202-06-6), (5.21) iminoctadine triacetate (57520-17- 9), (5.22) mancobre (53988-93-5), (5.23) mancozeb (8018-01-7), (5.24) maneb (12427-38-2), (5.25) metiram (9006-42-2) , (5.26) zinc (9006-42-2), (5.27) oxin-copper (10380-28-6), (5.28) pr opamidine (104-32-5), (5.29) propineb (12071-83-9), (5.30) sulfur and sulfur preparations including calcium polysulfide (7704-34-9), (5.31) extract (137-26- 8), (5.32) tolylfluanid (731 -27-1), (5.33) zineb (12122-67-7), (5.34) ziram (137-30-4), (5.35) anilazine (101 -05-3) , (6.1) acibenzolar-S-methyl (135158-54-2), (6.2) isotianyl (224049-04-1), (6.3) probenazole (27605-76-1), (6.4) thiadinyl (223580- 51 -6), (6.5) laminarin (900822-4), (7.1) andoprim (23951-85-1), (7.2) blasticidin-S (2079-00-7), (7.3) cyprodinil (121552-61 - 2), (7.4) kasugamycin (6980-18-3), (7.5) kasugamycin hydrochloride (19408-46-9), (7.6) mepanipirim (1 10235-47-7), (7.7) pyrimethanil (531 12-28-0), (7.8) 3- (5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl) quinoline (861647-32-7), (7.9) oxytetracycline (79-57-2), (7.10) streptomycin (57- 92-1), (8.1) fentin acetate (900-95-8), (8.2) fentin chloride (639-58-7), (8.3 ) fentine hydroxide (76-87-9), (8.4) siltiofam (175217-20-6), (9.1) be ntiavalicarb (177406-68-7), (9.2) dimetomorf (1 1048870-5), (9.3) flumorf (21 1867-47-9), (9.4) iprovalicarb (140923-17-7), (9.5) mandipropamid ( 374726-62-2), (9.6) polyoxins (1 1 1 13-80-7), (9.7) polyoxorin (22976-86-9), (9.8) validamycin A (37248-47-8), (9.9) valifenalate (283159-944; 283159-90-0), (9.10) polyoxin B (19396-06-6), (10.1) biphenyl (92-52-4), (10.2) chloroneb (2675-77-6), (10.3) dichloran (99 -30-9), (10.4) edifenfos (17109-49-8), (10.5) etridiazole (2593-15-9), (10.6) iodocarb (55406-53-6), (10.7) iprobenfos (26087-47) -8), (10.8) isoprothiolane (50512-35-1), (10.9) propamocarb (25606-41 -1), (10.10) propamocarb hydrochloride (25606-41-1), (10.1 1) protiocarb (1962208-3 ), (10.12) pyrazophos (13457-18-6), (10.13) quintozene (82-68-8), (10.14) tecnazene (1 17-18-0), (10.15) tolclofos-methyl (57018-04- 9), (11.1) carpropamid (104030-54-8), (1 1.2) diclocimet (139920- 32-4), (11.3) phenoxanil (115852-487), (11.4) phthalide (27355-22-2), (1 1.5) piroquilon (57369-32-1), (1 1.6) tricyclazole (41814-78-2), (11.7) 2,2,2-trifluoroethyl {3-methyl-1 - [(4-methylbenzoyl) amino ] butan-2-yl} carbamate (851524-22-6), (12.1) benalaxyl (71626-1 1 -4), (12.2) benalaxyl-M (kiralaxyl) (98243-83-5), (12.3) bupirimate (41483-43-6), (12.4) clozilacon (67932-85-8), (12.5) dimethyrimol (5221-53- 4), (12.6) etirimol (23947-60-6), (12.7) furalaxil (57646-30-7), (12.8) himexazole (10004-44-1), (12.9) metalaxyl (57837-19-1) , (12.10) metalaxyl-M (mefenoxam) (70630-17-0), (12.1 1) ofurace (58810-48-3), (12.12) oxadixyl (77732-09-3), (12.13) oxolinic acid (1469829-4), (13.1) clozolinate (84332-86-5), (13.2) fenpiclonil (74738-17-3), (13.3) fludioxonil (131341-86-1), (13.4) iprodione (36734-19 -7), (13.5) procymidone (32809-16-8), (13.6) quinoxifen (124495-18-7), (13.7) vinclozolin (50471-44-8), (14.1) binapacril (485-31 -4 ), (14.2) dinocap (131-72-6), (14.3) ferinzone (89269-64-7), (14.4) fluazinam (79622-59-6), (14.5) meptildinocap (131 -72-6), (15.1) bentiazole (21564-17-0), (15.2) betoxazin (163269-30-5), (15.3) capsimicin (70694-08-5), (15.4) carvona (99-49-0), (15.5 ) cinometionat (243901 -2), (15.6) pyrophenone (clazafenone) (688046-61-9), (15.7) cufraneb (1 109618-7), (15.8) ciflufenamid (180409-60-3), (15.9) cimoxanil (57966-95-7), (15.10) cyprosulfamide (221667-31 -8), (15 .1 1) dazomet (533-74-4), (15.12) debacarb (62732-91 -6), (15.13) dichlorophen (97-23-4), (15.14) diclomezine (62865-36-5), ( 15.15) difenzoquat (49866-87-7), (15.16) dipenzoquat methyl sulfate (43222-486), (15.17) diphenylamine (122-39-4), (15.18) ecomato, (15.19) phenpyrazamine (473798-59-3) , (15.20) flumetover (154025-04-4), (15.21) fluoroimide (4120521-4), (15.22) flusulfamide (106917-52-6), (15.23) flutianil (304900-25-2), (15.24) fosetil-aluminum (39148-24-8), (15.25) fosetyl-calcium, (15.26) fosetil-sodium (39148-16-8), (15.27) hexachlorobenzene (1 18-74-1), (15.28) irumamicin (81604-73-1), (15.29) metasulfocarb (66952-49-6), (15.30) methyl isothiocyanate (556-61 -6), (15.31) metrafenone (220899-03-6), (15.32) mildiomycin (6752771 -3), (15.33) natamycin (7681-93-8), (15.34) nickel dimethyldithiocarbamate (15521 -65-0), (15.35) nitrotal-isopropyl (10552-74-6), (15.36) octylinone (2653020-1), (15.37) oxamocarb (917242-12-7), (15.38) oxifentiin (34407-87-9), (15.39) pentachlorophenol es more (87-86-5), (15.40) phenothrin, (15.41) phosphorous acid and its salts (13598-36-2), (15.42) propamocarb-phosethylate, (15.43) propanosine-sodium (88498- 02-6) , (15.44) proquinazid (189278-12-4), (15.45) pyrimorf (868390-90-3), (15.45e) (2E) -3- (4-tert-butylphenyl) -3- (2-chloropyridin- 4-yl) -1 - (mo holin-4-yl) prop-2-en-1-one (1231776-28-5), (15.45z) (2Z) -3- (4-tert-butylphenyl) - 3- (2-chloropyridin-4-yl) - 1 - (morphoin-4-yl) prop-2-en- 1-one (1231776-296), (15.46) pyrrolnitrin (1018-71 -9), (15.47 ) tebufloquin (376645-78-2), (15.48) keyboard software (76280-91-6), (15.49) tolnifanide (304911-98-6), (15.50) triazoxide (72459-58-6), (15.51) triclamide (70193-21 -4), (15.52) zarilamid (84527-51 -5), (15.53) (3S, 6S, 7R, 8R) -8-benzyl-3 - [({3 - [(isobutyryloxy) methoxy]] -4- methoxypyridin-2-yl} carbonyl) amino] -6-methyl-4,9-dioxo-1,5-dioxonan-7-yl 2-methylpropanoate (517875- 34-2), (15.54) l - ( 4- {4 - [(5R) -5- (2,6-difluorophenyl) -4,5-dihydro-1,2-oxazol-3-yl] -1,3-thiazol-2-yl} piperidi 1- yl) -2- [5-methyl-3- (trifluoromethyl) -1 H- pyrazol-1-yl] ethanone (1003319-79-6), (15.55) 1- (4- {4 - [(5S) -5- (2,6-difluorophenyl) -4,5-dihydro-1,2 - oxazol-3-yl] -1,3-thiazoI-2-yl} piperidin-1-yl) -2- [5-methyl-3- (trifluoromethyl) -1 H-pyrazol-1-yl] ethanone (1003319 -80-9), (15.56) 1- (4- {4- [5- (2,6-difluorophenyl) -4,5-dihydro-1,2-oxazol-3-yl] - 1,3-thiazole -2-yl} piperidin-1-yl) -2- [5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl] ethanone (1003318-67-9), (15.57) 1 - (4 -methoxyphenoxy) -3,3-dimethylbutan-2-yl 1 H-imidazol-1 - carboxylate (11 1227-17-9), (15.58) 2,3,5,6-tetrachloro-4- (methylsulfonyl) pyridine ( 13108-52-6), (15.59) 2,3-dibutyl-6-chlorothieno [2,3-d] pyrimidin-4 (3H) -one (221451-58-7), (15.60) 2,6-dimethyl -1 H, 5H- [1,4] dithino [2,3-c: 5,6-c '] dipyrrol- 1,3,5,7 (2H, 6H) -tetrone, (15.61) 2- [5 -methyl-3- (trifluoromethyl) - 1 H-pyrazol- 1-yl] - 1 - (4- {4 - [(5R) -5-pheni 1-4,5-dihydro- 1,2-oxazole- 3 -yl] - 1,3-thiazol-2-yl} piperidin-1-yl) ethanone (1003316-53-7), (15.62) 2- [5-methyl- 3- (trifluoromethyl) - 1 H-pyrazole- 1 -il] - 1 - (4- {4 - [(5 S) -5-phenyl-4,5-dih idro-1,2-oxazol-3-yl] -1, 3-thiazol-2-yl} piperidin-1-yl) ethanone (1003316-54-8), (15.63) 2- [5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl] - 1 - {4- [4- (5-phenyl-4,5-dihydro-1,2-oxazol-3-yl) - 1,3-thiazole- 2-yl] piperidin-1-yl} ethanone (1003316-51-5), (15.64) 2-butoxy-6-iodo-3-propyl-4H-chromen-4-one, (15.65) 2-chloro-5 - [2-chloro-1 - (2,6-difluoro-4-methoxyphenyl) -4-methyl-1 H-imidazol-5-yl] pyridine, (15.66) 2-phenylphenol and salts (90-437), ( 15.67) 3- (4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl) quinoline (861647-85-0), (15.68) 3) 4,5-trichloropyridine-2 , 6-dicarbonitrile (17824-85-0), (15.69) 3- [5- (4-chlorophenyl) -2,3-dimethyl-1,2-oxazolidin-3-yl] pyridine, (15.70) 3-chlorine - 5- (4-chlorophenyl) -4- (2,6-difluorophenyl) -6-methylpyridazine, (15.71) 4- (4-chlorophenyl) -5- (2,6-difluorophenyl) -3,6-dimethylpyridazine, (15.72) 5-amino-1,3,4-thiadiazole-2-thiol, (15.73) 5-chloro-N'-phenyl-N '- (prop-2-in-1-yl) thiophene-2-suIfonohydrazide (134-31 -6), (15.74) 5-fluoro-2 - [(4-fluorobenzyl) oxy] pyrimidin-4-amine (1,174376 -1 1-4), (15.75) 5-fluoro-2 - [(4-methylbenzyl) oxy] pyrimidin-4-amine (1 174376-25-0), (15.76) 5-methyl-6-octyl [1 , 2,4] ethyl triazolo [1,5-a] pyrimidin-7-amine, (15.77) (2Z) -3-amino-2-cyano-3-pheniIprop-2-enoate, (15.78) N'- (4 - {[3- (4-chlorobenzyl)-1,2,4-thiadiazol-5-yl] oxy} -2,5-dimethylphenyl) -N-ethyl-N-methylimidoformamide, (15.79) N- (4 -chlorobenzyl) - 3- [3-methoxy-4- (prop-2-in-1-yloxy) phenyl] propanamide, (15.80) N - [(4-chlorophenyl) (cyano) methyl] -3- [3- methoxy-4- (prop-2-in-1-yloxy) phenyl] propanamide, (15.81) N - [(5-bromo-3-chloropyridin-2-yl) methyl] -2,4-dichloropyridine-3-carboxamide , (15.82) N- [1- (5-bromo-3-chloropyridin-2-yl) ethyl] -2,4-dichloropyridine-3-carboxamide, (15.83) N- [l- (5-bromo-3- chloropyridin-2-yl) ethyl] -2-fluoro-4-iodopyridine-3-carboxamide, (15.84) N - {(E) - [(cyclopropylmethoxy) imino] [6- (difluoromethoxy) -2,3-difluorophenyl] methyl} -2-phenylacetamide (221201-92-9), (15.85) N - {(Z) - [(cyclopropylmethoxy) imino] [6- (difluoromethoxy) -2,3-difluorophenyl] methyl} -2-phenylacetamide ( 221201-92-9), (15.86) N '- {4- [(3-tert-butyl-4-cyano-1,2-thiazol-5-yl) oxy] -2-chloro-5-methylphenyl} -N-ethyl-N-methylimidoformamide, (15.87) N-methyl-2 - (l - {[5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl] acetyl} piperidin-4-yl) -N- (1,2,3,4-tetrahydronaphthalen-1-yl ) - 1,3-thiazole-4-carboxamide (922514-49-6), (15.88) N-methyl-2- (1 - {[5-methyl-3- (trifluoromethyl) -1 H-pyrazol-l- yl] acetyl} piperidin-4-yl) -N - [(1 R) - 1,2,3,4-te1rahydronaphthalen-1-yl] -1, 3-thiazol-4-carboxamide (922514-07-6) , (15.89) N-methyl 1-2- (1 - {[5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl] acetyl 1} piperidin-4-yl) -N - [(l S) -1, 2,3,4-tetrahydronaphthalen-1-yl] -1, 3-thiazol-4-carboxamide (922514-48-5), (15.90) pentyl {6 - [({[(1 -methyl) -1 H-tetrazol-5-yl) (phenyl) methylidene] amino} oxy) methyl] pyridin-2-yl} carbamate, (15.91) phenazine-1-carboxylic acid, (15.92) quinolin-8-ol (134- 31-6), (15.93) quinolin-8-ol sulfate (2: 1) (134-31 - 6), (15.94) tert-butyl {6 - [({[(1-methyl-1 H-tetrazole- 5- yl) (phenyl) methylene] amino} oxy) methyl] pyridin-2-yl} carbamate, (16.1) 1-methyl -3- (trifluoromethyl) -N- [2 '- (trifluoromethyl) biphenyl-2-yl] - 1 H-pyrazol-4-carboxamide, (16.2) N- (4'-chlorobiphenyl-2-yl) -3- (difluoromethyl) - 1-methyl-1 H-pyrazol-4-carboxamide, (16.3) N- (2 ', 4'-dichlorobiphenyl-2-yl) -3- (difluoromethyl) -1-methyl-1 H-pyrazol -4- carboxamide, (16.4) 3- (difluoromethyl) - 1-methyl-N- [4 '- (trifluoromethyl) biphenyl-2-yl] - 1 H-pyrazol-4-carboxamide, (16.5) N- (2 ,, 5'-difluorobiphenyl-2-yl) -l-methyl-3- (trifluoromethyl) -l H-pyrazol-4-carboxamide, (16.6) 3- (difluoromethyl) - 1-methyl-N- [4'- (prop-1-in-1-yl) biphenyl-2-yl] - 1 H-pyrazol-4-carboxamide, (16.7) 5- fluoro-1,3-dimethyl- N- [4 '- (prop-l -in-1-yl) biphenyl-2-yl] -1 H-pyrazol-4-carboxamide, (16.8) 2-chloro-N- [4'- (prop-1-in-1-yl) biphenyl-2 -yl] pyridine-3-carboxamide, (16.9) 3- (difluoromethyl) -N- [4'- (3,3-dimethyl Ibut- 1 -in- 1 -yl) biphenyl-2-yl] - 1-methyl - 1 H-pyrazol-4-carboxamide, (16.10) N- [4 '- (3,3-dimethylbut-1-in-1-yl) biphenyl-2-yl] -5-fluoro 1,3-dimethyl- 1 H-pyrazol-4-carboxamide, (16.1 1) 3- (difluoromethyl) -N- (4'-ethynylbiphenyl -2-yl) -1-methyl-1 H-pyrazol-4-carboxamide, (16.12) N- (4'-ethinylbiphenyl-2-yl) -5-fluoro-1,3-dimethyl-1 H-pyrazol- 4-carboxamide, (16.13) 2-chloro-N- (4'-ethynylbiphenyl-2-yl) pyridine-3-carboxamide, (16.14) 2-chloro-N- [4 '- (3,3-dimethylbut- 1 -in- 1-yl) biphenyl-2-yl] pyridine-3-carboxamide, (16.15) 4- (difluoromethyl) -2-methyl-N- [4 '- (trifluoromethyl) biphenyl-2-yl] - 1, 3-thiazol-5-carboxamide, (16.16) 5-fluoro-N- [4 '- (3-hydroxy-3-methylbut- 1 -in-1-yl) biphenyl-2-yl] - 1,3-dimethyl - 1 H-pyrazol-4-carboxamide, (16.17) 2-chloro-N- [4 '- (3-hydroxy-3-methylbut- 1-in-1 - yl) biphenyl-2-yl] pyridine-3- carboxamide, (16.18) 3- (difluoromethyl) -N- [4 '- (3-methoxy-3-methylbut- 1 -in- 1 -yl) biphenyl-2-yl] - 1-methyl- 1 H-pyrazole- 4-carboxamide, (16.19) 5-fluoro-N- [4 '- (3-methoxy-3-methylbut-1-in-1-yl) biphenyl-2-yl] -1, 3-dimethyl-1 H- pyrazol-4-carboxamide, (16.20) 2-chloro-N- [4 '- (3-methoxy-3-methylbut- 1 -in- 1 -yl) biphenyl-2-yl] pyridine-3-carboxamide, (16.21 ) (5-bromo-2-methoxy-4-methylpyridin-3-i) (2,3,4-trimethoxy-6-methylphenyl) methanone, (16.22) N- [2- (4 - {[3- (4-chlorophenyl) prop-2-in-1-yl] oxy} -3-methoxyphenyl) ethyl] -N2- (methylsulfonyl) valinamide (220706 -93-4), (16.23) 4-oxo-4 - [(2-phenylethyl) amino] butanoic acid, (16.24) but-3-in-l-yl {6 - [({[(Z) - ( 1-methyl- 1 H-tetrazol-5-yl) (phenyl) methylene] amino} oxy) methyl] pyridin-2-yl} carbamate, (16.25) 4- Amino-5-fluid irimidin-2-ol (mesomere Form : 6-Amino-5-fluid irimidin-2 (1 H) -on), (16.26) propyl 3,4,5-trihydroxybenzoate, (16.27) 1,3-dimethyl-N- (1, 1,3-trimethyl -2,3- dihydro- 1 H-inden-4-yl) - 1 H-pyrazol-4-carboxamide (1051 13-56-2), (16.28) 1,3-dimethyl-N - [(3R) - 1,3-trimethyl-2,3-dihydro-1 H-inden-4-yl] -1 H-pyrazol-4-carboxamide, (16.29) 1,3-dimethyl-N - [(3S) - 1 , 1,3-trimethyl-2,3-dihydro-1 H-inden-4-yl] - 1 H-pyrazol-4-carboxamide, (16.30) [3- (4-chloro-2-fluorophenyl) -5- (2,4-difluorophenyl) -1, 2-oxazol-4-yl] (pyridin-3-yl) methanol (1229605-96-2), (16.31) (S) - [3- (4-chloro-2 - fluorophenyl) -5- (2,4-difluorophenyl) - 1,2-oxazol-4-yl] (pyridin-3-yl) methanol (1229606-465), (16.32) (R) - [3- (4 -chlorine- 2-fluorophenyl) -5- (2,4-difluorophenyl) - 1,2-oxazol-4-yl] (pyridin-3-yl) methanol (1229606-02-3), (16.33) 2 - {[3- (2-chlorophenyl) -2- (2,4-difluorophenyl) oxiran-2-yl] methyl} -2,4-dihydro-3H- 1,2,4-triazole-3-thione (1342260-198), ( 16.34) 1 - {[3- (2-chlorophenyl) -2- (2,4-difluorophenyl) oxiran-2-yl] methyl} -1 Hl, 2,4-triazol-5-yl thiocyanate (1342260-26- 7), (16.35) 5- (allylsulfanyl) -l - {[3- (2-chlorophenyl) - 2- (2,4-difluorophenyl) oxiran-2-yl] methyl} - 1 H- 1,2,4 -triazole (1342260-41 -6), (16.36) 2-fluoro-6- (trifluoro-methyl) -N- (1, 1,3-trimethyl-2,3-dihydro-1 H-inden-4-yl ) benzamide, (16.37) 2-fluoro-6- (trifluoromethyl) -N- [(3R) -1,3-trimethyl-2,3-dihydro-1 H-inden-4-yl] benzamide and (16.38 ) 2-fluoro-6- (trifluoromethyl) -N - [(3S) - 1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl] benzamide, and salts thereof. Component (B) is preferably selected from the compounds mentioned in List L2: cyproconazole (1 13096-99-4), diphenoconazole (1 19446-68-3), epoxiconazole (106325-08-0), fenhexamid (126833-17 -8), fenpropidin (67306-00-7), iεnpropfπio ^ li (67306-03-0), fluquinconazole (136426-54-5), hexaconazole (79983-71-4), ipconazole (125225-28- 7), metconazole (1251 16-23-6), myclobutanil (88671-89-0), prochloraz (67747-09-5), propiconazole (60207-90-1), protioconazole (178928-70-6), spiroxamine (1 18134-30-8), tebuconazole (107534-96-3), tetraconazole (1 12281-77-3), triadimenol (89482-17-7), bixafen (581809- 46-03), boscalid (188425- 85-6), fluopyram (658066-35-4), flutolanil (66332-96-5), isopirazam (mixture of sin-epimeric racemate 1 RS, 4SR, 9RS and anti-epimeric racemate 1 RS, 4SR, 9SR) ( 88165-58-1), isopirazam (syn-epimeric racemate 1 RS, 4SR, 9RS), isopirazam (syn-epimeric enantiomer 1 R, 4S, 9R), isopirazam (syn-epimeric enantiomer 1 S, 4R, 9S), isopirazam (anti-epimeric racemate 1 RS, 4SR, 9S R), isopirazam (anti-epimeric enantiomer 1 R, 4S, 9S), isopirazam (anti-epimeric enantiomer 1 S, 4R, 9R), penflufen (494793-67-8), pentiopirad (183675-82-3), silkxane (874967-67-6), 3- (difluoromethyl) -1-methyl-N- [2- (1,1, 2,2-tetrafluoroethoxy) phenyl] - 1 H-pyrazol-4-carboxamide, 3- (difluoromethyl ) -N- [4-fluoro-2- (1,1,2,3,3,3-hexa-fluoropropoxy) phenyl] -1-methyl-1 H-pyrazol-4-carboxamide, fluxpyroxad (90720431-3) , benzovindiflupir, N- [1 - (2,4-dichlorophenyl) - 1-methoxypropan-2-yl] -3- (difluoromethyl) - 1-methyl-1 H-pyrazol-4-carboxamide, ametoctradin (865318-974) , amisulbrom (348635-87-0), azoxystrobin (131860-33-8), ciazofamid (1201 16-88-3), dimoxystrobin (141600-52-4), enestroburin (238410-1 1-2), fenamidone ( 161326-34-7), fluoxastrobin (361377-29-9), kresoxim-methyl (143390-89-0), metominostrobin (133408- 50-1), orisastrobin (189892-69-1), picoxistrobin (1 17428- 22-5), pyraclostrobin (175013-18-0), trifloxystrobin (141517-21 -7), pencicuron (66063-05-6), thiophanate-methyl (23564-05-8), f luopicolide (2391 10-15-7), thiophanate (23564-06-9), Bordeaux mixture (801 1 -63-0), chlorothalonil (1897-45-6), dithionon (3347-22-6) , dodine (2439-10-3), folpet (133-07-3), guazatin, copper oxide (1317-39-1), copper oxichloride (1332-40-7), copper hydroxide (20427- 59-2), copper sulfate (7758-98-7), mancozeb (8018-01-7), maneb (12427-38-2), copper oxin (10380-28-6), propineb (12071 -83) -9), sulfur and sulfur preparations including calcium polysulfide, extract (137-26-8), copper naphthenate (1338-02-9), isothianyl (22404904-1), cyprodinil (121552-61 -2 ), pyrimethanil (53 1 12-28-0), bentiavalicarb (177406-68-7), dimetomorf (1 10488-70-5), iprovalicarb (140923-17-7), mandipropamid (374726-62-2), propamocarb (25606-41 -1), propamocarb-hydrochloride (25606-41-1), tricyclazole (41814-78-2), benalaxyl (71626-1 1-4), benalaxyl-M (kiralaxil) (98243-83- 5), metalaxyl (57837-19-1), metalaxyl-M (mefenoxam) (70630-17-0), fludioxonil (131341-86-1), iprodione (36734-19-7), vinclozolin (5047 1 -44-8), fluazinam (79622-59-6), meptildinocap (131 -72-6), fosetyl-AI (39148-24-8), metrafenone (220899-03-6), propamocarb-phosetylate, proquinazid (189278-12-4), N-methyl-2- (l - {[5-methyl-3- (trifluorom tetrahydronaphthalen-1-yl] - 1,3-thiazol-4-carboxamide (922514-07-6) , N-methyl-2- (l - {[5-methyl-3- (trifluoromethyl) - 1 H-pyrazol-1-yl] acetyl} piperidin-4-yl) -N- (1,2,3,4 - tetrahydronaphthalen-1-yl) - 1,3-thiazole-4-carboxamide (922514-49-6), 1 - (4- {4- [5- (2,6-difluorophenyl) -4,5-dihydro- 1,2-oxazol-3-yl] -1,3-thiazol-2-yl} piperidin-1-yl) -2- [5-methyl-3- (trifluoromethyl) -1 H-pyrazol-1-yl] ethanone (1003318-67-9) and 2-butoxy-6-iodo-3-propyl-4H-chromen-4-one, N '- (4 - {[3- (4-chlorobenzyl) -1,2,4 -thiadiazol-5-yl] oxy} -2,5-dimethylphenyl) -N- ethyl-N-methylimidoformamide and salts thereof. Component (B) is most preferably selected from the compounds mentioned in the L3 list: cyproconazole (113096-99-4), epoxiconazole (106325-08-0), fenhexamid (12683317-8), metconazole (1251 16-23-6), propiconazole (60207-90-1), protioconazole (178928-70-6), spiroxamine (118134-30-8), tebuconazole (107534-96-3), bixafen (581809-46-03), fluopiram (658066-35 -4), isopirazam (mixture of 1 RS, 4SR, 9RS syn-epimeric racemate and 1 RS, 4SR, 9SR anti-epimeric racemate) (8816558-1), isopirazam (1 RS, 4SR, 9RS syn-epimeric racemate), isopirazam (1 R, 4S, 9R sin-epimeric enantiomer), isopirazam (1 S, 4R, 9S sin-epimeric enantiomer), isopirazam (1 RS, 4SR, 9SR anti-epimeric racemate), isopirazam (1 R-epimeric enantiomer) , 4S, 9S), isopirazam (1 S, 4R, 9R anti-epimeric enantiomer), penflufen (494793-67-8), pentiopirad (183675-82-3), silkxane (874967-67-6), fluxapiroxad (907204 -31 -3), benzovindiflupir, N- [1 - (2,4-dichlorophenyl) - 1-methoxypropan-2-yl] -3- (difluoromethyl) - 1-methyl- 1 H-pyrazole-4-carboxam ida, ametoctradin (865318-97-4), azoxystrobin (131860-33-8), fluoxastrobin (361377-29-9), pyraclostrobin (175013-18-18), trifloxystrobin (141517-21-7), fluopicolide (239110 -15-7), chlorothalonil (1897-45-6), folpet (13307-3), mancozeb (8018-01 -7), propineb (12071-83-9), isothianyl (224049-04-1), pyrimethanil (53 1 12-28-0), iprovalicarb (140923-17-7), propamocarb (25606-41 - 1), metalaxyl (57837-19-1), metalaxyl-M (mefenoxam) (70630-17-0) , fludioxonil (131341 -86-1) and fosetyl-Al (39148-24-8), N '- (4 - {[3- (4-chlorobenzyl) -yl, 2,4-thiadiazol-5-yl] oxy } -2,5-dimethylphenyl) -N-ethyl-N-methylimidoformamide and salts thereof. In a preferred embodiment, this invention relates to mixtures comprising compound A1 as the compound of formula (I) and a compound selected from the compounds listed in list L1, list List L2 or list L3. In a preferred embodiment, this invention relates to the mixture comprising compound A2 as the compound of formula (I) and a compound selected from the compounds listed in list L1, list L2 or list L3. In a preferred embodiment, this invention relates to mixtures comprising compound A3 as the compound of formula (I) and a compound selected from the compounds listed in list L1, list L2 or list L3.
    [045] In a preferred embodiment this invention relates to compound A4 as the compound of the formula (I) and a compound selected from the compounds listed in list L1, list L2 or list L3. In a preferred embodiment, this invention relates to mixtures comprising compound A5 as the compound of formula (I) and a compound selected from the compounds listed in list L1, list L2 or list L3. In a preferred embodiment this invention relates to the mixture comprising compound A6 as the compound of the formula (I) and a compound selected from the compounds listed in list L1, list L2 or list L3. In a preferred embodiment, this invention relates to mixtures comprising compound A7 as the compound of formula (I) and a compound selected from the compounds listed in list L 1, list L2 or list L3. In a preferred embodiment this invention relates to mixtures comprising compound A8 as the compound of formula (I) and a compound selected from the compounds listed in the list listed in the list L1, in the list L2 or in the list L3. In a preferred embodiment, this invention relates to mixtures comprising compound A9 as the compound of formula (I) and a compound selected from the compounds listed in list L1, list L2 or list L3. In a preferred embodiment this invention relates to mixtures comprising compound A 10 as the compound of formula (I) and a compound selected from the compounds listed on the L1 list, the L2 list or the L3 list.
    [046] In a preferred embodiment this invention relates to mixtures comprising the compound A1 as the compound of the formula (I) and a compound selected from the compounds listed on the L1 list, the L2 list or the L3 list.
    [047] In a preferred embodiment this invention relates to mixtures comprising compound A 12 as the compound of formula (I) and a compound selected from the compounds listed on the L1 list, the L2 list or the L3 list.
    [048] In a preferred embodiment this invention relates to mixtures comprising compound A 13 as the compound of formula (I) and a compound selected from the compounds listed on the L1 list, the L2 list or the L3 list.
    [049] In a preferred embodiment this invention relates to mixtures comprising compound A14 as the compound of formula (I) and a compound selected from the compounds listed on the L1 list, the L2 list or the L3 list.
    [050] In a preferred embodiment this invention relates to mixtures comprising compound A15 as the compound of formula (I) and a compound selected from the compounds listed on the L1 list, the L2 list or the L3 list.
    [051] In a preferred embodiment this invention relates to mixtures comprising compound A 16 as the compound of formula (I) and a compound selected from the compounds listed on the L1 list, the L2 list or the L3 list.
    [052] In a preferred embodiment this invention relates to mixtures comprising compound A 17 as the compound of formula (I) and a compound selected from the compounds listed on the L1 list, the L2 list or the L3 list.
    [053] In a preferred embodiment this invention relates to mixtures comprising compound A 18 as the compound of formula (I) and a compound selected from the compounds listed on the L1 list, the L2 list or the L3 list.
    [054] In a preferred embodiment this invention relates to mixtures comprising compound A 19 as the compound of formula (I) and a compound selected from the compounds listed on the L1 list, the L2 list or the L3 list.
    [055] In a preferred embodiment this invention relates to mixtures comprising compound A20 as the compound of formula (I) and a compound selected from the compounds listed on the L1 list, the L2 list or the L3 list.
    [056] In a particular embodiment, this invention relates to mixtures consisting of a compound selected from the list consisting of A1, A2, A3, A4, A5, A6, A7, A8, A9, A10, A11, A12, A 13, A14, A 15, A 16, A 17, A 18, A 19, and A20, and a compound selected from the compounds listed in list L1, list L2 or list L3.
    [057] If only active compounds in the active compound combinations according to the invention are present in certain weight ratios, the synergistic effect will be particularly pronounced. However, the weight ratios of the active compounds in the active compound combinations can be varied within a relatively wide range.
    [058] In the combinations according to the invention, compounds (A) and (B) are present in a synergistically effective weight ratio of A: B in a range of 1000: 1 to 1: 1000, preferably in a ratio of weight from 100: 1 to 1: 100, more preferably at a weight ratio of 50: 1 to 1: 50, even more preferably at a weight ratio of 20: 1 to 1: 20. Other A: B ratios that can be used according to the present invention with increasing preference in the order indicated are: 95: 1 to 1: 95, 90: 1 to 1: 90, 85: 1 to 1: 85, 80: 1 to 1: 80, 75: 1 to 1: 75, 70: 1 to 1: 70, 65: 1 to 1: 65, 60: 1 to 1: 60, 55: 1 to 1: 55, 45: 1 to 1: 45, 40: 1 to 1: 40, 35: 1 to 1: 35, 30: 1 to 1: 30, 25: 1 to 1: 25, 15: 1 to 1: 15, 10: 1 to 1: 10, 5: 1 to 1: 5, 4: 1 to 1: 4, 3: 1 to 1: 3, 2: 1 to 1: 2.
    [059] Where a compound (A) or a compound (B) may be present in tautomeric form, such a compound will be considered here above and here below as including, if applicable, corresponding tautomeric forms, even when not specifically mentioned in each case.
    [060] Compounds (A) or compounds (B) with at least one basic center can form, for example, acid addition salts, for example with strong inorganic acids, such as mineral acids, for example perchloric acid, sulfuric acid, acid nitric, nitrous acid, a phosphoric acid or a hydrohalic acid with strongly organic carboxylic acids such as unsubstituted or substituted, for example halo-substituted C1-C4-alkanecarboxylic acids, for example acetic acid, saturated or unsaturated dicarboxylic acids, for example oxalic, malonic, suscinic, maleic, fumaric and phthalic, hydroxycarboxylic acids, for example ascorbic, lactic, malic, tartaric and citric acid, or benzoic acid, or with sulfonic acids such as unsubstituted or substituted acids, for example C1-C4-alkane- or halo-substituted arylsulfonics, for example methane- or p-toluenesulfonic acid. Compounds (A) or compounds (B) with at least one acid group can form, for example, salts with bases, for example metal salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium or salts with ammonia or an organic amine such as morpholine, piperidine, pyrrolidine, a short chain mono-, di- or tri-alkylamine, for example ethyl-, diethyl-, triethyl- or dimethyl-propylamine, or a short chain mono-, di- or trihydroxyalkylamine, for example mono-, di- or tri-ethanolamine. In addition, corresponding internal salts can optionally be formed. In the context of the invention, agrochemically advantageous salts are preferred. In view of the close relationship between compounds (A) or compounds (B) in free form and in the form of their salts, here above or below any reference to free compounds (A) or free compounds (B) or their salts it should be understood as including also the corresponding salts or free compounds (A) or free compounds (B), respectively, where appropriate and necessary. The same applies to tautomers of compounds (A) or compounds (B) and their salts. According to the invention, the expression "combination" represents the various combinations of compounds (A) and (B), for example, in a simple "mixed-ready" form, in a combined spray mixture composed of simple active compounds, such as a "tank mix", and in a combined use of the simple active substances when applied sequentially, ie one after the other with a relatively short period such as a few hours or days. Preferably the order of application of compounds (A) and (B) is not essential for the realization of the present invention.
    [061] The present invention also relates to compositions for combating / controlling unwanted microorganisms comprising combinations of active compound according to the invention. Preferably, the compositions are fungicidal compositions comprising agriculturally suitable auxiliaries, solvents, carriers, surfactants or extenders.
    [062] In addition, the invention refers to a method of combating unwanted microorganisms, characterized by the fact that the combinations of active compound according to the invention are applied to phytopathogenic fungi and / or their habitat.
    [063] According to the invention, a carrier is understood to mean a natural or synthetic, organic or inorganic substance that is mixed or combined with the active compounds for better applicability, particularly for application to plants or parts of plants or seeds. The carrier, which can be solid or liquid, is generally inert and must be suitable for use in agriculture.
    [064] Solid or liquid carriers are: for example, ammonium salts and natural soil minerals, such as kaolines, kaolins, clays, talc, chalk, quartz, atapulgite, montmorillonite or diatomaceous earth minerals, and ground synthetic minerals, such as finely divided silica, alumina and synthetic or natural silicates, resins, waxes, solid fertilizers, water, alcohols, especially butanol, organic solvents, mineral oils and vegetable oils and also derivatives thereof. It is also possible to use mixtures of such carriers. Solid carriers suitable for granules are: for example, crushed and fractionated natural minerals such as calcite, calcite, marble, pumice, sepiolite and dolomite, as well as synthetic granules of inorganic or organic flours, and granules of organic material, such as sawdust , coconut shells, grain cobs and tobacco stalks.
    [065] Properly liquefied gas carriers or carriers are liquids that are gaseous at room temperature and under atmospheric pressure, for example aerosol propellants, such as butane, propane, nitrogen and carbon dioxide.
    [066] Thickeners, such as carboxymethylcellulose and natural and synthetic polymers in the form of powders, granules and latex, such as gum arabic, polyvinyl alcohol, polyvinyl acetate, or natural phospholipids such as cephalins and lecithins and synthetic phospholipids can be used in formulations. Other possible additives are mineral and vegetable oils and waxes, optionally modified.
    [067] If the extender used is water, it is also possible to use, for example, organic solvents as auxiliary solvents. Suitable liquid solvents are essentially: aromatic compounds, such as xylene, toluene or alkylnaphthalenes, chlorinated aromatic compounds or chlorinated aliphatic hydrocarbons, such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons, such as cyclohexane or paraffins, for example mineral oil fractions , alcohols, such as butanol or glycol, and also ethers and esters thereof, ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents, such as dimethylformamide and dimethyl sulfoxide, and also water.
    [068] The compositions according to the invention can comprise other additional components such as, for example, surfactants. Suitable surfactants are emulsifiers, dispersants or wetting agents with ionic or non-ionic properties or mixtures of these surfactants. Examples of these are salts of polyacrylic acid, salts of lignosulfonic acid, salts of phenolsulfonic acid or naphthalenesulfonic acid, polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines, substituted phenols (preferably alkylphenols or arylphenols), ester salts sulfosuccinic, derivatives of taurine (preferably alkyl taurates), phosphoric esters of polyethoxylated alcohols or phenols, fatty esters of polyols and derivatives of compounds containing sulfates, sulfonates and phosphates. The presence of a surfactant is necessary if one of the active compounds and / or one of the inert carriers is insoluble in water and if the application is made in water. The proportion of surfactants is between 5 and 40 weight percent of the composition according to the invention.
    [069] It is possible to use colorants such as inorganic pigments, for example, iron oxide, titanium oxide, Prussian blue and organic paints, such as alizarin dyes, azo dyes and metallic phthalocyanine dyes and trace nutrients such as salts iron, manganese, boron, copper, cobalt, molybdenum and zinc.
    [070] If appropriate, other additional components may also be present, for example protective colloids, binders, adhesives, thickeners, thixotropic substances, penetrants, stabilizers, sequestering agents, complexing agents. In general, the active compounds can be combined with any solid or liquid additive normally used for formulation purposes.
    [071] In general, the compositions according to the invention comprise between 0.05 and 99 weight percent, 0.01 and 98 weight percent, preferably between 0.1 and 95 weight percent, particularly preferably between 0.5 and 90 weight percent of the composition active compound according to the invention, most preferably between 10 and 70 weight percent.
    [072] The combinations of active compound or compositions according to the invention can be used as or, depending on their respective physical and / or chemical properties in the form of their formulations or the forms of use prepared from them such as aerosols, capsule suspensions, cold fogging concentrates, hot fogging concentrates, encapsulated granules, fine granules, drainable concentrates for seed treatment, ready-to-use solutions, dustable powders, emulsifiable concentrates, oil-in-water emulsions, water-in-oil emulsions, macrogranules, oil-dispersible powders, oil-miscible flowable concentrates, oil-miscible liquids, foams, pastes, pesticide-coated seed, suspension concentrates, suspoemulsion concentrates, soluble concentrates, suspensions, wettable powders, soluble powders, powders and granules, water-soluble or compressed granules, water-soluble powders for seed treatment, wettable powders, natural products and substances synthetic substances in the impregnated with active compound, as well as microencapsulations in polymeric substances and in seed coating materials, as well as formulations of cold nebulization and ULV hot nebulization.
    [073] The mentioned formulations can be prepared in a manner known per se, for example, by mixing the active compounds or combinations of active compound with at least one additive. Suitable additives are all conventional formulation aids such as, for example, organic solvents, extenders, solvents or diluents, solid carriers and fillers, surfactants (such as adjuvants, emulsifiers, dispersants, protective colloids, wetting and thickening agents), dispersants and / or binders or fixatives, preservatives, dyes and pigments, defoamers, organic and inorganic thickeners, water repellents, if necessary sicatives and UV stabilizers, gibberellins and also water and other processing aids. Depending on the type of formulation to be prepared respectively, other processing steps may be necessary, such as, for example, wet milling, dry milling or granulation.
    [074] The compositions according to the invention not only comprise ready-to-use compositions that can be applied with equipment suitable for the plant or seed, but also commercial concentrates that must be diluted with water before use.
    [075] The active compound combinations according to the invention can be present in (commercial) formulations and in the forms of use prepared from these formulations as a mixture with other (known) active compounds, such as insecticides, attractants, sterilants, bactericides, acaricides, nematicides, fungicides, growth regulators, herbicides, fertilizers, protective and semi-chemical agents.
    [076] The treatment according to the invention of plants and plant parts with the active compounds or compositions is carried out directly or by action in their vicinity, habitat or storage space using conventional treatment methods, for example, by immersion , spraying, atomization, irrigation, evaporation, dusting, misting, diffusion, foaming, applying coat, spreading, watering (dripping), drip irrigation and, in the case of propagating material, particularly in the case of seeds, in addition as a powder for dry seed treatment, a solution for seed treatment, a water-soluble powder for treatment with bituminous layer, by incrustation, by coating with one or more layers, etc. In addition, it is also possible to apply the active compounds by the ultra low volume method or to inject the active compound preparation or the active compound itself into the soil.
    [077] The invention also comprises a method for treating seed. The invention, moreover, relates to seed treated according to one of the methods described in the previous paragraph.
    [078] The active compounds or compositions according to the invention are especially suitable for seed treatment. A large part of the damage to crop plants caused by harmful organisms is triggered by an infection of the seed during storage or after sowing as well as during and after germination of the plant. This phase is particularly critical since the roots and buds of the growing plant are particularly sensitive and even minor damage can cause the plant to die. Correspondingly, there is a great interest in protecting the seed and the germination of the plant using appropriate compositions. The control of phytopathogenic fungi by the treatment of plant seeds has long been known and is the target of continuous improvements. However, seed treatment entails a number of problems that cannot always be satisfactorily solved. Therefore, it is desired to develop methods of protecting the seed and plant germination that do not require the additional application of crop protection agents after sowing or after the emergence of the plants or that at least considerably reduce the additional application. In addition, it is desired to optimize the amount of active compound used in order to provide maximum protection for the seed and the germination of the plant against attack by phytopathogenic fungi, but without damaging the plant through the active compound used. In particular, methods for seed treatment must also take into account the intrinsic fungal properties of transgenic plants in order to obtain ideal protection from the seed and plant germination, with a minimum of crop protection agents.
    [079] Correspondingly, the present invention also relates particularly to a method of protecting seeds and germinating plants against attack by phytopathogenic fungi by treating the seed with a composition according to the invention. The invention also relates to the use of the compositions according to the invention for the treatment of seed to protect the seed and the germination of the plant against phytopathogenic fungi. In addition, the invention relates to seed treated with a composition according to the invention for protection against phytopathogenic fungi.
    [080] The control of phytopathogenic fungi that damage post-emergence of plants is carried out initially by treating the soil and parts of aerial plants with crop protection compositions. Due to concerns regarding a possible impact of the crop protection composition on the environment and the health of humans and animals, efforts are made to reduce the amount of active compounds applied.
    [081] One of the advantages of the present invention is that, due to the particular systemic properties of the compositions according to the invention, the treatment of the seed with these compositions not only protects the seed, but also the resulting plants after emergence are protected against phytopathogenic fungi . Thus, immediate treatment of the crop at the moment of sowing or shortly afterwards can be dispensed with. It is also advantageous that the mixtures according to the invention can be used particularly for transgenic seed where the growth of the plant from that seed is able to express a protein that acts against pests. By treating such a seed with combinations of active compound or compositions according to the invention, even by expressing, for example, the insecticidal protein, certain pests can be controlled. Surprisingly, another synergistic effect can be seen here, which also increases the effectiveness of protection against pest attack.
    [082] The compositions according to the invention are suitable to protect the seed from any variety of plant used in agriculture, in the greenhouse, in forests or in horticulture or viticulture. In particular, this takes the form of cereal seed (such as wheat, barley, rye, triticale, millet, oats), corn (cereal), cotton, soybeans, rice, potatoes, sunflower, beans, coffee, beets (for example sugar beet and fodder beets), peas, rapeseed, poppies, olives, coconuts, cacao, sugar cane, tobacco, vegetables (such as tomatoes, cucumbers, onions and lettuce), grass and ornamental plants (see also below). The treatment of cereal seeds (such as wheat, barley, rye, triticale and oats), corn (grain) and rice is of particular importance.
    [083] According to the invention, all plants and plant parts can be treated. Plants are understood to mean all plants and plant populations such as desired and unwanted wild plants, cultivars and plant varieties (whether or not protected by plant breeder or plant variety rights). Cultivars and plant varieties can be plants obtained by conventional propagation and plant breeding methods that can be assisted or supplemented by one or more biotechnological methods such as the use of double haploids, protoplast fusion, random or targeted mutagenesis, molecular markers or genetic or methods of bioengineering and genetic engineering. Plant parts are understood to be all the parts and organs of aerial and underground plants, such as bud, leaf, flower and root, which can be mentioned as examples: leaves, stems, stems, trunks, flowers, fruit pulps, fruits and seeds and also roots, tubers and rhizomes. Plant parts also include cultivated material and vegetative and generative material, for example, sowing, tubers, rhizomes, cuttings and seeds.
    [084] Among the plants that can be protected by the method according to the invention, reference is made to larger field crops such as grain, soy beans, cotton, Brassica oil seed such as Brassica napus (for example canola), Brassica rapa, B. juncea (eg mustard) and Brassica carinata, rice, wheat, sugar beet, sugar cane, oats, barley, rye, millet, triticale, flax, vine and various fruits and vegetables of various botanical species such as Rosaceae sp. (for example, fruits such as apples and pears, but also stone fruits, such as avocados, cherries, almonds and peaches and berries such as strawberries), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Faga - ceae sp., Moraceae sp., Olaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (for example, banana trees and plantations), Rubiaceae sp. (for example, coffee), Theaceae sp., Sterculiceae sp., Rutaceae sp. (for example, lemons, oranges and grapefruit); Solanaceae sp. (for example, tomatoes, potatoes, peppers, eggplants), Liliaceae sp., Compositiae sp. (for example, lettuce, artichoke and chicory - including root, endive or common chicory), Umbelliferae sp. (for example, carrot, parsley, celery and celery root), Cucurbitaceae sp. (for example, cucumber- including pickle cucumber, zucchini, watermelon, pumpkin [melon and melon), Alliaceae sp. (for example onions and leeks), Cruciferae sp. (for example white cabbage, red cabbage, brocoli, cauliflower, brussels sprouts, Chinese cabbage, kohlrabi, radish, horseradish, watercress, chinese cabbage), Leguminosae sp. (for example peanuts, peas and fava beans - such as climbing beans and broad beans), Chenopodiaceae sp. (for example chard, red beets, spinach, beets), Malvaceae (for example okra), Asparagaceae (for example asparagus); horticultural crops and forest crops; ornamental plants; as well as genetically modified counterparts from these cultures.
    [085] The treatment method according to the invention can be used for the treatment of genetically modified organisms (GMOs), for example plants or seeds. Genetically modified plants (or transgenic plants) are plants in which a heterologous gene has been stably integrated into the genome. Essentially, the term "heterologous gene" refers to a gene that is either provided or assembled outside the plant and which, when introduced into the nuclear genome, the chloroplast genome or the mitochondrial genome of the transformed plant, confers new or improved agrochemical properties or others by the expression of an important protein or polypeptide, or by downregulation or shutdown of another gene, or other genes, present in the plant (for example by means of antisense technology, cosupressure technology or RNAi technology [RNA interference]). A heterologous gene that is present in the genome is also called a transgene. A transgene that is defined by its specific presence in the plant's genome is called a transformation event, or transgenic event. Depending on the plant species or plant varieties, their location and growing conditions (soil, climate, vegetation period, nutrition), the treatment according to the invention can also result in superadditive ("synergistic") effects. For example, side effects are possible, which extend beyond the effects that are currently expected: reduced rates of application and / or an expanded spectrum of action and / or an increased effectiveness of the active substances and compositions that can be used accordingly. with the invention, better plant growth, increased tolerance to high and low temperatures, increased tolerance to drought or water or soil salinity, improved flowering performance, easier harvesting, accelerated ripening, higher yields, greater fruit, greater weight of plant, more intense green color of the leaf, easier flowering, better quality and / or higher nutritional value of the harvested products, higher concentration of sugar in the fruits, better storage capacity and / or processability of the harvested products. At certain application rates, the active substances also have a strengthening effect on plants. Therefore, they are suitable for mobilizing the plant's defense system against attack by microbial pathogens and animals. This may be one of the reasons for the increased effectiveness of the combinations according to the invention, for example, against fungi. Plant strengthening substances (resistance-inducing) in the present context should also be understood as those substances or combinations of substances that are capable of simulating the defense system of the plant so that the treated plants, when subsequently inoculated with microbial pathogens and animals, show a considerable degree of resistance to these microbial and animal pathogens. The substances according to the invention can therefore be used to protect plants against attack by the aforementioned pathogens within a given post-treatment period. In general, the period of time for which a protective effect is obtained extends from 1 to 10 days, preferably from 1 to 7 days, after the treatment of the plants with the active substances.
    [086] Plants and varieties of plants are preferably treated according to the invention include all plants that contain hereditary material which gives particular advantages, useful characteristics to these plants (regardless of whether this was obtained by breeding and / or biotechnology).
    [087] Plants and plant varieties that are preferably treated also according to the invention, are resistant to one or more factors of biotic stress, that is, these plants have an improved defense against animal and microbial pathogens such as nematodes, insects, mites, phytopathogenic fungi, bacteria, viruses and / or viroids.
    [088] Examples of nematode resistant plants are described, for example, in American patent applications Nos. 1 1 / 765,491, 1 1 / 765,494, 10 / 926,819, 10 / 782,020, 12 / 032,479, 10 / 783,417, 10 / 782,096, 10 / 782,096 , 1 1 / 657,964, 12 / 192,904, 1 1 / 396,808, 12 / 166,253, 12 / 166,239, 12 / 166,124, 12 / 166,209, 1 1 / 762,886, 12 / 364,335, 1 1 / 763,947, 12 / 252,453, 12 / 209,354, 12 / 491,396 or 12 / 497,221.
    [089] Plants and plant varieties that are also treated according to the invention are those plants that are resistant to one or more abiotic stressors. Abiotic stress conditions may include, for example, drought, low temperature and high temperature conditions, osmotic stress, waterlogging, increased soil salinity, increased exposure to minerals, ozone conditions, intense light conditions, limited availability of nitrogen nutrients, availability limited amount of phosphorus nutrients, or escape from the shade.
    [090] Plants and plant varieties that can also be treated according to the invention are those plants that are characterized by improved yield characteristics. In these plants, an increased yield can be caused, for example, by improved plant physiology, improved plant growth and improved plant development, such as water use efficiency, water retention efficiency, improved nitrogen usage, improved assimilation carbon, improved photosynthesis, increased germination efficiency, and accelerated maturation. The crop can also be affected by the improvement in plant architecture (under stress and non-stress conditions), including, but not restricted to early flowering, fluorescence control for hybrid seed production, seedling vigor, plant size, number and internode distance, root growth, seed size, fruit size, pod size, number of pods or ears, number of seeds per pod or ear, seed mass, increased seed filling, reduced seed dispersion, reduced dehiscence of ears, and resistance to housing. In addition, yield-related characteristics include seed composition such as carbohydrate content, protein content, oil content and composition, nutritional value, reduction in anti-nutritional compounds, improved processability and better storage stability.
    [091] Plants that can be treated according to the invention are hybrid plants that already express the characteristics of hybrid heterosis or vigor that generally results in greater production, greater vigor, better health, and resistance to biotic and abiotic stress factors. Such plants are typically prepared by crossing a natural male-sterile parent line (female parent) with another natural male-fertile parent line (male parent). Hybrid seed is typically harvested from male-sterile plants and sold to growers. Male-sterile plants can sometimes (eg, in the case of corn) be produced by stripping ("detasseling") (ie, the mechanical removal of male reproductive organs or male flowers); however, more typically, male sterility is the result of genetic determinants in the plant's genome. In that case, and especially when the seed is the desired product to be harvested from hybrid plants, it is typically useful to ensure that male fertility is fully restored in hybrid plants that contain the determinants genetically responsible for male sterility. The genetic determinants for male sterility may be located in the cytoplasm. Examples of cytoplasmic male sterility (CMS) are those described for Brassica species (WO 92/05251, WO 95/09910, WO 98/27806, WO 05/002324, WO 06/021972 and US 6,229,072). However, genetic determinants for male sterility may also be located in the nuclear genome. Male-sterile plants can also be obtained through methods of plant biotechnology, such as genetic engineering. A particularly useful means of obtaining male-sterile plants is described in WO / 10396 in which, for example, a ribonuclease such as barnase, is selectively expressed in the membrane cells ("tapetum") of a ribonuclease inhibitor such as protein barstar (for example WO 91/02069).
    [092] Plants or plant varieties (obtained by plant biotechnology methods such as genetic engineering) that can be treated according to the invention are herbicide-tolerant plants, that is, plants made tolerant to one or more determined herbicides. Such plants can be obtained either by genetic transformation, or by selecting plants containing a mutation that allows such tolerance to herbicides.
    [093] Herbicide-tolerant plants are, for example, glyphosate-tolerant plants, that is, plants made tolerant to the glyphosate herbicide or salts thereof. Plants can become tolerant to glyphosate through different means. For example, glyphosate-tolerant plants can be obtained by transforming the plant with a gene encoding the 5-enolpyruvylshiquimato-3-phosphate enzyme (EPSPS) synthase. Examples of such EPSPS genes are the AroA gene (CT7 mutant) from the bacterium Salmonella typhimurium (Comai et al., 1983, Science 221, 370-371), the CP4 gene from bacterium Agrobacterium sp. (Barry et al., 1992, Curr. Topics Plant Physiol. 7, 139- 145), the genes encoding a Petunia EPSPS (Shah et al., 1986, Science 233, 478-481), an EPSPS Tomato (Gasser et al., 1988, J. Biol. Chem. 263, 4280-4289), or an Eleusina EPSPS (WO 01/66704). It can also be a mutated EPSPS as described for example in patent documents EP 0837944, WO 00/66746, WO 00/66747 or WO 02/26995. Glyphosate-tolerant plants are also obtained by expressing a gene that encodes a glyphosate oxidoreductase enzyme as described in U.S. Patent Application documents. 5,776,760 and 5,463, 175. Glyphosate-tolerant plants can also be obtained by expressing a gene encoding a glyphosate acetyl transferase enzyme as described for example in patent documents WO 02/36782, WO 03/092360, WO 05/012515 and WO 07 / 024782. Glyphosate-tolerant plants can also be obtained containing naturally occurring mutations of the above genes as described in the patent documents WO 01/024615 or WO 03/013226. Plants expressing EPSPS genes that confer glyphosate tolerance are described for example in US patent applications US Patent Application Nos. 1 1 / 517,991, 10 / 739,610, 12 / 139,408, 12 / 352,532, 1 1 / 312,866, 1 1 / 315,678, 12 / 421,292, 1 1 / 400,598, 1 1 / 651,752, 1 1 / 681,285, 1 1 / 605,824, 12 / 468,205, 1 1 / 760,570, 1 1 / 762,526, 1 1 / 762,526, 1 1 / 769,327, 1 1 / 769,255, 1 1 / 769,255, 1 1 / 943801 or 12 / 362,774. Plants that comprise other genes that confer glyphosate tolerance such as decarboxylase genes are described for example in US patent applications US patent applications 1 1 / 588.81 1, 1 1 / 185,342, 12 / 364,724, 1 1 / 185,560 or 12 / 423,926.
    [094] Other herbicide-resistant plants are, for example, plants that are made tolerant of herbicides that inhibit the enzyme glutamine synthase, such as bialafos, phosphinothricin or glufosinate. Such plants can be obtained by the expression of an enzyme that detoxifies the herbicide or a mutant of the enzyme glutamine synthase that is resistant to inhibition, for example, described in the patent document US Patent Application No 1 1 / 760,602. Such an effective detoxifying enzyme is an enzyme that encodes a phosphinothricin acetyltransferase (such as the Streptomyces species bar or pat protein). Plants that express an exogenous phosphinothricin acetyltransferase are, for example, described, for example, in U.S. patent documents U.S. Patent Nos. 5,561,236; 5,648,477; 5,646,024; 5,273,894; 5,637,489; 5,276,268; 5,739,082; 5,908,810 and 7,112,665. Other herbicide-tolerant plants are also plants that are made tolerant to herbicides that inhibit the enzyme hydroxyphenylpyruvatodioxigenase (HPPD). Hydroxyphenylpyruvatodioxigenases are enzymes that catalyze the reaction in which parahydroxyphenylpyruvate (HPP) is transformed into homogentisate. Plants tolerant to HPPD inhibitors can be transformed with a gene encoding a naturally occurring resistant HPPD enzyme or a gene encoding a mutant in the HPPD enzyme. Tolerance to HPPD inhibitors can also be obtained by transforming plants with genes that encode certain enzymes that enable the formation of homogentisate despite the inhibition of the native HPPD enzyme through the HPPD inhibitor. Plant tolerance to HPPD inhibitors can also be improved by transforming plants with a gene that encodes a prefenate dehydrogenase enzyme in addition to a gene that encodes an HPPD-tolerant enzyme as described in patent documents WO 96/38567, WO 99/24585, WO 99/24586, WO 2009/144079, WO 2002/046387, or US 6,768,044. Tolerance to HPPD inhibitors can also be obtained by transforming plants with genes that encode certain enzymes that enable the formation of homogentisate despite the inhibition of the native HPPD enzyme through the HPPD inhibitor. Such plants and genes are described in WO 99/34008 and WO 02/36787. Plant tolerance to HPPD inhibitors can also be improved by transforming plants with a gene encoding a prefenate dehydrogenase enzyme in addition to a gene encoding an HPPD-tolerant enzyme, as described in WO 2004/024928. In addition, plants can be made more tolerant of HPPD-inhibiting herbicides by adding in their genome a gene encoding an enzyme capable of metabolizing or degrading HPPD-inhibitors such as the CYP450 enzymes shown in WO 2007/103567 and WO 2008 / 150473. Other herbicide-resistant plants are plants that are made tolerant of acetolactate synthase (ALS) inhibitors. Known ALS inhibitors include, for example, sulfonylurea, imidazolinone, triazolopyrimidines, pyrimidinyloxy (thio) benzoates and / or sulfonylaminocarbonyltriazolinone herbicides. Different mutations in the ALS enzyme (also known as acetohydroxyacid synthase, AHAS) are known to confer tolerance to different herbicides and groups of herbicides, as described, for example, in Tranel and Wright (2002, Weed Science 50: 700-712), but also in the US patent application US Patent No. 5,605,011, 5,378,824, 5,141,870, and 5,013,659. The production of sulfonylurea-tolerant plants and imidazolinone-tolerant plants has been described in U.S. Patent Nos. 5,605,011; 5,013,659; 5, 141,870; 5,767,361; 5,731,180; 5,304,732; 4,761,373; 5.331, 107; 5,928,937; and 5,378,824; and international publication WO 96/33270. Other sulfonylurea- and imidazolinone-tolerant plants have also been described, for example in WO 2004/040012, WO 2004/106529, WO 2005/020673, WO 2005/093093, WO 2006/007373, WO 2006/015376, WO 2006/024351 , and WO 2006/060634. Other sulfonylurea and imidazolinone tolerant plants are also described, for example, in WO 07/024782 and US Patent Application No 61/288958.
    [095] Other imidazolinone and / or sulfonylurea tolerant plants can be obtained by induced mutagenesis, selection in cell cultures in the presence of herbicide or mutation induction as described for example for soy beans in US Patent 5,084,082, for rice in WO 97 / 41218, for sugar beet in US Patent 5,773,702 and WO 99/057965, for lettuce in US Patent 5, 198,599, or for sunflower in WO 01/065922.
    [096] Plants or plant cultivars (obtained by biotechnological methods such as genetic engineering) that can also be treated according to the invention are insect-resistant plants, that is, plants made resistant to attack by certain target insects. Such plants can be obtained by genetic transformation or by selecting plants that contain a mutation that confers such resistance to insects. In the present context, the term "insect resistant transgenic plant" includes any plant containing at least one transgene comprising a coding sequence that encodes: 1) an insecticidal crystal protein from Bacillus thuringiensis or an insecticidal portion thereof, such as, such as proteins crystal insecticide listed by Crickmore et al. (1998, Microbiology and Molcular Biology Reviews, 62: 807813), updated by Crickmore et al. (2005) in the toxin nomenclature Bacillus thuringiensis, online at: http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore Bt /), or insecticidal portions of these, for example, proteins from the Cry Cry1Ab protein classes, Cry1Ac, Cry1F, Cry2Ab, Cry3Ae, or Cry3Bb or insecticidal portions thereof (for example, in EP 1999141 and WO 2007/107302), or such proteins encoded by synthetic genes as for example described in US Patent Application No 12 / 249,016 ; or 2) a Bacillus thuringiensis crystal protein or a portion of it that is insecticidal in the presence of a second Bacillus thuringiensis crystal protein or a portion thereof, such as the binary toxin made from the crystal proteins Cy34 and Cy35 (Moellenbeck et al. 2001, Nat Bio-technol. 19: 668-72; Schnepf et al. 2006, Applied Environm. Microbiol. 71, 1765-1774) or the binary toxin made from proteins Cryl A or Cry IF and proteins Cry2Aa or Cry2Ab or Cry2Ae (US Patent Appl. No. 12 / 214,022 and EP 08010791.5); or 3) a hybrid insecticidal protein comprising parts of two different insecticidal crystalline proteins from Bacillus thuringiensis, such as a hybrid of the proteins from 1) above or a hybrid of the proteins from 2) above, eg the Cry1A.105 protein produced by MON98034 corn (WO 2007/027777); or 4) a protein of any one from 1) to 3) above where some, particularly from 1 to 10, amino acids have been replaced by another amino acid to obtain greater insecticidal activity in relation to target insect species, and / or to enlarge the range of target insect species affected, and / or because of changes introduced in DNA coding during cloning or transformation, such as the Cry3Bb1 protein in MON863 or MON88017 corn events, or the Cry3A protein in MIR 604 corn event; or 5) an insecticidal protein secreted from Bacillus thuringiensis or Bacillus cereus, or an insecticidal portion thereof, such as the vegetative insecticidal proteins (VIP) listed at: http://www.lifesci.sussex.ac.uk/home/Neil_Crickmore/ Bt / vip.html, for example, proteins of the VIP3Aa protein class; or 6) a secreted protein from Bacillus thuringiensis or Bacillus cereus that is insecticidal in the presence of a second secreted protein from Bacillus thuringiensis or B. cereus, such as the binary toxin made from the VIP1A and VIP2A proteins (WO 94/21795); or 7) a hybrid insecticidal protein, comprising parts of different proteins secreted from Bacillus thuringiensis or Bacillus cereus, such as a hybrid of the proteins in 1) above or a hybrid of the proteins in 2) above; or 8) a protein of any one from 1) to 3) above with some, particularly from 1 to 10, amino acids being replaced by another amino acid to obtain greater insecticidal activity in relation to affected target insect species, and / or because of changes introduced in the DNA coding during cloning or transformation (while the coding of an insecticidal protein remains), such as the VIP3Aa protein in a COT 102 cotton event; or 9) a secreted protein from Bacillus thuringiensis or Bacillus cereus, which is insecticidal in the presence of a crystal protein from Bacillus thuringiensis, such as the binary toxin made from VIP3 and Cryl A or Cryl F (US Patent Appl. No. 61/126083 and 61/195019), or the binary toxin made from the VIP3 protein and the Cry2Aa or Cry2Ab or Cry2Ae proteins (US Patent Appl. No. 12 / 214,022 and EP 08010791.5). 10) a protein from 9) above with some, particularly 1 to 10, amino acids being replaced by another amino acid to obtain higher insecticidal activity in relation to target insect species, and / or to expand the range of insect species target groups affected, and / or due to changes introduced in the DNA coding during cloning or transformation (and at the same time encodes an insecticidal protein).
    [097] Naturally, an insect-resistant transgenic plant, as used herein, also includes any plant comprising a combination of genes that encode the proteins of any of the classes above 1 to 10. In one embodiment, an insect-resistant plant resistant contains more than one transgene that encodes a protein of any of the classes above 1 to 10, to enlarge the range of affected target insect species or to delay the development of insect resistance in relation to plants by the use of different insecticidal proteins to the same species of target insect but which have a different mode of action, such as binding to different receptor binding sites in the insect.
    [098] In the present context, the term "insect resistant transgenic plant" includes any plant containing at least one transgene comprising a sequence that produces after expression a double-stranded RNA that after ingestion through a plant insect pest inhibits growth of this insect pest as described, for example, in patent documents WO 2007/080126, WO 2006/129204, WO 2007/074405, WO 2007/080127 and WO 2007/035650.
    [099] Plants or plant cultivars (obtained by biotechnological methods such as genetic engineering) that can also be treated according to the invention are plants resistant to abiotic stress. Such plants can be obtained by genetic transformation or by selecting plants that contain a mutation that confers such resistance or stress. Particularly useful stress-tolerant plants include: 1) plants that contain a transgene capable of reducing the expression and / or activity of the poly (ADP-ribose) polymerase (PARP) gene in plant cells or plants as described in WO patent documents 00/04173, WO / 2006/045633, EP 04077984.5, or EP 06009836.5. 2) plants that contain a transgene that improves stress tolerance capable of reducing the expression and / or activity of PARG genes encoding plants or plant cells as described for example in patent document WO 2004/090140. 3) plants that contain a transgene that improves stress tolerance, which encodes a plant-functional enzyme, however, nicotinamide adenine dinucleotide enhancement biosynthesis, including nicotinamidase, nicotinate phosphoribosyltransferase, mononucleotide adenyltransynide, nicotinide, nicotinide, nicotinamide, adenine phosphoribosyltransferase as described for example in patent documents EP 04077624.7, WO 2006/133827, PCT / EP07 / 002433, EP 1999263, or WO 2007/107326.
    [0100] Plants or plant cultivars (obtained by plant biotechnological methods such as genetic engineering) which can also be treated according to the invention, show quality, storage stability and / or altered quantity of the harvested product and / or properties alterations of specific ingredients of the harvested product such as: 1) transgenic plants that synthesize a modified starch, which is altered in terms of its physico-chemical characteristics, particularly the amylase content or the amylase / amylopectin ratio, the degree of branching, the length medium chain, side chain distribution, viscosity behavior, gelation resistance, starch grain size and / or starch grain morphology, compared to starch synthesized in wild-type cells or plants, that this modified starch is more suitable for special applications. Said transgenic plants that synthesize a modified starch are described, for example, in patent documents EP 0571427, WO 95/04826, EP 0719338, WO 96/15248, WO 96/19581, WO 96/27674, WO 97/1 1 188, WO 97/26362, WO 97/32985, WO 97/42328, WO 97/44472, WO 97/45545, WO 98/27212, WO 98/40503, W099 / 58688, WO 99/58690, WO 99/58654, WO 00/08184, WO 00/08185, WO 00/08175, WO 00/28052, WO 00/77229, WO 01/12782, WO 01/12826, WO 02/101059, WO 03/071860, WO 2004/056999, WO 2005/030942, WO 2005/030941, WO 2005/095632, WO 2005/095617, WO 2005/095619, WO 2005/095618, WO 2005/123927, WO 2006/018319, WO 2006/103107, WO 2006/108702, WO 2007/009823, WO 00/22140, WO 2006/063862, WO 2006/072603, WO 02/034923, EP 06090134.5, EP 06090228.5, EP 06090227.7, EP 07090007.1, EP 07090009.7, WO 01/14569, WO 02/79410, WO 03/33540, WO 2004/078983, WO 01/19975, WO 95/26407, WO 96/34968, WO 98/20145, WO 99/12950, WO 99/66050, WO 99/53072, US 6,734,341, WO 00 / 1 1 192, WO 98/22604, WO 98/32326, WO 01/98509, WO 0 1/98509, WO 2005/002359, US 5,824,790, US 6,013,861, WO 94/04693, WO 94/09144, WO 94/1 1520, WO 95/35026, WO 97/20936. 2) transgenic plants that synthesize non-starch carbohydrate polymers with altered properties compared to wild type plants without genetic modification. Examples are plants that produce polyfructose, especially inulin and levan type, as described in patent documents EP 0663956, WO 96/01904, WO 96/21023, WO 98/39460, and WO 99/24593, plants that produce alpha-1, 4-glucans as described in patent documents WO 95/31553, US 2002031826, US 6,284,479, US 5,712, 107, WO 97/47806, WO 97/47807, WO 97/47808 and WO 00/14249, plants that produce alpha-1 , 6 branched afa-1,4-glucans, as described in patent documents WO 00/73422, plants that produce alternan as described for example in patent documents WO 00/47727, WO 00/73422, EP 06077301.7, US 5,908,975 and EP 0728213 , 3) transgenic plants that produce hyaluronan, as described for example in patent documents WO 2006/032538, WO 2007/039314, WO 2007/039315, WO 2007/039316, JP 2006304779, and WO 2005/012529, 4) transgenic plants or hybrids, such as onions with characteristics such as' highly soluble solids content ',' low pungé nci '(LP) and / or' long storage '(LS), as described in the US Patent Appl. No. 12 / 020,360 and 61 / 054,026.
    [0101] Plants or plant cultivars (obtained by plant biotechnological methods, such as genetic engineering) that can also be treated according to the invention, are plants, such as cotton plants, with altered fiber characteristics. Such plants can be obtained by genetic transformation, or by selecting plants containing a mutation that confers such altered fiber characteristics and include: a) plants, such as cotton plants, containing an altered form of cellulose synthase genes as described in the document patent WO 98/00549. b) plants, such as cotton plants, containing an altered form of homologous nucleic acids rsw2 or rsw3 as described in patent document WO 2004/053219. c) plants, such as cotton plants, with increased expression of sucrose phosphate synthase as described in patent document WO 01/17333. d) plants, such as algae plants, with increased expression of sucrose synthase as described in patent document WO 02/45485. e) plants, such as cotton plants, where the moment of plasmododematal passage at the base of the fiber cell is altered, eg through the infra-regulation of fiber-selective β-1,3-glucanase as described in the document WO 2005/017157, or described in EP 08075514.3 or US Patent Appl. No. 61 / 128,938. f) plants, such as algoson plants, containing fibers with altered reactivity, eg through expression of the N-acetylglucosamine transferase gene including nodC and chitin synthase genes as described in patent document WO 2006/136351.
    [0102] Plants or plant cultivars (obtained by biotechnological plant methods, such as genetic engineering) that can also be treated according to the invention, are plants, such as oilseed rape or associated Brassica plants, with profile characteristics altered oil. Such plants can be obtained by genetic transformation or by selecting plants containing a mutation that gives such altered oil profile characteristics and include: a) plants, such as oilseed rape plants, which produce oil with a high oleic acid content as described, for example, in patent documents US 5,969, 169, US 5,840,946 or US 6,323,392 or US 6,063,947. b) plants such as oilseed rape plants, which produce oil with a low content of linolenic acid, as described in patent documents US 6,270,828, US 6,169,190, or US 5,965,755. c) plants such as oilseed rape plants, which produce oil with a low level of fatty acids as described, for example, in US Patent No. 5,434,283 or US Patent Application No 12/668303.
    [0103] Plants or plant cultivars (obtained by biotechnological plant methods, such as genetic engineering) that can also be treated according to the invention, are plants, such as oilseed rape or associated Brassica plants, with shattering characteristics of altered seed. Such plants can be obtained by genetic transformation or by selecting plants that contain a mutation that confers such altered seed shattering characteristics and include plants such as late or reduced rape plants as described in the US Patent Appl patent documents. No. 61 / 135,230 WO09 / 068313 and WO10 / 006732.
    [0104] Particularly useful transgenic plants that can be treated according to the invention, are plants containing transformation events or combination of transformation events that are the subject of unregulated state petitions in the United States of America, to Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture (USDA) whether such petitions are granted or are still pending. This transformation is readily available at any time by APHIS (4700 River Road Riverdale, MD 20737, USA), for example, on its website (URL http://www.aphis.usda.gov/brs/not_reg.html) . On the filing date of this request, petitions to an unregulated state that were pending with APHIS or were granted by APHIS were those that contain the following information: Petition: the petition identification number. Technical descriptions of the transformation events can be found in the individual petition documents that are available through APHIS, for example on the APHIS website by reference to this petition number. These descriptions are hereby incorporated by reference. Extension of the petition: reference to a previous petition for which extension is requested. Institution: the name of the entity submitting the petition. - regulated article: the plant species of interest. Transgenic phenotype: the characteristic given to plants by the transformation event. Transformation or line event: the name of the event or events (sometimes also called lines or lines) for which an unregulated state is requested. APHIS documents: several documents published by APHIS in relation to the petition and which can be requested from APHIS. Additional particularly useful plants containing unique transformation events or combinations of transformation events are listed, for example, in databases from national and regional regulatory agencies (see, for example, http://gmoinfo.jrc.it/gmp_browse .aspx and http://vvww.agbios.com dbase.php). Particularly useful transgenic plants that can be treated according to the invention are plants containing transformation events or a combination of transformation events and which are listed for example in the databases of various national and regional regulatory agencies including Event 1 143-14A ( cotton, insect control, not deposited, described in patent document WO 2006/128569); Event 1 143-5 I B (cotton, insect control, not deposited, described in WO 2006/128570); Event 1445 (cotton, herbicide tolerance, not deposited, described in US-A 2002120964 or WO 02/034946); Event 17053 (rice, herbicide tolerance, deposited as PTA-9843, described in WO 2010/1 17737); Event 17314 (rice, herbicide tolerance, deposited as PTA-9844, described in WO 2010/1 17735); Event 281-24- 236 (cotton, insect control - herbicide tolerance, deposited as PTA-6233, described in WO 2005/103266 or US-A 2005-216969); Event 3006-210-23 (cotton, insect control - herbicide tolerance, deposited as PTA-6233, described in US-A 2007-143876 or WO 2005/103266); Event 3272 (grain, quality characteristic, deposited as PTA-9972, described in WO 2006/098952 or US-A 2006-230473); Event 40416 (grain, insect control - herbicide tolerance, deposited as ATCC PTA-1 1508, described in WO 201 1/075593); Event 43A47 (grain, insect control - herbicide tolerance, deposited as ATCC PTA-1 1509, described in WO 201 1/075595); Event 5307 (grain, insect control, deposited as ATCC PTA-9561, described in WO 2010/077816); Event ASR-368 (pasture, herbicide tolerance, deposited as ATCC PTA-4816, described in US-A 2006-162007 or WO 2004/053062); Event B16 (grain, herbicide tolerance, not deposited, described in US-A 2003-126634); Event BPS-CV 127-9 (soybean, herbicide tolerance, deposited as NCIMB No. 41603, described in WO 2010/080829); Event CE43-67B (cotton, insect control, deposited as DSM ACC2724, described in US-A 2009-217423 or WO2006 / 128573); Event CE44-69D (cotton, insect control, not deposited, described in US-A 2010-0024077); Event CE44-69D (cotton, insect control, not deposited, described in WO 2006/128571); Event CE46-02A (cotton, insect control, not deposited, described in WO 2006/128572); Event COT 102 (cotton, insect control, not deposited, described in US-A 2006-130175 or WO 2004/039986); Event COT202 (cotton, insect control, not deposited, described in US-A 2007-067868 or WO 2005/054479); Event COT203 (cotton, insect control, not deposited, described in WO 2005/054480); DAS40278 event (grain, herbicide tolerance, deposited as ATCC PTA-10244, described in WO 201 1/022469); Event DAS-59122-7 (grain, insect control - herbicide tolerance, deposited as ATCC PTA 1 1384, described in US-A 2006 070139); Event DAS-59132 (grain, insect control - herbicide tolerance, not deposited, described in WO 2009/100188); DAS68416 event (soybean, herbicide tolerance, deposited as ATCC PTA-10442, described in WO 201 1/066384 or WO 201 1/066360); Event DP-098140-6 (grain, herbicide tolerance, deposited as ATCC PTA-8296, described in US-A 2009-137395 or WO 2008/1 12019); Event DP-305423-1 (soybean, quality characteristic, not deposited, described in US-A 2008-312082 or WO 2008/054747); Event DP-32138-1 (grain, hybridization system, deposited as ATCC PTA-9158, described in US-A 2009-0210970 or WO 2009/103049); Event DP-356043-5 (soybean, herbicide tolerance, deposited as ATCC PTA-8287, described in US-A 2010-0184079 or WO 2008/002872); Event EE-1 (eggplant, insect control, not deposited, described in WO 2007/091277); Event FI1 17 (grain, herbicide tolerance, deposited as ATCC 209031, described in US-A 2006-059581 or WO 98/044140); Event GA21 (grain, herbicide tolerance, deposited as ATCC 209033, described in US-A 2005-086719 or WO 98/044140); Event GG25 (with, herbicide tolerance, deposited as ATCC 209032, described in USA 2005-188434 or WO 98/044140); Event GHB 1 19 (cotton, insect control - herbicide tolerance, deposited as ATCC PTA-8398, described in WO 2008/151780); Event GHB614 (cotton, herbicide tolerance, deposited as ATCC PTA-6878, described in US-A 2010-050282 or WO 2007/017186); Event GJ 11 (with, herbicide tolerance, deposited as ATCC 209030, described in US-A 2005-188434 or WO 98/044140); GM RZ13 event (sugar beet, virus resistance, deposited as NCIMB-41601, described in WO 2010/076212); Event H7-1 (sugar beet, herbicide tolerance, deposited as NCI B 41 158 or NC1MB 41 159, described in US-A 2004-172669 or WO 2004/074492); Event JOPL1N 1 (wheat, disease tolerance, not deposited, described in US-A 2008-064032); Event LL27 (soybean, herbicide tolerance, deposited as NCIMB41658, described in WO 2006/108674 or US-A 2008-320616); Event LL55 (soybean, herbicide tolerance, deposited as NCIMB 41660, described in WO 2006/108675 or US-A 2008-196127); Event LLalg cotton25 (cotton, herbicide tolerance, deposited as ATCC PTA-3343, described in WO 03/013224 or US-A 2003-097687); Event LLARROZ06 (rice, herbicide tolerance, deposited as ATCC-23352, described in US 6,468,747 or WO 00/026345); Event LLARROZ601 (rice, herbicide tolerance, deposited as ATCC PTA-2600, described in US-A 2008-2289060 or WO 00/026356); Event LY038 (with, quality feature, deposited as ATCC PTA-5623, described in US-A 2007-028322 or WO 2005/061720); Event MIR162 (with, insect control, deposited as PTA-8166, described in US-A 2009-300784 or WO 2007/142840); Event MIR604 (with, insect control, not deposited, described in US-A 2008-167456 or WO 2005/103301); Event MON 15985 (cotton, insect control, deposited as ATCC PTA-2516, described in US-A 2004-250317 or WO 02/100163); MON810 event (grain, insect control, not deposited, described in US-A 2002-102582); MON863 event (grain, insect control, deposited as ATCC PTA-2605, described in WO 2004/01 1601 or US-A 2006-095986); Event MON87427 (grain, pollination control, deposited as ATCC PTA-7899, described in WO 201 1/062904); Event MON87460 (grain, tolerance to stress, deposited as ATCC PTA-8910, described in WO 2009/1 1 1263 or US-A 201 1-0138504); Event MON87701 (soybean, insect control, deposited as ATCC PTA-8194, described in US-A 2009-130071 or WO 2009/064652); Event MON87705 (soybean, quality characteristic - herbicide tolerance, deposited as ATCC PTA-9241, described in US-A 2010- 0080887 or WO 2010/037016); Event MON87708 (soybean, herbicide tolerance, deposited as ATCC PTA9670, described in WO 201 1/034704); Event MON87754 (soybean, quality characteristic, deposited as ATCC PTA-9385, described in WO 2010/024976); Event MON87769 (soybean, quality characteristic, deposited as ATCC PTA-891 1, described in US-A 2011-0067141 or WO 2009/102873); Event MON88017 (grain, insect control - herbicide tolerance, deposited as ATCC PTA-5582, described in US-A 2008-028482 or WO 2005/059103); Event MON88913 (cotton, herbicide tolerance, deposited as ATCC PTA-4854, described in WO 2004/072235 or US-A 2006- 059590); Event MON89034 (grain, insect control, deposited as ATCC PTA-7455, described in WO 2007/140256 or US-A 2008-260932); Event MON89788 (soybean, herbicide tolerance, deposited as ATCC PTA-6708, described in US-A 2006-282915 or WO 2006/130436); Event MS 11 (rapeseed, pollination control - herbicide tolerance, deposited as ATCC PTA-850 or PTA-2485, described in WO 01/031042); Event MS8 (rapeseed, pollination control - herbicide tolerance, deposited as ATCC PTA-730, described in WO 01/041558 or US-A 2003-188347); Event NK603 (grain, herbicide tolerance, deposited as ATCC PTA-2478, described in US-A 2007-292854); Event PE-7 (rice, insect control, not deposited, described in WO 2008/1 14282); Event RF3 (rapeseed, pollination control - herbicide tolerance, deposited as ATCC PTA-730, described in WO 01/041558 or US-A 2003-188347); Event RT73 (rapeseed, herbicide tolerance, not deposited, described in WO 02/036831 or US-A 2008-070260); Event T227-1 (sugar beet, herbicide tolerance, not deposited, described in WO 02/44407 or US-A 2009-265817); Event T25 (grain, herbicide tolerance, not deposited, described in US-A 2001-029014 or WO 01/051654); Event T304-40 (cotton, insect control - herbicide tolerance, deposited as ATCC PTA-8171, described in US-A 2010-077501 or WO 2008/122406); Event T342-142 (cotton, insect control, not deposited, described in WO 2006/128568); Event TCI 507 (grain, insect control - herbicide tolerance, not deposited, described in US-A 2005-039226 or WO 2004/099447); VIP Event 1034 (grain, insect control - herbicide tolerance, deposited as ATCC PTA-3925., Described in WO 03/052073), Event 32316 (grain, herbicide insect-tolerance control, deposited as PTA-1 1507, described in WO 201 1/084632), Event 41 14 (grain, insect control-tolerance to herbicide, deposited as PTA-1 1506, described in WO 201 1/084621).
    [0105] In the context of the present invention, combinations of active compound or compositions according to the invention are applied separately or in a suitable formulation in the seed. Preferably the seed is treated in a state in which it is so stable that no damage occurs during treatment. In general, seed treatment can be done at any time between harvest and sowing. Usually, seed that has been separated from the plant and free of corn cob, husks, stems, skins, fluff or pulp is used. In this way, for example, seed that has been harvested, cleaned and dried to a moisture content of less than 15% by weight can be used. Alternatively, seed can also be used which, after drying, has been treated, for example, with water and then dried again. Generally in the case of seed treatment, it is necessary to observe carefully so that the amount of the composition according to the invention applied to the seed and / or the amount of other additives is selected in such a way that the germination of the seed is not adversely affected, or that the resulting plant is not damaged. Care should be taken especially in the case of active compounds that may have phytotoxic effects at certain rates of application.
    [0106] The compositions, according to the invention, can be applied directly, that is, without understanding other components and without having been diluted. In general, it is preferred to apply the composition to the seed in the form of a suitable formulation. Suitable formulations and methods for seed treatment are known to those skilled in the art and are described, for example, in the following documents: US 4,272,417, US 4,245,432, US 4,808,430, US 5,876,739, US 2003/0176428 AI, WO 2002/080675, WO 2002/028186 A2. The combinations of active compound that can be used according to the invention can be converted into conventional seed coating formulations, such as solutions, emulsions, suspensions, powders, foams, pastes or other seed coating materials, and also ULV formulations. .
    [0107] These formulations are prepared in a conventional manner by mixing the active compounds or combinations of active compost with conventional additives, such as, for example, conventional extenders, and also solvents or diluents, dyes, wetting agents, dispersants, emulsifiers, anti- foam, preservatives, secondary thickeners, adhesives, gibberellins and also water.
    [0108] Suitable dyes can be present in the seed coating formulations that can be used according to the invention include all normal dyes for such purposes. In this case, poorly water-soluble pigments can be used as dyes that are water-soluble. Examples that we can cite include the dyes known under the names rhodamine B, C.I. Pigment Red 112, and C.I. Solvent Red 1.
    [0109] Suitable wetting agents that may be present in seed coating formulations include all substances that promote moisture and are normally applied in the formulation of active agrochemicals. Alkylnaphthalene sulfonates, such as diisopropyl- or diisobutylnaphthalene sulfonates, are preferably used.
    [0110] Suitable dispersants and / or emulsifiers that may be present in seed coating formulations that can be used according to the invention include all nonionic, anionic, and cationic dispersants, which are usually used in the formulation of active agrochemicals . Preferably, it is possible to use nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants. Particularly suitable non-ionic dispersants are block polymers of ethylene oxide - propylene oxide, alkylphenol polyglycol ethers, and tristyrylphenol polyglycol ethers, and their phosphate or sulfate derivatives. Particularly, suitable anionic dispersants are lignosulfonates, polyacrylic salts, and arylsulfonate-formaldehyde condensates.
    [0111] Suitable defoamers that can be present in seed coating formulations that can be used according to the invention include all inhibitory substances that are usually in the formulation of active agrochemicals. It is preferably possible to use silicone defoamers and magnesium stearate.
    [0112] Suitable preservatives can be present in seed coating formulations that can be used according to the invention include all substances that can be used for such purposes in agrochemical compositions. As an example, we can mention diclofen and hemiformal benzyl alcohol.
    [0113] Suitable secondary thickeners that can be present in seed coating formulations that can be used according to the invention include all substances that can be used for such purposes in agrochemical compositions. Cellulose derivatives, derivatives of acrylic acid, xanthan, modified clays, and finely divided silica are preferably suitable.
    [0114] Suitable adhesives that may be present in the seed coating formulations that can be used according to the invention include all the usual binders that can be used in the seed coating. We can preferably mention polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and tylose.
    [0115] Suitable gibberellins which may be present in seed coating formulations which can be used according to the invention are preferably gibberellins A1, A3 (= gibberellinic acid), A4 and A7; gibberellinic acid is particularly preferably used. Gibberellins are known (cf. R. Wegler „Chemie der Pflanzenschutz- and Schadlingsbekampfungsmittel“, Vol. 2, Springer Verlag, 1970, pp. 401-412). The seed coating formulations that can be used according to the invention can be used directly or after previous dilution with water to treat the seed of any other wide variety of types, including seed from transgenic plants. In this context, additional synergistic effects may also arise in interaction with substances formed by expression.
    [0116] Mixing equipment suitable for seed treatment with the seed coating formulations that can be used according to the invention or the preparations prepared therefrom by adding water, includes all the mixing equipment that can usually be used for coating . Especially the specific procedure adopted during the coating includes introducing the seed in a mixer, adding the particularly desired amount of seed coating formulation, either as such or after previous dilution with water, and carrying out the mixing until the formulation is evenly distributed in the seed . Optionally, you can follow a drying operation.
    [0117] The active compounds or compositions according to the invention have strong microbicidal action and can be used to combat unwanted microorganisms, such as fungi and bacteria, in crop protection and in material protection. Fungicides can be used in crop protection, for example, to combat plasmodioforomycetes, Oomycetes, chytridiomycetes, zygomycetes, ascomycetes, basidiomycetes and deuteromycet.
    [0118] In the protection culture, bactericides can be used to combat, for example, Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.
    [0119] The fungicidal compositions, according to the invention, can be used for curative or protective control of phytopathogenic fungi. Correspondingly, the invention also relates to curative and protective methods for combating phytopathogenic fungi using the active compounds or compositions according to the invention, which are applied to the seed, plant or plant parts, fruit or soil on which plants grow.
    [0120] The compositions according to the invention for combating phytopathogenic fungi in the protection of culture comprise an effective, but not phytotoxic, amount of the active compounds according to the invention. "Effective but not phytotoxic amount" means an amount of the composition according to the invention that is sufficient to combat fungal diseases of the plant in a satisfactory manner or to eradicate fungal disease completely, and at the same time, does not cause any symptoms In general, this rate of application can vary within a relatively wide range. This depends on a plurality of factors, for example, the fungus to be combated, the plant, the climatic conditions and the substances of the compositions according with the invention.
    [0121] All plants and parts of plants can be treated according to the invention. Plants in this case are understood to mean all plants and plant populations, such as desired or unwanted wild plants or crop plants (including naturally occurring crop plants). Cultivation plants can be plants that can be obtained by conventional genetic improvement and optimization methods or by biotechnological or genetic engineering methods or combinations of these methods, including transgenic plants and including plant cultivars that may or may not be protected by breeding certificates. of plants. Plant parts are understood to be all the parts and organs of aerial and underground plants, such as bud, leaf, flower and root, which can be mentioned as examples: leaves, stems, stems, trunks, flowers, fruit pulps, fruits and seeds and also roots, tubers and rhizomes. Plant parts also include cultivated material and vegetative and generative material, for example, sowing, tubers, rhizomes, cuttings and seeds. The treatment of plants such as bud, leaf, flower and root is preferred. Examples that can be mentioned are leaves, needles, stems, trunks, flowers and fruits.
    [0122] The active compounds of the invention, in combination with good tolerance in plants and favorable toxicity towards warm-blooded animals and with good tolerance to the environment are suitable to protect plants and plant organs to increase harvest yields, to improve the quality of the cultivated material. They can preferably be used as a phytoprotective medium. They act against normally sensitive and resistant types as well as against all stages of development or in some of them.
    [0123] The following plants can be mentioned as plants that can be treated according to the invention: cotton, flax, vines, fruit, vegetables, such as Rosaceae sp. (for example, pomegranate fruit, such as apples and pears, but also stone fruit, such as avocados, cherries, almonds and peaches and berries such as strawberries), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp. , Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (for example, banana trees and plantations), Rubiaceae sp. (for example, coffee), Theaceae sp., Sterculiceae sp., Rutaceae sp. (for example, lemons, oranges and grapefruits), Solanaceae sp. (for example, tomatoes), Liliaceae sp., Asteraceae sp. (for example, lettuce), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp. (for example, peinos), Alliaceae sp. (for example, leeks, onions), Papilionaceae sp. (for example, peas); larger crop plants, such as Gramineae sp. (for example, maize, grass, cereals such as wheat, rye, rice, barley, oats, millet and triticale), Asteraceae sp. (for example, sunflowers), Brassicaceae sp. (for example, white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, chard, kohlrabi, radish, and also oilseed rape, mustard, horseradish and watercress), Fabacae sp. (for example, beans, peanuts), Papilionaceae sp. (for example, soy beans), Solanaceae sp. (for example, potatoes), Chenopodiaceae sp. (eg sugar beet, fodder beet, chard, beet root); crop plants and ornamental garden and forest plants; and also respectively genetically modified varieties of these plants.
    [0124] As mentioned above, all plants or parts of plants can be treated according to the invention. In a preferred embodiment, naturally occurring plant types or obtained by conventional biological breeding methods such as crossing or fusing protoplasts and plant classes as well as their parts are treated. In another preferred embodiment, transgenic plants and plant classes that have been obtained through genetic engineering methods are eventually treated in combination with conventional methods (genetically modified organisms) and their parts. The term "parts" or "parts of plants" or "parts of plants" has been clarified above. Especially preferably plants are treated according to the invention of the classes of plants respectively commercial or in use. properties ("characteristics") that have been obtained by conventional breeding, mutagenesis or even by recombinant DNA techniques, which can be varieties, strains, biotypes and genotypes.
    [0125] In material protection the substances of the invention can be used for the protection of technical materials against infestation and destruction of unwanted fungi and / or microorganisms.
    [0126] Technical materials should be understood as materials not present in the present context that have been prepared for use in genetic engineering. For example, technical materials that must be protected against microbiological alteration or destruction by active materials of the invention may be adhesives, glues, paper and cardboard, textile materials, carpets, leather, wood, paint and plastic articles, cooling lubricants and other materials that they can be infested or destroyed by microorganisms. In terms of materials to be protected, we can also mention parts of production plants and buildings, for example, water-cooling circuits, cooling and heating systems and ventilation equipment and air conditioners that can be adversely attacked by the multiplication of microorganisms. . Industrial materials that can be mentioned preferably for the purposes of the present invention are glues, handles, paper and cardboard, leather, wood logs, paints, cold lubricants and heat transfer fluids, especially preferably wood logs. The active compositions or compounds according to the invention can avoid disadvantageous effects such as rotting, decomposition, discoloration, fading or the formation of mold. In addition, the compounds, according to the invention, can be used to protect against the vegetation layer of objects, especially ship hulls, sieves, nets, works, docks and signaling facilities, which are in contact with the water of the sea or brackish water. The treatment method according to the invention can also be used in the field of protection of stock goods against the attack of fungi and microorganisms. In this case, stock goods are understood to be natural substances of animal or vegetable origin or process products of these natural origins, for which long-term protection is desired. Stock goods of plant origin such as for example plants or plant parts, such as stems, leaves, tubers, seeds, fruits, grains, can be protected immediately after being harvested or after processing by (pre) drying, moistening, grinding, grinding, pressing or roasting. Stock goods also include logs, both unprocessed, such as construction timber, and poles of electricity and barriers, as well as in the form of finished products, such as furniture and objects made of wood. Stock goods of animal origin are, for example, animal skins, hides, pelts and hair and the like. The combinations according to the present invention can have disadvantageous events such as decay, disintegration, discoloration, fading or the formation of mold. Preferably the term "stock goods" should be understood to mean natural substances of vegetable origin and their processed forms, more preferably fruits and their processed forms such as pumice, stone fruit, berries and citrus and their processed forms.
    [0127] Some fungal disease pathogens that can be treated according to the invention can be mentioned by way of example, but not in a restrictive manner: Diseases caused by pathogens of powdery mold, such as, for example, species of Blumeria, such as example, Blumeria graminis; Podosphaera species, such as Podosphaera leucotrich; Sphaerotheca species such as Sphaerotheca fuliginea; Uncinula species such as Uncinula necator; Diseases caused by pathogens of rust disease such as, for example, Gymnosporangium species such as, for example, Gymnosporangium sabinae; Hemileia species such as Hemileia vastatrix; Phakopsora species, such as Phakopsora pachyrhizi and Phakopsora meibomiae; Puccinia species, such as, for example, Puccinia recondita, Puccinia graminis or Puccinia striformis; Uromyces species, such as Uromyces appendiculatus; Diseases caused by pathogens from the Oomycete group, such as, for example, Albugo species, such as, for example, Albugo cundida, Bremia species, such as, for example, Bremia lactucae; Peronospora species, such as for example Peronospora pisi or P. brassicae; Phytophthora species, such as for example Phytophthora infestans; Plasmopara species such as, for example, Plasmopara viticola; Pseudoperonospora species, such as, for example, Pseudoperonospora humuli or Pseudoperonospora cubensis; Pythium species, such as Pythium ultimum; Leaf spot diseases caused, for example, by Alternaria species, such as Alternaria solani; Cercospora species, such as Cercospora beticola; Cladiosporium species such as, for example, Cladiosporium cucumerinum; species of Cochliobolus, such as Cochliobolus sativus (conidia form: Drechslera, Sin: Helminthosporium) or Cochliobolw miyabeanus; Colletotrichum species, such as Colletotrichum lindemuthanium; Cycloconium species, such as Cycloconium oleaginum; Diaporthe species, such as Diaporthe citri; Elsinoe species, such as, for example, Elsinoe fawcettii; Gloeosporium species, such as Gloeosporium laeticolor; Glomerella species, such as Glomerella cingulata; Guignardia species, such as Guignardia bidwelli; Leptosphaeria species, such as Leptosphaeria maculans; Magnaporthe species, such as Magnaporthe grisea; Microdochium species, such as Microdochium nivale; Mycosphaerella species, such as, for example, Mycosphaerella graminicola, Mycosphaerella arachidicola or Mycosphaerella fijiensis; Phaeosphaeria species, such as Phaeosphaeria nodorum; Pyrenophora species, such as Pyrenophora teres or Pyrenophora tritici repentis; Ramularia species, such as Ramularia collo-cygni or Ramulania areola; Rhynchosporium species, such as Rhynchosporium secalis; Septoria species, such as Septoria apii or Septoria lycopersici; species of Stagonospora, such as, for example, Stagonospora nodorum; Typhula species, such as Typhula incarnata; Venturia species, such as Venturia inaequalis; Root and stem diseases caused, for example, by species of Corticium, such as, for example, Corticium graminearum; Fusarium species, such as Fusarium oxysporum; Gaeumannomyces species, such as Gaeumannomyces graminis; Plasmodiophora species, such as Plasmodiophora brassicae; Rhizoctonia species, such as Rhizoctonia solani; Sarocladium species, such as Sarocladium oryzae; Sclerotium species, such as Sclerotium oryzae; Tapesia species, such as Tapesia acuformis; Thielaviopsis species, such as Thielaviopsis basicola; Ear and panicle diseases (including ears of corn) caused, for example, by Alternaria species, such as Alternaria spp .; Aspergillus species, such as Aspergillus flavus; Cladosporium species, such as, for example, Cladosporium cladosporioides; species of Claviceps, such as, for example, Claviceps purpurea; Fusarium species, such as Fusarium culmorum; Gibberella species, such as Gibberella zeae; Monographella species, such as Monographella nivalis; Septoria species, such as Septoria nodorum; Diseases caused by sooty fungi, such as Sphacelotheca species, such as Sphacelotheca reiliana; Tilletia species, such as, for example, Tilletia caries or controversial Tilletia; Urocystis species, such as Urocystis occulta; Ustilago species, such as Ustilago nuda, U. nuda tritici; Fruit rot caused, for example, by Aspergillus species, such as Aspergillus flavus; Botrytis species, such as for example Botrytis cinerea; Penicillium species, such as for example Penicillium expansum or Penicillium purpurogenum; Rhizopus species, such as for example Rhizopus stolonifer; Sclerotinia species, such as for example Sclerotinia sclerotiorum; Verticilium species, such as Verticilium alboatrum; Seed and soil rot and wilt diseases and also sowing diseases, caused for example by Fusarium species, such as Fusarium culmorum; Phytophthora species, such as Phytophthora cactorum; Pythium species, such as Pythium ultimum; Rhizoctonia species, such as Rhizoctonia solani; Sclerotium species, such as, for example, Sclerotium rolfsii; Cancerous diseases, biles and witches' brooms, for example, by species of Nectria, such as, for example, Nectria galligena; Wilt caused, for example, by species of Monilinia, such as, for example, Monilinia laxa; Deformations of leaves, flowers and fruits caused, for example, by Exobasidium species, such as Exobasidium vexams; Taphrina species, such as Taphrina deformans; Degenerative diseases of cotton plants caused, for example by Esca species, such as, for example, Phaeomoniella chlamydospora, Phaeoacremonium aleophilum or Fomitiporia mediterranea; Diseases of flowers and seeds, for example, by Botrytis species, such as, for example, Botrytis cinerea; Diseases of plant tubers caused, for example, by Rhizoctonia species, such as, for example, Rhizoctonia solani; Helminthosporium species, such as Helminthosporium solani; Diseases caused by bacterial pathogens, such as Xanthomonas species, such as Xanthomonas campestris pv. oryzae; Pseudomonas species, such as Pseudomonas syringae pv. lachrymans; Erwinia species, such as Erwinia amylovora.
    [0128] Preferably, the following diseases of soy beans can be combated: fungal diseases of leaves, stems, pods and seeds caused by, for example, alternaria spot (Alternaria spec. Atrans tenuissima), anthracnose (Colletotrichum gloeosporoides dematium var. truncatum), brown spot (Septoria glycines), leaf spot by cercospora and pests (Cercospora kikuchii), leaf pest by choanephora (Choanephora infundibulifera trispora (Syn.)), leaf spot by dactuliophora (Dactuliophora glycines), mact (Peronospora manshurica), pest by drechslera (Drechslera glycini), leaf spot by fungus (Cercospora sojina), leaf spot by leptosphaerulina (Leptosphaerulina trifolii), leaf spot by (Phyllostictaoyaecola), pod pest and stem (Phomea pod), stem and stem pulvurulento (Microsphaera diffusa), leaf spot by pyrenochaeta (Pyrenochaeta glycines), rhizoctonia aerial, foliage pest, and minicuttings (Rhizoctonia solani), rust (Phakop sora pachyrhizi Phakopsora meibomiae), crust (Sphaceloma glycines), leaf pest by stemphylium (Stemphylium botryosum), target spot (Corynespora cassiicola). Fungal diseases of roots and at the base of the stem caused, for example, by black rot (Calonectria crotalariae), gray stem rot (Macrophomina phaseolina), fusarium or wilt pest, root rot, and pod and colon rot (Fusarium oxysporum , Fusarium orthoceras, Fusarium semitectum, Fusarium equiseti), root rot by mycoleptodiscus (Mycoleptodiscus terrestris), neocosmospora (Neocosmospora vasinfecta), pod and stem burning (Diaporthe phaseolorum), cancer on the stem (Diaporthe phaseolorum var. Caulivora). phytophthora (Phytophthora megasperma), brown stem rot (Phialophora gregata), pythium rot (Pythium aphanidermatum, Pythium irregulare, Pythium debaryanum, Pythium myriotylum, Pythium ultimum), root rot due to rhizoctonia, and rhizoctonia, ), stem decomposition by sclerotinia (Sclerotinia sclerotiorum), southern wilt by sclerotinia (Sclerotinia rolfsii), root rot by thie laviopsis (Thielaviopsis basicola).
    [0129] It is also possible to control strains resistant to the control of the organisms mentioned above.
    [0130] Microorganisms that can degrade or alter the industrial materials that we can mention are, for example, bacteria, fungi, yeasts, algae and viscous organisms. The active compounds according to the invention preferentially act against fungi, particularly molds, fading wood and wood destroying fungi (Basidiomycetes) and against viscous organisms and algae. Microorganisms of the following genera that we can mention as examples are: Alternaria, such as Alternaria tenuis; Aspergillus, such as Aspergillus niger; Chaetomium, such as Chaetomium globosum; Coniophora, such as Coniophora puetana; Lentinus, such as Lentinus tigrinus; Penicillium, such as Penicillium glaucum; Polyporus, such as Polyporus versicolor; Aureobasidium, such as Aureobasidium pullulans; Sclerophoma, such as Sclerophoma pityophila; Trichoderma, such as Trichoderma viride; Escherichia, such as Escherichia coli; Pseudomonas, such as Pseudomonas aeruginosa; Staphylococcus, such as Staphylococcus aureus.
    [0131] In addition, the compounds of formula (I) according to the invention also have very good antimycotic activity. They have a very extensive spectrum of animicotic activity, particularly against dermatophytes and yeasts, molds and diphasic fungi (for example, against Candida species such as Candida albicans, Candida glabrata) and Epidermophyton floccosum, Aspergillus species such as Aspergillus niger and Aspergillus fumigatus, species of Trichophyton such as Trichophyton mentagrophytes, Microsporon species such as Microsporon canis and audouinii. The relationship of these fungi does not under any circumstances represent a restriction of the mycotic spectrum that can be covered, but only by way of illustration.
    [0132] When applying the compounds according to the invention, the application rates can be varied within a wide range. The dose of active compound / application rate usually applied in the treatment method according to the invention is advantageous • in the treatment of plant parts, for example, leaves: from 0.1 to 10,000 g / ha, preferably from 10 to 1000 g / ha, particularly preferably from 50 to 300 g / ha if the application is made by watering or immersion, it is also possible to further reduce the application rate, particularly when inert substrates such as stone wool or perlite are used; • in seed treatment: from 2 to 200 g per 100 kg of seed, preferably from 3 to 150 g per 100 kg of seed, particularly preferably from 2.5 to 25 g per 100 kg of seed, very particularly preferably from 2, 5 to 12.5 g per 100 kg of seed; • in soil treatment: from 0.1 to 10,000 g / ha, preferably from 1 to 5000 g / ha.
    [0133] The doses indicated here are presented as illustrative examples of the method according to the invention. The person skilled in the art will know how to adapt the application rates, notably according to the nature of the plant or crop to be treated.
    [0134] The combination according to the invention can be used to protect plants within a determined time range after treatment with pests and / or phytopathogenic fungi and / or microorganisms. The range of time in which protection is carried out generally ranges from 1 to 28 days, preferably 1 to 14 days, more preferably 1 to 10 days, even more preferably 1 to 7 days after treatment of the plants with the combinations or up to 200 days after the treatment of plant propagation material.
    [0135] Furthermore, combinations and compositions according to the invention can also be used to reduce the levels of mycotoxins in plants and in plant material grown and therefore in food and animal feed made from them. Especially but not exclusively the following mycotoxins can be specified: Deoxynivalenol (DON), Nivalenol, 15-Ac-DON, 3-Ac-DON, T2- and HT2- Toxin, Fumonisin, Zearalenon, Moniliformin, Fusarin, Diaceotoxyscirpenol (DAS), Beauvericin, Enniatin, Fusaroproli-ferin, Fusarenol, Ochratoxin, Patulin, ergot alkaloid and Aflatoxin, which can arise for example from the following fungi: Fusarium species, such as Fusarium acuminatum, F. avenaceum, F. crookwellense, F. culmorum, F culmorum, F graminearum (Gibberella zeae), F. equiseti, F. fujikoroi, F. musarum, F. oxysporum, F. proliferatum, F. poae, F. pseudograminearum, F. sambucinum, F. scirpi, F. semitectum, F. solani , F. sporotrichoides, F. lang-sethiae, F. subglutinans, F. tricinctum, F. verticillioides among others as well as Aspergillus species, Penicillium species, Claviceps purpurea, Stachybotrys species among others.
    [0136] The present invention also relates to a composition as defined herein comprising at least one other active substance selected from the group of insecticides, attractants, sterilizers, bactericides, acaricides, nematicides, fungicides, growth regulators, herbicides, fertilizers, protective and semi-chemical agents. The present invention also relates to a method of controlling harmful phytopathogenic fungi characterized by the fact that the combination of active compound defined herein is applied to harmful phytopathogenic fungi and / or their habitat.
    [0137] The present invention also relates to a process for producing compositions for the control of harmful phytopathogenic fungi, characterized by the fact that a combination of active compound as defined herein is mixed with extenders and / or surfactants.
    [0138] The present invention also relates to the use of a combination of active compound as defined herein to control harmful phytopathogenic fungi.
    [0139] The present invention also relates to the use of a combination of active compound as defined herein for the treatment of transgenic plants.
    [0140] The present invention also relates to the use of a combination of active compound as defined herein for the treatment of seed of transgenic plants.
    [0141] The advanced fungicidal activity of the active compound combinations according to the invention is evident from the following example. While the individual compounds exhibit weaknesses in relation to the fungicidal activity, the combinations show an activity that goes beyond a simple addition of activities.
    [0142] A synergistic effect of fungicides is always present when the fungicidal activity of the active compound combinations exceeds the total activities of the active compounds, when applied individually. The expected activity for a given combination of two active compounds can be calculated as follows (cf. Colby, SR, "Calculating Synergistic and Antagonistic Responses of Herbicide combinations", Weeds 1967, 15, 2022): if X is effective when the compound A is applied at an application rate of x ppm (or g / ha), Y is effective when o when the active compound B is applied at an application rate of y ppm (or g / ha), AND is effective when active compounds A and B are applied at rates of application of x and y ppm (or g ha), respectively, and then at 100.
    [0143] The degree of effectiveness, expressed in% is shown. 0% means an efficacy that corresponds to that of the control whereas an efficacy of 100% means that no disease was found.
    [0144] If the current fungicidal activity exceeds the calculated value, then the activity of the combination is superadditive, i.e. a synergistic effect exists. In this case, the effectiveness that has been observed needs to be greater than the value for the expected effectiveness (E) calculated from the above formula.
    [0145] Another way of demonstrating a synergistic effect is the Tammes method (cf. "Isobols, the graphic representation of synergism in pesticides" in Neth. J. Plant Path., 1964, 70, 73-80).
    [0146] The invention is illustrated by the following examples. However, the invention is not limited to the example. Example 1: Phytophthora (tomatoes) / preventive test Solvent: 24.5 parts by weight of acetone 24.5 parts by weight of N, N-dimethylacetamide Emulsifier: 1 part by weight of alkylaryl polyglycol ether
    [0147] To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the indicated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
    [0148] For the preventive activity test, young plants are sprayed with the preparation of active compound at the indicated rate of application. After the spray coating has dried, the plants are inoculated with an aqueous spore suspension of Phytophthora infestans. The plants are then placed in an incubation chamber at approximately 20 ° C and a relative atmospheric humidity of 100%.
    [0149] The test is evaluated 3 days after inoculation. 0% means an efficacy that corresponds to that of the untreated control, while a 100% efficacy means that no disease was observed.
    [0150] The following table clearly shows that the observed activity of the active compound combination according to the invention is greater than the calculated activity, ie a synergistic effect is present. TABLE 1A: PHYTOPHTHORA TEST (TOMATOES) / PROTECTOR


    EXAMPLE 2: VENTURY TEST (APPLES) / PREVENTIVE Solvent: 24.5 parts by weight of acetone 24.5 parts by weight of N, N-dimethylacetamide Emulsifier: 1 part by weight of alkylaryl polyglycol ether
    [0151] To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the indicated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration. For the preventive activity test, young plants are sprayed with the preparation of active compound at the indicated rate of application. After the spray coating has dried, the plants are inoculated with an aqueous conidial suspension of the apple scab causal agent (Veturia inaequalis) and then permeate for 1 day in an incubation chamber at approximately 20 ° C and a relative atmospheric humidity of 100%.
    [0152] The plants are then placed at approximately 21 ° C and a relative atmospheric humidity of approximately 90%.
    [0153] The test is evaluated 10 days after inoculation. 0% means an efficacy that corresponds to that of the untreated control, while a 100% efficacy means that no disease was observed. The following table clearly shows that the observed activity


    * enc .: activity found ** calc .: activity found using Colby's formula EXAMPLE 3: ALTERNATE TEST (TOMATOES) / PREVENTIVE Solvent: 24.5 parts by weight of acetone 24.5 parts by weight of N, N-dimethylacetamide Emulsifier: 1 part by weight of alkylaryl polyglycol ether
    [0154] To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the indicated amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration.
    [0155] For the preventive activity test, young plants are sprayed with the preparation of active compound at the indicated rate of application. After the spray coating has dried, the plants are inoculated with an aqueous spore suspension of Alternaria solani. The plants are then placed in an incubation chamber at approximately 20 ° C and a relative atmospheric humidity of 100%. The test is evaluated 3 days after inoculation. 0% means an efficacy that corresponds to that of the untreated control whereas an efficacy of 100% means that no disease was observed.
    [0156] The following table clearly shows that the observed activity of the active compound combination according to the invention is greater than the calculated activity, ie a synergistic effect is present.


    EXAMPLE 4: SPHAEROTHECA TEST (PEPINOS) / PREVENTIVE Solvent: 24.5 parts by weight of acetone 24.5 parts by weight of N, N-dimethylacetamide Emulsifier: 1 part by weight of alkylaryl polyglycol ether
    [0157] To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the indicated amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration.
    [0158] To test the protective activity, young plants are sprayed with the preparation of active compound at the indicated rate of application. After the spray coating has dried, the plants are inoculated with an aqueous spore suspension of Sphaerotheca fuliginea. The plants are then placed at approximately 23 ° C and a relative atmospheric humidity of approximately 70%.
    [0159] The test is evaluated 7 days after inoculation. 0% means an efficacy that corresponds to that of the untreated control, while a 100% efficacy means that no disease was observed.
    [0160] The following table clearly shows that the observed activity of the active compound combination according to the invention is greater than the calculated activity, ie the synergistic effect is present.


    EXAMPLE 5: BOTRYTIS TEST (BEANS) / PREVENTIVE Solvent: 24.5 parts by weight of acetone 24.5 parts by weight of N, N-dimethylacetamide Emulsifier: 1 part by weight of alkylaryl polyglycol ether
    [0161] To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the indicated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
    [0162] For the preventive activity test, young plants are sprayed with the preparation of the active compound. After the spray coating has dried, 2 small pieces of agar coated with Botrytis clnerea growth are placed on each leaf. The plants are placed in a darkened chamber at 20 ° C and a relative atmospheric humidity of 100%.
    [0163] 2 days after inoculation, the size of the leaf lesions is analyzed. 0% means an efficacy that corresponds to that of the untreated control, while a 100% efficacy means that no disease was observed. The following table clearly shows that the observed activity of the active compound combination according to the invention is greater than the calculated activity, ie the synergistic effect is present.
    * enc .: activity found ** calc .: activity found using Colby's formula EXAMPLE 6: BLUMERIA TEST (BARLEY) / PREVENTIVE Solvent: 49 parts by weight of N, N-dimethylacetamide Emulsifier: 1 part by weight of alkylaryl polyglycol ether
    [0164] To produce a suitable preparation of active compound, 1 part by weight of active compound or combination of active compound is mixed with the indicated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
    [0165] For the preventive activity test, young plants are sprayed with the preparation of active compound or combination of active compound at the indicated rate of application.
    [0166] After the spray coating had dried, the plants were powdered with spores of of Blumeria gramlnis f.sp. hordei.
    [0167] The plants were placed in the greenhouse at a temperature of approximately 18 ° C and a relative atmospheric humidity of approximately 80% to promote the development of mold pustules. The test is evaluated 7 days after inoculation. 0% means an efficacy that corresponds to that of the untreated control, while a 100% efficacy means that no disease was observed.

    权利要求:
    Claims (9)
    [0001]
    1. COMBINATION OF ACTIVE COMPOUND, characterized by comprising: (A1) N-cyclopropyl-3- (difluoromethyl) -5-fluoro-N- (2-isopropylbenzyl) -1-methyl-1H-pyrazol-4-carboxamide or a salt agro-chemically acceptable, and (81) an additional active fungicidal compound B, selected from the group consisting of: cyproconazole (113096-99-4), epoxiconazole (106325-08-0), fenhexamid (126833-17-8 ), metconazole (125116-23-6), spiroxamine (11813430-8), tebuconazole (107534-96-3), protioconazole (178928-70-6), bixafen (581809-46-03), fluopiram (658066-35 -4), isopirazam (mixture of 1RS, 4SR, 9RS syn-epimeric racemate and 1RS, 4SR, 9SR anti-epimeric racemate) (8816558-1), penflufen (494793-67-8), pentiopirad (183675-82-3 ), silkxane (87496767-6), fluxpyroxad (907204-31-3), ametoctradin (865318-97-4), fluoxastrobin (361377-29-9), pyraclostrobin (175013-18-0), trifloxystrobin (141517-21 -7), fluopicolid (239110-15-7), chlorothalonil (1897-45-6), folpet (133-07-3), mancozeb (8018-01-7), propineb (12071-83-9 ), isothianyl (224049-04-1), pyrimethanil (5311228-0), iprovalicarb (140923-17-7), propamocarb (25606-41-1), metalaxyl (5783719-1), metalaxyl-M (mefenoxam) ( 70630-17-0), fludioxonil (131341-86-1), fosetyl- Al (39148-24-8), N '- (4 - {[3- (4-chlorobenzyl) -1,2,4-thiadiazole -5-yl] oxy} -2,5-dimethylphenyl) - N-ethyl-N-methylimidoformamide, and salts thereof; or (A2) N- (5-chloro-2-isopropylbenzyl) -N-cyclopropyl-3- (difluoromethyl) -5-fluoro-1-methyl-1H-pyrazol-4-carboxamide or an agrochemically acceptable salt thereof, and (B2) an additional active fungicidal compound B, selected from the group consisting of: cyproconazole (113096-99-4), epoxiconazole (106325-08-0), fenhexamid (126833-17-8), metconazole (125116- 23-6), propiconazole (6020790-1), protioconazole (178928-70-6), spiroxamine (118134-30-8), tebuconazole (107534-96-3), bixafen (581809-46-03), fluopiram ( 658066-35-4), isopirazam (mixture of syn-epimeric racemate 1RS, 4SR, 9RS and anti-epimeric racemate 1RS, 4SR, 9SR) (88165-58-1), penflufen (494793-67-8), pentiopirad ( 18367582-3), silkxane (874967-67-6), fluxpyroxad (907204-31-3), benzovindiflupir, azoxystrobin (131860- 33-8), fluoxastrobin (361377-29-9), pyraclostrobin (175013-18-0 ), trifloxystrobin (141517-21-7), fluopicolid (239110-15-7), chlorothalonil (1897-45-6), folpet (133-07-3), mancozeb (8018-01-7), propineb (12071 -83-9), pir imetanil (53112-28-0), propamocarb (25606-41-1), metalaxyl (57837-19-1), metalaxyl-M (mefenoxam) (70630-17-0), fludioxonil (131341-861), fosetil- Al (39148-24-8), 2,6-dimethyl-1H, 5H- [1,4] dithiino [2,3-c: 5,6-c '] dipyrrol- 1,3,5,7 (2H , 6H) -tetrone, diphenoconazole, (3S, 6S, 7R, 8R) -8-benzyl-3 - [({3- [(isobutyryloxy) methoxy] -4-methoxypyridin-2-yl} carbonyl) amino] -6 -methyl-4,9-dioxo-1,5-dioxonan-7-yl 2-methylpropanoate, and salts thereof; or (A3) N-cyclopropyl-3- (difluoromethyl) -5-fluoro-N- (5-fluoro-2-isopropylbenzyl) -1-methyl-1H-pyrazol-4-carboxamide or an agrochemically acceptable salt thereof, and (B3) an additional active fungicidal compound B, selected from the group consisting of: protioconazole (178928-70-6), tebuconazole (107534-96-3), bixafen (581809-46-03), and salts thereof ; or (A4) N-cyclopropyl-3- (difluoromethyl) -5-fluoro-N- (2-isopropyl-5-methylbenzyl) -1-methyl-1H-pyrazol-4-carboxamide or an agrochemically acceptable salt thereof, and (B4) an additional active fungicidal compound B, selected from the group consisting of: protioconazole (178928-70-6), tebuconazole (107534-96-3), bixafen (581809-46-03), and salts thereof ; or (A5) N- [5-chloro-2- (trifluoromethyl) benzyl] -N-cyclopropyl-3- (difluoromethyl) -5-fluoro-1-methyl-1H-pyrazol-4-carboxamide or an agrochemical acceptable salt of same, and (85) an additional active fungicidal compound B, selected from the group consisting of: cyproconazole (113096-99-4), epoxiconazole (106325-08-0), fenhexamid (126833-17-8), metconazole (125116-23-6), propiconazole (6020790-1), protioconazole (178928-70-6), spiroxamine (118134-30-8), tebuconazole (107534-96-3), bixafen (581809-46-03) , fluopiram (658066-35-4), isopirazam (mixture of syn-epimeric racemate 1RS, 4SR, 9RS and anti-epimeric racemate 1RS, 4SR, 9SR) (88165-58-1), penflufen (494793-67-8) , pentiopirad (18367582-3), silkxane (874967-67-6), fluxpyroxad (907204-31-3), ametoctradin (865318-97-4), azoxystrobin (131860- 33-8), fluoxastrobin (361377-29- 9), pyraclostrobin (175013-18-0), trifloxystrobin (141517-21-7), fluopicolid (239110-15-7), chlorothalonil (1897-45-6), folpet (133-07-3), mancozeb ( 8018-017), propineb ( 12071-83-9), isothianyl (224049-04-1), pyrimethanil (53112-28-0), propamocarb (25606-41-1), metalaxyl (57837-19-1), fludioxonil (131341-86-1 ), fosetyl-Al (39148 -24-8), and salts thereof; or (A6) N- [2-chloro-6- (trifluoromethyl) benzyl] -N-cyclopropyl-3- (difluoromethyl) -5-fluoro-1-methyl-1H-pyrazol-4-carboxamide or an agrochemical acceptable salt of same, and (86) an additional active fungicidal compound B, selected from the group consisting of: cyproconazole (113096-99-4), fenhexamid (126833-17-8), metconazole (125116-23-6), propiconazole (60207-90-1), protioconazole (17892870-6), tebuconazole (107534-96-3), spiroxamine (118134-30-8), bixafen (581809-46-03), fluopyram (658066-35-4) , isopirazam (mixture of syn-epimeric racemate 1RS, 4SR, 9RS and anti-epimeric racemate 1RS, 4SR, 9SR) (8816558-1), penflufen (494793-67-8), pentiopirad (183675-82-3), silkxane (87496767-6), fluxpyroxad (907204-31-3), ametoctradin (865318-97-4), azoxystrobin (131860-33-8), fluoxastrobin (361377-29-9), pyraclostrobin (175013-18-0) , trifloxystrobin (141517-21-7), fluopicolid (239110-15-7), chlorothalonil (1897-456), folpet (133-07-3), mancozeb (8018-01-7), propineb (12071-83- 9), isothianyl (22404 9-04-1), pyrimethanil (53112-28-0), iprovalicarb (140923-17-7), propamocarb (25606-41-1), metalaxyl (57837-19-1), fludioxonil (131341-86-1 ), fosetyl-Al (39148 -24-8), and salts thereof; or (A7) N- [3-chloro-2-fluoro-6- (trifluoromethyl) benzyl] -N-cyclopropyl-3- (difluoromethyl) -5-fluoro-1-methyl-1H-pyrazol-4-carboxamide or agro-chemically acceptable salt thereof, and (87) an additional active fungicidal compound B, selected from the group consisting of: cyproconazole (113096-99-4), epoxiconazole (106325-08-0), fenhexamid (126833-17- 8), metconazole (125116-23-6), propiconazole (6020790-1), protioconazole (178928-70 -6), tebuconazole (107534-96-3), bixafen (581809-46-03), fluopiram (658066- 35-4), isopirazam (mixture of syn-epimeric racemate 1RS, 4SR, 9RS and anti-epimeric racemate 1RS, 4SR, 9SR) (8816558-1), penflufen (494793-67-8), fluxpyroxad (907204-31- 3), ametoctradin (865318-97-4), azoxystrobin (131860- 33-8), fluoxastrobin (361377-29-9), pyraclostrobin (175013-18-0), trifloxystrobin (141517-21-7), chlorothalonil ( 189745-6), folpet (133-07-3), mancozeb (8018-01-7), propineb (12071-83-9), isothianyl (224049-04-1), pyrimethanil (53112-28-0), iprovalicarb (140923-17-7), pr opamocarb (25606-41-1), metalaxyl (57837-19-1), metalaxyl-M (mefenoxam) (70630-17-0), fludioxonil (131341-86-1), fosetyl-Al (39148 -24-8 ), and salts thereof.
    [0002]
    2. COMBINATION OF ACTIVE COMPOUND, according to claim 1, characterized by the fact that the weight ratio of A: B is in the range of 1000: 1 to 1: 1000.
    [0003]
    3. COMBINATION OF ACTIVE COMPOUND, according to claim 1, characterized by the fact that the weight ratio of A: B is in the range of 100: 1 to 1: 100.
    [0004]
    4. COMPOSITION FOR THE CONTROL OF HARMFUL PHYTOPATHOGENIC FUNGI, characterized by a content of an active compound combination, as defined in any one of claims 1 to 3, in addition to extenders and / or surfactants.
    [0005]
    5. METHOD FOR THE CONTROL OF HARMFUL PHYTOPATHOGENIC FUNGI, characterized in that a combination of active compound, as defined in any one of claims 1 to 3, is applied to harmful phytopathogenic fungi and / or their habitats.
    [0006]
    6. PROCESS FOR THE PRODUCTION OF COMPOSITIONS FOR THE CONTROL OF HARMFUL PHYTOPHOGENIC FUNGI, characterized in that a combination of active compound, as defined in any one of claims 1 to 3, is mixed with extenders and / or surfactants.
    [0007]
    7. USE OF AN ACTIVE COMPOUND COMBINATION, as defined in any one of claims 1 to 3, characterized by being for the control of harmful phytopathogenic fungi.
    [0008]
    8. USE OF AN ACTIVE COMPOUND COMBINATION, as defined in any one of claims 1 to 3, characterized by being for the treatment of transgenic plants.
    [0009]
    9. USE OF AN ACTIVE COMPOUND COMBINATION, as defined in any one of claims 1 to 3, characterized in that it is for the treatment of seed and seed of transgenic plants.
    类似技术:
    公开号 | 公开日 | 专利标题
    US11147274B2|2021-10-19|Active compound combinations containing a thiazoylisoxazoline and a fungicide
    JP5870186B2|2016-02-24|Active compound combination comprising | carboxamide derivative and fungicidal active compound
    US9668477B2|2017-06-06|Active compound combinations
    KR20120090049A|2012-08-16|Synergistic fungicidal combinations containing a dithino-tetracarboxamide fungicide
    WO2011051243A1|2011-05-05|Active compound combinations
    JP6148332B2|2017-06-14|Combinations of active compounds comprising lipochitooligosaccharide derivatives and nematocide, insecticide or fungicide compounds
    BR112015004938B1|2020-07-28|synergistic fungicidal combinations comprising an amidine compound and an ergosterol biosynthesis inhibitor, their uses and methods for the control of phytopathogenic fungi
    AU2012244533B8|2016-06-16|Active compound combinations comprising a |carboxamide derivative and a fungicidal compound
    同族专利:
    公开号 | 公开日
    CN103635089A|2014-03-12|
    PL2699093T3|2016-04-29|
    BR112013027091A8|2018-01-16|
    WO2012143127A1|2012-10-26|
    LT2997825T|2019-02-25|
    MX2013012123A|2014-01-23|
    HRP20160061T1|2016-02-12|
    CO6831988A2|2014-01-10|
    PT2997825T|2019-03-25|
    HUE043158T2|2019-08-28|
    CN103635089B|2016-12-14|
    EA023712B1|2016-07-29|
    US20140038823A1|2014-02-06|
    PL2997825T3|2019-05-31|
    DK2997825T3|2019-03-11|
    EA029682B1|2018-04-30|
    EP2997825B1|2018-11-07|
    EP2997825A1|2016-03-23|
    CL2013003060A1|2014-08-01|
    US20210227828A1|2021-07-29|
    TR201901837T4|2019-03-21|
    CL2016003013A1|2017-12-29|
    AU2012244533A1|2012-10-26|
    NZ617827A|2015-05-29|
    HRP20190244T1|2019-04-05|
    WO2012143127A8|2012-12-27|
    AU2012244533B2|2016-06-09|
    AR086467A1|2013-12-18|
    AU2012244533A8|2016-06-16|
    AR116462A2|2021-05-12|
    EA201391566A1|2014-02-28|
    CA2833749A1|2012-10-26|
    DK2699093T3|2016-02-01|
    PT2699093E|2016-03-04|
    EA201501060A1|2016-08-31|
    JP5870186B2|2016-02-24|
    ECSP13013035A|2015-03-31|
    JP2014514311A|2014-06-19|
    EP2699093B1|2015-11-04|
    BR112013027091A2|2016-07-26|
    ES2561296T3|2016-02-25|
    KR20140028017A|2014-03-07|
    EP2699093A1|2014-02-26|
    HUE026627T2|2016-06-28|
    ES2714714T3|2019-05-29|
    MX346208B|2017-03-09|
    ZA201308770B|2016-08-31|
    KR101974227B1|2019-04-30|
    CA2833749C|2019-06-04|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US2036008A|1934-11-07|1936-03-31|White Martin Henry|Plug fuse|
    US3247908A|1962-08-27|1966-04-26|Robook Nicolay Nikolaevich|Adjustable blades hydraulic turbine runner|
    US4272417A|1979-05-22|1981-06-09|Cargill, Incorporated|Stable protective seed coating|
    US4245432A|1979-07-25|1981-01-20|Eastman Kodak Company|Seed coatings|
    US4761373A|1984-03-06|1988-08-02|Molecular Genetics, Inc.|Herbicide resistance in plants|
    US5331107A|1984-03-06|1994-07-19|Mgi Pharma, Inc.|Herbicide resistance in plants|
    US5304732A|1984-03-06|1994-04-19|Mgi Pharma, Inc.|Herbicide resistance in plants|
    ES2018274T5|1986-03-11|1996-12-16|Plant Genetic Systems Nv|VEGETABLE CELLS RESISTANT TO GLUTAMINE SYNTHETASE INHIBITORS, PREPARED BY GENETIC ENGINEERING.|
    US5276268A|1986-08-23|1994-01-04|Hoechst Aktiengesellschaft|Phosphinothricin-resistance gene, and its use|
    US5637489A|1986-08-23|1997-06-10|Hoechst Aktiengesellschaft|Phosphinothricin-resistance gene, and its use|
    US5273894A|1986-08-23|1993-12-28|Hoechst Aktiengesellschaft|Phosphinothricin-resistance gene, and its use|
    US5378824A|1986-08-26|1995-01-03|E. I. Du Pont De Nemours And Company|Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase|
    US5605011A|1986-08-26|1997-02-25|E. I. Du Pont De Nemours And Company|Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase|
    US5013659A|1987-07-27|1991-05-07|E. I. Du Pont De Nemours And Company|Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase|
    US4808430A|1987-02-27|1989-02-28|Yazaki Corporation|Method of applying gel coating to plant seeds|
    US5638637A|1987-12-31|1997-06-17|Pioneer Hi-Bred International, Inc.|Production of improved rapeseed exhibiting an enhanced oleic acid content|
    GB8810120D0|1988-04-28|1988-06-02|Plant Genetic Systems Nv|Transgenic nuclear male sterile plants|
    US5084082A|1988-09-22|1992-01-28|E. I. Du Pont De Nemours And Company|Soybean plants with dominant selectable trait for herbicide resistance|
    US6013861A|1989-05-26|2000-01-11|Zeneca Limited|Plants and processes for obtaining them|
    DK0412911T3|1989-08-10|2001-10-29|Aventis Cropscience Nv|Plants with modified flowers|
    US5739082A|1990-02-02|1998-04-14|Hoechst Schering Agrevo Gmbh|Method of improving the yield of herbicide-resistant crop plants|
    US5908810A|1990-02-02|1999-06-01|Hoechst Schering Agrevo Gmbh|Method of improving the growth of crop plants which are resistant to glutamine synthetase inhibitors|
    AT152572T|1990-04-04|1997-05-15|Pioneer Hi Bred Int|MANUFACTURE OF RAPESEED WITH A REDUCED LEVEL OF SATURATED FATTY ACIDS|
    US6395966B1|1990-08-09|2002-05-28|Dekalb Genetics Corp.|Fertile transgenic maize plants containing a gene encoding the pat protein|
    US5198599A|1990-06-05|1993-03-30|Idaho Resarch Foundation, Inc.|Sulfonylurea herbicide resistance in plants|
    AU655197B2|1990-06-25|1994-12-08|Monsanto Technology Llc|Glyphosate tolerant plants|
    FR2667078B1|1990-09-21|1994-09-16|Agronomique Inst Nat Rech|DNA SEQUENCE GIVING MALE CYTOPLASMIC STERILITY, MITOCHONDRIAL, MITOCHONDRIA AND PLANT CONTAINING THE SAME, AND PROCESS FOR THE PREPARATION OF HYBRIDS.|
    DE4104782B4|1991-02-13|2006-05-11|Bayer Cropscience Gmbh|Novel plasmids containing DNA sequences that cause changes in carbohydrate concentration and carbohydrate composition in plants, as well as plants and plant cells containing these plasmids|
    US5731180A|1991-07-31|1998-03-24|American Cyanamid Company|Imidazolinone resistant AHAS mutants|
    US6270828B1|1993-11-12|2001-08-07|Cargrill Incorporated|Canola variety producing a seed with reduced glucosinolates and linolenic acid yielding an oil with low sulfur, improved sensory characteristics and increased oxidative stability|
    DE4227061A1|1992-08-12|1994-02-17|Inst Genbiologische Forschung|A polyfructane sucrase DNA sequence from Erwinia Amylovora|
    GB9218185D0|1992-08-26|1992-10-14|Ici Plc|Novel plants and processes for obtaining them|
    EP0664835B1|1992-10-14|2004-05-19|Syngenta Limited|Novel plants and processes for obtaining them|
    GB9223454D0|1992-11-09|1992-12-23|Ici Plc|Novel plants and processes for obtaining them|
    AU684068B2|1993-03-25|1997-12-04|Syngenta Participations Ag|Novel pesticidal proteins and strains|
    EP1329154A3|1993-04-27|2004-03-03|Cargill, Inc.|Non-hydrogenated canola oil for food applications|
    WO1995004826A1|1993-08-09|1995-02-16|Institut Für Genbiologische Forschung Berlin Gmbh|Debranching enzymes and dna sequences coding them, suitable for changing the degree of branching of amylopectin starch in plants|
    DE4330960C2|1993-09-09|2002-06-20|Aventis Cropscience Gmbh|Combination of DNA sequences that enable the formation of highly amylose-containing starch in plant cells and plants, processes for producing these plants and the modified starch that can be obtained therefrom|
    CN1066487C|1993-10-01|2001-05-30|三菱商事株式会社|Gene that identifies sterile plant cytoplasm and process for preparing hybrid plant by using the same|
    AU692791B2|1993-10-12|1998-06-18|Agrigenetics, Inc.|Brassica napus variety AG019|
    US5908975A|1993-11-09|1999-06-01|E. I. Du Pont De Nemours And Company|Accumulation of fructans in plants by targeted expression of bacterial levansucrase|
    AU688006B2|1994-03-25|1998-03-05|Brunob Ii B.V.|Method for producing altered starch from potato plants|
    DK0759993T3|1994-05-18|2007-11-12|Bayer Bioscience Gmbh|DNA sequences encoding enzymes capable of facilitating the synthesis of linear alpha 1,4-glucans in plants, fungi and microorganisms|
    US5824790A|1994-06-21|1998-10-20|Zeneca Limited|Modification of starch synthesis in plants|
    CN1156951A|1994-06-21|1997-08-13|曾尼卡有限公司|Novel plants and processes for obtaining them|
    NL1000064C1|1994-07-08|1996-01-08|Stichting Scheikundig Onderzoe|Production of oligosaccharides in transgenic plants.|
    DE4441408A1|1994-11-10|1996-05-15|Inst Genbiologische Forschung|DNA sequences from Solanum tuberosum encoding enzymes involved in starch synthesis, plasmids, bacteria, plant cells and transgenic plants containing these sequences|
    DE19528046A1|1994-11-21|1996-05-23|Bayer Ag|New sulphur substd tri:azole derivs|
    DE4447387A1|1994-12-22|1996-06-27|Inst Genbiologische Forschung|Debranching enzymes from plants and DNA sequences encoding these enzymes|
    DK0795018T3|1995-01-06|2008-01-21|Plant Res Int Bv|DNA sequences encoding carbohydrate polymer synthesizing enzymes and method for producing transgenic plants|
    DE19509695A1|1995-03-08|1996-09-12|Inst Genbiologische Forschung|Process for the preparation of a modified starch in plants, and the modified starch isolatable from the plants|
    BR9604993B1|1995-04-20|2009-05-05|a mutant encoding a mutant ahas protein of acetohydroxy acid synthesis and mutant ahas proteins.|
    US5853973A|1995-04-20|1998-12-29|American Cyanamid Company|Structure based designed herbicide resistant products|
    WO1996034968A2|1995-05-05|1996-11-07|National Starch And Chemical Investment Holding Corporation|Improvements in or relating to plant starch composition|
    FR2734842B1|1995-06-02|1998-02-27|Rhone Poulenc Agrochimie|DNA SEQUENCE OF A HYDROXY-PHENYL PYRUVATE DIOXYGENASE GENE AND OBTAINING PLANTS CONTAINING A HYDROXY-PHENYL PYRUVATE DIOXYGENASE GENE, TOLERANT TO CERTAIN HERBICIDES|
    US5712107A|1995-06-07|1998-01-27|Pioneer Hi-Bred International, Inc.|Substitutes for modified starch and latexes in paper manufacture|
    US6284479B1|1995-06-07|2001-09-04|Pioneer Hi-Bred International, Inc.|Substitutes for modified starch and latexes in paper manufacture|
    GB9513881D0|1995-07-07|1995-09-06|Zeneca Ltd|Improved plants|
    FR2736926B1|1995-07-19|1997-08-22|Rhone Poulenc Agrochimie|5-ENOL PYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE MUTEE, CODING GENE FOR THIS PROTEIN AND PROCESSED PLANTS CONTAINING THIS GENE|
    DK1435205T3|1995-09-19|2010-03-29|Bayer Bioscience Gmbh|Process for preparing a modified starch|
    GB9524938D0|1995-12-06|1996-02-07|Zeneca Ltd|Modification of starch synthesis in plants|
    DE19601365A1|1996-01-16|1997-07-17|Planttec Biotechnologie Gmbh|Nucleic acid molecules from plants encoding enzymes involved in starch synthesis|
    DE19608918A1|1996-03-07|1997-09-11|Planttec Biotechnologie Gmbh|Nucleic Acid Molecules Encoding New Debranching Enzymes from Maize|
    US5773704A|1996-04-29|1998-06-30|Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College|Herbicide resistant rice|
    DE19618125A1|1996-05-06|1997-11-13|Planttec Biotechnologie Gmbh|Nucleic acid molecules that encode new potato debranching enzymes|
    DE19619918A1|1996-05-17|1997-11-20|Planttec Biotechnologie Gmbh|Nucleic acid molecules encoding soluble starch synthases from maize|
    DE69737448T2|1996-05-29|2007-11-15|Bayer Cropscience Ag|NUCLEIC ACID MOLECULES CODING FOR ENZYMES FROM WHEAT INVOLVED IN STARCH SYNTHESIS|
    WO1997047807A1|1996-06-12|1997-12-18|Pioneer Hi-Bred International, Inc.|Substitutes for modified starch in paper manufacture|
    JP2001503607A|1996-06-12|2001-03-21|パイオニアハイ―ブレッドインターナショナル，インコーポレイテッド|A substitute for modified starch in papermaking.|
    AU731253B2|1996-06-12|2001-03-29|Pioneer Hi-Bred International, Inc.|Substitutes for modified starch in paper manufacture|
    US5876739A|1996-06-13|1999-03-02|Novartis Ag|Insecticidal seed coating|
    AUPO069996A0|1996-06-27|1996-07-18|Australian National University, The|Manipulation of plant cellulose|
    US5850026A|1996-07-03|1998-12-15|Cargill, Incorporated|Canola oil having increased oleic acid and decreased linolenic acid content|
    US5773702A|1996-07-17|1998-06-30|Board Of Trustees Operating Michigan State University|Imidazolinone herbicide resistant sugar beet plants|
    GB9623095D0|1996-11-05|1997-01-08|Nat Starch Chem Invest|Improvements in or relating to starch content of plants|
    US6232529B1|1996-11-20|2001-05-15|Pioneer Hi-Bred International, Inc.|Methods of producing high-oil seed by modification of starch levels|
    DE19653176A1|1996-12-19|1998-06-25|Planttec Biotechnologie Gmbh|New maize nucleic acid molecules and their use to produce a modified starch|
    CA2193938A1|1996-12-24|1998-06-24|David G. Charne|Oilseed brassica containing an improved fertility restorer gene for ogura cytoplasmic male sterility|
    US5981840A|1997-01-24|1999-11-09|Pioneer Hi-Bred International, Inc.|Methods for agrobacterium-mediated transformation|
    DE19708774A1|1997-03-04|1998-09-17|Max Planck Gesellschaft|Enzymes encoding nucleic acid molecules which have fructosyl polymerase activity|
    DE19709775A1|1997-03-10|1998-09-17|Planttec Biotechnologie Gmbh|Nucleic acid molecules encoding corn starch phosphorylase|
    AR012335A1|1997-04-03|2000-10-18|Dekalb Genetics Corp|TRANSGENIC FERTILIZER CORN PLANT AND METHOD FOR PREPARING IT, SUCH ENDOGAMIC AND CROSS-RAISED PLANTS RESISTANT TO GLYPHOSATE, METHODS TO GROW AND INCREASE YIELD OF CORN, PRODUCE FORAGE, FOOD FOR HUMAN BEINGS, STARCHES, AND CRIED|
    GB9718863D0|1997-09-06|1997-11-12|Nat Starch Chem Invest|Improvements in or relating to stability of plant starches|
    DE19749122A1|1997-11-06|1999-06-10|Max Planck Gesellschaft|Enzymes encoding nucleic acid molecules that have fructosyl transferase activity|
    FR2770854B1|1997-11-07|2001-11-30|Rhone Poulenc Agrochimie|DNA SEQUENCE OF A GENE OF HYDROXY-PHENYL PYRUVATE DIOXYGENASE AND PRODUCTION OF PLANTS CONTAINING SUCH A GENE, HERBICIDE TOLERANT|
    FR2772789B1|1997-12-24|2000-11-24|Rhone Poulenc Agrochimie|PROCESS FOR THE ENZYMATIC PREPARATION OF HOMOGENTISATE|
    AU3478499A|1998-04-09|1999-11-01|E.I. Du Pont De Nemours And Company|Starch r1 phosphorylation protein homologs|
    DE19820608A1|1998-05-08|1999-11-11|Hoechst Schering Agrevo Gmbh|New nucleic acid encoding isoamylase from wheat and related transgenic plants producing starch with altered properties|
    DE19820607A1|1998-05-08|1999-11-11|Hoechst Schering Agrevo Gmbh|New enzyme with starch synthase activity, useful for producing starch for foods and packaging materials|
    DE59913709D1|1998-05-13|2006-09-07|Bayer Bioscience Gmbh|TRANSGENIC PLANTS WITH CHANGED ACTIVITY OF A PLASTIC ADP / ATP TRANSLOCATOR|
    DE19821614A1|1998-05-14|1999-11-18|Hoechst Schering Agrevo Gmbh|Sugar beet mutants which are tolerant to sulfonylurea herbicides|
    DK1092033T3|1998-06-15|2009-05-18|Brunob Ii Bv|Improvements to or relating to plants and plant products|
    US6693185B2|1998-07-17|2004-02-17|Bayer Bioscience N.V.|Methods and means to modulate programmed cell death in eukaryotic cells|
    DE19836097A1|1998-07-31|2000-02-03|Hoechst Schering Agrevo Gmbh|Nucleic acid molecules coding for an alpha-glucosidase, plants that synthesize a modified starch, process for producing the plants, their use and the modified starch|
    DE19836099A1|1998-07-31|2000-02-03|Hoechst Schering Agrevo Gmbh|Nucleic acid molecules coding for a β-amylase, plants which synthesize a modified starch, process for the preparation of the plants, their use and the modified starch|
    DE19836098A1|1998-07-31|2000-02-03|Hoechst Schering Agrevo Gmbh|Plants that synthesize a modified starch, process for producing the plants, their use and the modified starch|
    AU6018399A|1998-08-25|2000-03-14|Pioneer Hi-Bred International, Inc.|Plant glutamine: fructose-6-phosphate amidotransferase nucleic acids|
    EP1109916A1|1998-09-02|2001-06-27|Planttec Biotechnologie GmbH|Nucleic acid molecules encoding an amylosucrase|
    DK1117802T3|1998-10-09|2010-05-25|Bayer Bioscience Gmbh|Nucleic acid molecules encoding a branching enzyme from bacteria of the genus Neisseria as well as a process for producing alpha-1,6-branched alpha-1,4-glucans|
    AU1336200A|1998-11-03|2000-05-22|Aventis Cropscience N.V.|Glufosinate tolerant rice|
    US6333449B1|1998-11-03|2001-12-25|Plant Genetic Systems, N.V.|Glufosinate tolerant rice|
    EP1131452B1|1998-11-09|2014-01-22|Bayer CropScience Aktiengesellschaft|Nucleic acid molecules from rice and their use for the production of modified starch|
    US6503904B2|1998-11-16|2003-01-07|Syngenta Crop Protection, Inc.|Pesticidal composition for seed treatment|
    US6531648B1|1998-12-17|2003-03-11|Syngenta Participations Ag|Grain processing method and transgenic plants useful therein|
    DE19905069A1|1999-02-08|2000-08-10|Planttec Biotechnologie Gmbh|Alternansucrase encoding nucleic acid molecules|
    US6323392B1|1999-03-01|2001-11-27|Pioneer Hi-Bred International, Inc.|Formation of brassica napus F1 hybrid seeds which exhibit a highly elevated oleic acid content and a reduced linolenic acid content in the endogenously formed oil of the seeds|
    AU4133100A|1999-04-29|2000-11-17|Syngenta Limited|Herbicide resistant plants|
    IL146063D0|1999-04-29|2002-07-25|Marlow Foods Ltd|Herbicide resistant plants|
    DE19924342A1|1999-05-27|2000-11-30|Planttec Biotechnologie Gmbh|Genetically modified plant cells and plants with increased activity of an amylosucrase protein and a branching enzyme|
    DE19926771A1|1999-06-11|2000-12-14|Aventis Cropscience Gmbh|Nucleic acid molecules from wheat, transgenic plant cells and plants and their use for the production of modified starch|
    DE19937348A1|1999-08-11|2001-02-22|Aventis Cropscience Gmbh|Nucleic acid molecules from plants encoding enzymes involved in starch synthesis|
    DE19937643A1|1999-08-12|2001-02-22|Aventis Cropscience Gmbh|Transgenic cells and plants with altered activity of the GBSSI and BE proteins|
    WO2001014569A2|1999-08-20|2001-03-01|Basf Plant Science Gmbh|Increasing the polysaccharide content in plants|
    US6423886B1|1999-09-02|2002-07-23|Pioneer Hi-Bred International, Inc.|Starch synthase polynucleotides and their use in the production of new starches|
    US6472588B1|1999-09-10|2002-10-29|Texas Tech University|Transgenic cotton plants with altered fiber characteristics transformed with a sucrose phosphate synthase nucleic acid|
    GB9921830D0|1999-09-15|1999-11-17|Nat Starch Chem Invest|Plants having reduced activity in two or more starch-modifying enzymes|
    AR025996A1|1999-10-07|2002-12-26|Valigen Us Inc|NON-TRANSGENIC PLANTS RESISTANT TO HERBICIDES.|
    US6509516B1|1999-10-29|2003-01-21|Plant Genetic Systems N.V.|Male-sterile brassica plants and methods for producing same|
    US6506963B1|1999-12-08|2003-01-14|Plant Genetic Systems, N.V.|Hybrid winter oilseed rape and methods for producing same|
    US6395485B1|2000-01-11|2002-05-28|Aventis Cropscience N.V.|Methods and kits for identifying elite event GAT-ZM1 in biological samples|
    DE60111613T2|2000-03-09|2006-05-18|Monsanto Technology Llc.|METHOD FOR PRODUCING GLYPHOSATE TOLERANT PLANTS|
    ES2414438T3|2000-03-09|2013-07-19|E.I. Du Pont De Nemours And Company|Sunflower plants tolerant to sulfonylureas|
    US6768044B1|2000-05-10|2004-07-27|Bayer Cropscience Sa|Chimeric hydroxyl-phenyl pyruvate dioxygenase, DNA sequence and method for obtaining plants containing such a gene, with herbicide tolerance|
    BRPI0100752B1|2000-06-22|2015-10-13|Monsanto Co|DNA Molecules and Pairs of Molecules, Processes for Detecting DNA Molecules and for Creating a Glyphosate Tolerant Trait in Corn Plants, as well as DNA Detection Kit|
    US6713259B2|2000-09-13|2004-03-30|Monsanto Technology Llc|Corn event MON810 and compositions and methods for detection thereof|
    BR0114322A|2000-09-29|2004-06-15|Syngenta Ltd|Glyphosate-resistant epsps enzyme, isolated polynucleotide, vector, plant material, fertile, morphologically normal whole plants, soybean, canola, brassica, cotton, sugar beet, sunflower, peas, potatoes and weeds, methods for selectively controlling weeds in a field, and to produce plants that are substantially tolerant or substantially resistant to glyphosate herbicide, use of polynucleotide, methods for selecting transformed biological material to express a gene of interest, and for regenerating a transformed fertile plant to contain a foreign one. and diagnostic kit|
    US6660690B2|2000-10-06|2003-12-09|Monsanto Technology, L.L.C.|Seed treatment with combinations of insecticides|
    US6734340B2|2000-10-23|2004-05-11|Bayer Cropscience Gmbh|Monocotyledon plant cells and plants which synthesise modified starch|
    US6740488B2|2000-10-25|2004-05-25|Monsanto Technology Llc|Cotton event PV-GHGT07 compositions and methods for detection thereof|
    AU3089902A|2000-10-30|2002-05-15|Monsanto Technology Llc|Canola event pv-bngt04 and compositions and methods for detection thereof|
    EP2322629A3|2003-04-29|2011-11-02|Pioneer Hi-Bred International Inc.|Novel glyphosate-n-acetyltransferase genes|
    EP1399566A2|2000-10-30|2004-03-24|Maxygen, Inc.|Novel glyphosate n-acetyltransferase genes|
    FR2815969B1|2000-10-30|2004-12-10|Aventis Cropscience Sa|TOLERANT PLANTS WITH HERBICIDES BY METABOLIC BYPASS|
    EP1337669A2|2000-11-30|2003-08-27|Ses Europe N.V./S.A.|Glyphosate resistant transgenic sugar beet characterised by a specific transgene insertion , methods and primers for the detection of said insertion|
    AU1415802A|2000-12-07|2002-06-18|Syngenta Ltd|Herbicide resistant plants|
    BR0115782A|2000-12-08|2004-01-20|Commonwealh Scient And Ind Res|Modification of sucrose synthase gene expression in plant tissue and uses|
    US20020134012A1|2001-03-21|2002-09-26|Monsanto Technology, L.L.C.|Method of controlling the release of agricultural active ingredients from treated plant seeds|
    WO2002079410A2|2001-03-30|2002-10-10|Basf Plant Science Gmbh|Glucan chain length domains|
    EG26529A|2001-06-11|2014-01-27|مونسانتو تكنولوجى ل ل سى|Cotton event mon 15985 and compositions and methods for detection thereof|
    CA2465884A1|2001-06-12|2002-12-19|Bayer Cropscience Gmbh|Transgenic plants synthesising high amylose starch|
    US6818807B2|2001-08-06|2004-11-16|Bayer Bioscience N.V.|Herbicide tolerant cotton plants having event EE-GH1|
    AU2002322435A1|2001-08-09|2003-02-24|Cibus Genetics|Non-transgenic herbicide resistant plants|
    JP2005508166A|2001-10-17|2005-03-31|ビーエーエスエフプラントサイエンス，ゲーエムベーハー|Starch|
    WO2003052073A2|2001-12-17|2003-06-26|Syngenta Participations Ag|Novel corn event|
    DE10208132A1|2002-02-26|2003-09-11|Planttec Biotechnologie Gmbh|Process for the production of maize plants with an increased leaf starch content and their use for the production of maize silage|
    WO2003092360A2|2002-04-30|2003-11-13|Verdia, Inc.|Novel glyphosate-n-acetyltransferase genes|
    UA87808C2|2002-07-29|2009-08-25|Монсанто Текнолоджи, Ллс|Cereal crops pv-zmir13 and compositions and methods for detection thereof|
    FR2844142B1|2002-09-11|2007-08-17|Bayer Cropscience Sa|TRANSFORMED PLANTS WITH ENHANCED PRENYLQUINON BIOSYNTHESIS|
    PL377055A1|2002-10-29|2006-01-23|Basf Plant Science Gmbh|Compositions and methods for identifying plants having increased tolerance to imidazolinone herbicides|
    GB0225129D0|2002-10-29|2002-12-11|Syngenta Participations Ag|Improvements in or relating to organic compounds|
    US20040110443A1|2002-12-05|2004-06-10|Pelham Matthew C.|Abrasive webs and methods of making the same|
    JP2006508680A|2002-12-05|2006-03-16|モンサント　テクノロジー　エルエルシー|Konukagusa event ASR-368 and compositions and methods for its detection|
    DK1578973T3|2002-12-19|2008-11-24|Bayer Cropscience Ag|Plant cells and plants that synthesize a starch with increased final viscosity|
    WO2004072235A2|2003-02-12|2004-08-26|Monsanto Technology Llc|Cotton event mon 88913 and compositions and methods for detection thereof|
    CA2502981C|2003-02-20|2012-09-11|Kws Saat Ag|Transgenic glyphosate tolerant sugar beet event h7-1|
    US7335816B2|2003-02-28|2008-02-26|Kws Saat Ag|Glyphosate tolerant sugar beet|
    JP2006521099A|2003-03-07|2006-09-21|ビーエーエスエフプラントサイエンスゲーエムベーハー|Promotion of amylose production in plants|
    ZA200508019B|2003-04-09|2006-12-27|Bayer Bioscience Nv|Methods and means for increasing the tolerance of plants to stress conditions|
    MXPA05011795A|2003-05-02|2006-02-17|Dow Agrosciences Llc|Corn event tc1507 and methods for detection thereof.|
    WO2005002359A2|2003-05-22|2005-01-13|Syngenta Participations Ag|Modified starch, uses, methods for production thereof|
    EP1633875B1|2003-05-28|2012-05-02|Basf Se|Wheat plants having increased tolerance to imidazolinone herbicides|
    EP1493328A1|2003-07-04|2005-01-05|Institut National De La Recherche Agronomique|Method of producing double low restorer lines of brassica napus having a good agronomic value|
    ES2354696T3|2003-07-31|2011-03-17|Toyo Boseki Kabushiki Kaisha|PLANT THAT PRODUCES HIALURONIC ACID.|
    WO2005017157A1|2003-08-15|2005-02-24|Commonwealth Scientific And Industrial Research Organisation |Methods and means for altering fiber characteristics in fiber-producing plants|
    AR047107A1|2003-08-29|2006-01-11|Inst Nac De Tecnologia Agropec|RICE PLANTS THAT HAVE A GREATER TOLERANCE TO IMIDAZOLINONA HERBICIDES|
    AT491784T|2003-09-30|2011-01-15|Bayer Cropscience Ag|PLANTS WITH REDUCED ACTIVITY OF A CLASS 3 BRANCHING SYSTEM|
    WO2005030941A1|2003-09-30|2005-04-07|Bayer Cropscience Gmbh|Plants with increased activity of a class 3 branching enzyme|
    WO2005054479A1|2003-12-01|2005-06-16|Syngenta Participations Ag|Insect resistant cotton plants and methods of detecting the same|
    WO2005054480A2|2003-12-01|2005-06-16|Syngenta Participations Ag|Insect resistant cotton plants and methods of detecting the same|
    US7157281B2|2003-12-11|2007-01-02|Monsanto Technology Llc|High lysine maize compositions and event LY038 maize plants|
    US8212113B2|2003-12-15|2012-07-03|Monsanto Technology Llc|Corn plant Mon88017 and compositions and methods for detection thereof|
    AR048025A1|2004-03-05|2006-03-22|Bayer Cropscience Gmbh|PLANTS WITH INCREASED ACTIVITY OF AN ALMIDON FOSFORILING ENZYME|
    AR048026A1|2004-03-05|2006-03-22|Bayer Cropscience Gmbh|PROCEDURES FOR THE IDENTIFICATION OF PROTEINS WITH ENZYMATIC ACTIVITY FOSFORILADORA DE ALMIDON|
    EP1725666B1|2004-03-05|2012-01-11|Bayer CropScience AG|Plants with reduced activity of the starch phosphorylating enzyme phosphoglucan, water dikinase|
    AR048024A1|2004-03-05|2006-03-22|Bayer Cropscience Gmbh|PLANTS WITH INCREASED ACTIVITY OF DIFFERENT ENZYMES FOSFORILANTES DEL ALMIDON|
    US7432082B2|2004-03-22|2008-10-07|Basf Ag|Methods and compositions for analyzing AHASL genes|
    EP2289311B1|2004-03-25|2016-02-10|Syngenta Participations AG.|Corn event MIR604|
    EP2862934B1|2004-03-26|2019-05-29|Dow AgroSciences LLC|Cry1F and Cry1AC transgenic cotton lines and event-specific identification thereof|
    EP1766030A2|2004-06-16|2007-03-28|BASF Plant Science GmbH|Polynucleotides encoding mature ahasl proteins for creating imidazolinone-tolerant plants|
    DE102004029763A1|2004-06-21|2006-01-05|Bayer Cropscience Gmbh|Plants that produce amylopectin starch with new properties|
    TR200700491T2|2004-07-30|2007-04-24|Basf Agrochemical Products B.V.|Herbicide resistant sunflower plants, polynucleotides encoding herbicide resistant acetohydroxyacid synthase wide subunit proteins|
    AR050095A1|2004-08-04|2006-09-27|Basf Plant Science Gmbh|SEQUENCES OF SMALL SUBINITIES OF SINTASA ACETOHIDROXIACIDE OF MONOCOTILEDONEAS AND METHODS OF USE.|
    ES2340183T3|2004-08-18|2010-05-31|Bayer Cropscience Ag|PLANTS WITH GREATER PLASTIC ACTIVITY OF ENZIMA R3 FOSFORILANTE DE ALMIDON.|
    WO2006021972A1|2004-08-26|2006-03-02|Dhara Vegetable Oil And Foods Company Limited|A novel cytoplasmic male sterility system for brassica species and its use for hybrid seed production in indian oilseed mustard brassica juncea|
    PL1805312T3|2004-09-23|2009-12-31|Bayer Ip Gmbh|Methods and means for producing hyaluronan|
    CA2588243C|2004-09-29|2013-06-11|Pioneer Hi-Bred International, Inc.|Corn event das-59122-7 and methods for detection thereof|
    EP1807519B1|2004-10-29|2012-02-01|Bayer BioScience N.V.|Stress tolerant cotton plants|
    AR051690A1|2004-12-01|2007-01-31|Basf Agrochemical Products Bv|MUTATION INVOLVED IN THE INCREASE OF TOLERANCE TO IMIDAZOLINONE HERBICIDES IN PLANTS|
    EP1672075A1|2004-12-17|2006-06-21|Bayer CropScience GmbH|Transformed plant expressing a dextransucrase and synthesizing a modified starch|
    EP1679374A1|2005-01-10|2006-07-12|Bayer CropScience GmbH|Transformed plant expressing a mutansucrase and synthesizing a modified starch|
    EP1868426B1|2005-03-16|2018-02-21|Syngenta Participations AG|Corn event 3272 and methods of detection thereof|
    JP2006304779A|2005-03-30|2006-11-09|Toyobo Co Ltd|Plant producing hexosamine in high productivity|
    EP1707632A1|2005-04-01|2006-10-04|Bayer CropScience GmbH|Phosphorylated waxy potato starch|
    BRPI0608667B1|2005-04-08|2018-05-02|Bayer Cropscience Nv|NUCLEIC ACID, INITIATOR PAIRS, PROBES, KITS AND METHODS FOR IDENTIFYING ELITE A2704-12 EVENTS IN BIOLOGICAL SAMPLES, CONFIRMING SEED PURPOSE AND ANALYZING SEEDS FOR PRESENCE OF ELITE EVENT|
    EP1710315A1|2005-04-08|2006-10-11|Bayer CropScience GmbH|High phosphate starch|
    EP1871901B1|2005-04-11|2011-06-29|Bayer BioScience N.V.|Elite event a5547-127 and methods and kits for identifying such event in biological samples|
    AP2693A|2005-05-27|2013-07-16|Monsanto Technology Llc|Soybean event MON89788 and methods for detection thereof|
    WO2006129204A2|2005-05-31|2006-12-07|Devgen Nv|Rnai for control of insects and arachnids|
    MX2007014833A|2005-06-02|2008-02-15|Syngenta Participations Ag|Ce43-67b insecticidal cotton.|
    WO2006128568A2|2005-06-02|2006-12-07|Syngenta Participations Ag|T342-142, insecticidal transgenic cotton expressing cry1ab|
    BRPI0611508A2|2005-06-02|2010-09-14|Syngenta Participations Ag|ce44-69d insecticide cotton|
    WO2006128570A1|2005-06-02|2006-12-07|Syngenta Participations Ag|1143-51b insecticidal cotton|
    WO2006128572A1|2005-06-02|2006-12-07|Syngenta Participations Ag|Ce46-02a insecticidal cotton|
    WO2006128569A2|2005-06-02|2006-12-07|Syngenta Participations Ag|1143-14a, insecticidal transgenic cotton expressing cry1ab|
    WO2006133827A2|2005-06-15|2006-12-21|Bayer Bioscience N.V.|Methods for increasing the resistance of plants to hypoxic conditions|
    MX2008000097A|2005-06-24|2008-03-19|Bayer Bioscience Nv|Methods for altering the reactivity of plant cell walls.|
    AR054174A1|2005-07-22|2007-06-06|Bayer Cropscience Gmbh|OVERPRINTING OF ALMIDON SYNTHEASE IN VEGETABLES|
    CN101238217B|2005-08-08|2016-01-20|拜尔作物科学公司|The vegetable lamb of herbicide-tolerant and for the identification of its method|
    RS20080076A|2005-08-24|2009-07-15|Pioneer Hi-Brend International Inc.,|Compositions providing tolerance to multiple herbicides and methods of use thereof|
    EA015908B1|2005-08-31|2011-12-30|Монсанто Текнолоджи, Ллс|Insecticidal protein b.thuringiensis cry1a.105, encoding polynucleotide thereof and use thereof|
    SG166097A1|2005-09-16|2010-11-29|Monsanto Technology Llc|Methods for genetic control of insect infestations in plants and compositions thereof|
    PT2295584E|2005-09-16|2015-09-22|Devgen Nv|Transgenic plant-based methods for plant pests using rnai|
    CA2624973C|2005-10-05|2016-01-19|Bayer Cropscience Ag|Production of hyaluronan from plants transgenic for hyaluronan synthase, gfat and udp-glucose dehydrogenase|
    WO2007039314A2|2005-10-05|2007-04-12|Bayer Cropscience Ag|Plants with increased hyaluronan production|
    CN101297041A|2005-10-05|2008-10-29|拜尔作物科学股份公司|Plants with an increased production of hyaluronan II|
    JP5474356B2|2006-01-12|2014-04-16|デブジェンエヌブイ|Method for controlling pests using RNAi|
    WO2007080126A2|2006-01-12|2007-07-19|Devgen N.V.|Dsrna as insect control agent|
    AR056882A1|2006-02-01|2007-10-31|Bayer Cropscience Sa|DERIVATIVES OF THE FUNGICIDE N- CICLOALQUIL- BENCIL- AMIDA|
    WO2007091277A2|2006-02-10|2007-08-16|Maharashtra Hybrid Seeds Company Limited |TRANSGENIC BRINJAL EXPRESSING THE CRYlAC GENE|
    US20070214515A1|2006-03-09|2007-09-13|E.I.Du Pont De Nemours And Company|Polynucleotide encoding a maize herbicide resistance gene and methods for use|
    CN101405296B|2006-03-21|2014-04-30|拜尔作物科学公司|Novel genes encoding insecticidal proteins|
    KR20090007718A|2006-03-21|2009-01-20|바이엘 바이오사이언스 엔.브이.|Stress resistant plants|
    KR101366363B1|2006-05-26|2014-02-21|몬산토 테크놀로지 엘엘씨|Corn plant and seed corresponding to transgenic event mon89034 and methods for detection and use thereof|
    WO2007142840A2|2006-06-03|2007-12-13|Syngenta Participations Ag|Corn event mir162|
    US7951995B2|2006-06-28|2011-05-31|Pioneer Hi-Bred International, Inc.|Soybean event 3560.4.3.5 and compositions and methods for the identification and detection thereof|
    US7928295B2|2006-08-24|2011-04-19|Bayer Bioscience N.V.|Herbicide tolerant rice plants and methods for identifying same|
    US20080064032A1|2006-09-13|2008-03-13|Syngenta Participations Ag|Polynucleotides and uses thereof|
    US7897846B2|2006-10-30|2011-03-01|Pioneer Hi-Bred Int'l, Inc.|Maize event DP-098140-6 and compositions and methods for the identification and/or detection thereof|
    US7928296B2|2006-10-30|2011-04-19|Pioneer Hi-Bred International, Inc.|Maize event DP-098140-6 and compositions and methods for the identification and/or detection thereof|
    WO2008054747A2|2006-10-31|2008-05-08|E. I. Du Pont De Nemours And Company|Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof|
    WO2008114282A2|2007-03-19|2008-09-25|Maharashtra Hybrid Seeds Company Limited|Transgenic rice comprising pe-7 event and method of detection thereof|
    MX2009010755A|2007-04-05|2009-10-29|Bayer Bioscience Nv|Insect resistant cotton plants and methods for identifying same.|
    CN101998988A|2007-05-30|2011-03-30|先正达参股股份有限公司|Cytochrome P450 genes conferring herbicide resistance|
    EP2162542A1|2007-06-11|2010-03-17|Bayer BioScience N.V.|Insect resistant cotton plants comprising elite event ee-gh6 and methods for identifying same|
    CA2692767C|2007-07-31|2016-02-09|Bayer Cropscience Sa|Fungicidal n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n'-substituted-amidine derivatives|
    DE102007045922A1|2007-09-26|2009-04-02|Bayer Cropscience Ag|Drug combinations with insecticidal and acaricidal properties|
    MX2010005352A|2007-11-15|2010-07-02|Monsanto Technology Llc|Soybean plant and seed corresponding to transgenic event mon87701 and methods for detection thereof.|
    WO2009068313A2|2007-11-28|2009-06-04|Bayer Bioscience N.V.|Brassica plant comprising a mutant indehiscent allele|
    WO2009100188A2|2008-02-08|2009-08-13|Dow Agrosciences Llc|Methods for detection of corn event das-59132|
    AU2009214457B2|2008-02-14|2014-07-31|E. I. Du Pont De Nemours And Company|Plant genomic DNA flanking SPT event and methods for identifying SPT event|
    CA2712445C|2008-02-15|2018-11-06|Monsanto Technology Llc|Soybean plant and seed corresponding to transgenic event mon87769 and methods for detection thereof|
    PE20091558A1|2008-02-29|2009-11-06|Monsanto Technology Llc|MAIZE MON87460 EVENT AND COMPOSITIONS AND METHODS TO DETECT IT|
    US20110039706A1|2008-04-14|2011-02-17|Marco Busch|New mutated hydroxyphenylpyruvate dioxygenase, dna sequence and isolation of plants which are tolerant to hppd inhibitor herbicides|
    AU2009270539B2|2008-07-17|2015-04-23|BASF Agricultural Solutions Seed US LLC|Brassica plant comprising a mutant indehiscent allelle|
    WO2010024976A1|2008-08-29|2010-03-04|Monsanto Technology Llc|Soybean plant and seed corresponding to transgenic event mon87754 and methods for detection thereof|
    CA2738474C|2008-09-29|2020-05-12|Monsanto Technology Llc|Soybean transgenic event mon87705 and methods for detection thereof|
    EP2201838A1|2008-12-05|2010-06-30|Bayer CropScience AG|Active ingredient-beneficial organism combinations with insecticide and acaricide properties|
    US9133474B2|2008-12-16|2015-09-15|Syngenta Participations Ag|Corn event 5307|
    US20120144516A1|2008-12-19|2012-06-07|Syngenta Participations Ag|Transgenic sugar beet event gm rz13|
    UA102136C2|2009-01-07|2013-06-10|Басф Се|Pesticidal mixtures|
    MY176497A|2009-03-30|2020-08-12|Monsanto Technology Llc|Transgenic rice event 17314 and methods of use thereof|
    KR101818775B1|2009-03-30|2018-01-15|몬산토 테크놀로지 엘엘씨|Rice transgenic event 17053 and methods of use thereof|
    AR076839A1|2009-05-15|2011-07-13|Bayer Cropscience Ag|FUNGICIDE DERIVATIVES OF PIRAZOL CARBOXAMIDAS|
    CA3038144A1|2009-08-19|2011-02-24|Yunxing Cory Cui|Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof|
    AR077956A1|2009-09-14|2011-10-05|Bayer Cropscience Ag|COMBINATIONS OF ACTIVE COMPOUNDS|
    ES2866126T3|2009-09-17|2021-10-19|Monsanto Technology Llc|MON 87708 GM soy event and procedures for its use|
    CA2992347A1|2009-11-23|2011-05-26|Monsanto Technology Llc|Transgenic maize event mon 87427 and the relative development scale|
    WO2011066360A1|2009-11-24|2011-06-03|Dow Agrosciences Llc|Detection of aad-12 soybean event 416|
    BR112012012511A2|2009-11-24|2015-09-15|Dow Agrosciences Llc|event 416 of the aad-12 gene related to transgenic soybean strains and their event-specific identification|
    WO2011075593A1|2009-12-17|2011-06-23|Pioneer Hi-Bred International, Inc.|Maize event dp-040416-8 and methods for detection thereof|
    US20110154526A1|2009-12-17|2011-06-23|Pioneer Hi-Bred International, Inc.|Maize event DP-043A47-3 and methods for detection thereof|
    CN113373174A|2009-12-17|2021-09-10|先锋国际良种公司|Maize event DP-004114-3 and methods for detecting same|
    US20110154524A1|2009-12-17|2011-06-23|Pioneer Hi-Bred International, Inc.|Maize event DP-032316-8 and methods for detection thereof|
    CA2833746C|2011-04-22|2019-06-04|Bayer Intellectual Property Gmbh|Active compound combinations comprising a carboxamide derivative and an insecticidal or acaricidal or nematicidal active compound|CA2833746C|2011-04-22|2019-06-04|Bayer Intellectual Property Gmbh|Active compound combinations comprising a carboxamide derivative and an insecticidal or acaricidal or nematicidal active compound|
    MX2014008860A|2012-01-24|2014-10-06|Sumitomo Chemical Co|Plant disease control composition.|
    MX2014008861A|2012-01-25|2014-10-06|Sumitomo Chemical Co|Plant disease control composition.|
    KR102123218B1|2012-10-19|2020-06-16|바이엘 크롭사이언스 악티엔게젤샤프트|Active compound combinations comprising carboxamide derivatives and a biological control agent|
    EP2908641B1|2012-10-19|2018-01-10|Bayer Cropscience AG|Method for treating plants against fungi resistant to fungicides using carboxamide or thiocarboxamide derivatives|
    UA114647C2|2012-10-19|2017-07-10|Байєр Кропсайнс Аг|Method for enhancing tolerance to abiotic stress in plants using carboxamide or thiocarboxamide derivatives|
    UA114822C2|2012-10-19|2017-08-10|Байєр Кропсайнс Аг|Active compound combinations comprising carboxamide derivatives|
    EP2908640B1|2012-10-19|2019-10-02|Bayer Cropscience AG|Method of plant growth promotion using carboxamide derivatives|
    UA116223C2|2012-11-30|2018-02-26|Байєр Кропсайєнс Акцієнгезелльшафт|Binary fungicidal mixtures|
    WO2014083012A1|2012-11-30|2014-06-05|Bayer Cropscience Ag| enantiomers of carboxamides for controlling of harmful microorganisms or for enhancing plant health|
    CN105007740B|2013-03-05|2017-05-03|日本曹达株式会社|Method for controlling phytopathogenic filamentous fungi other than oomycete microorganisms|
    JP2016166131A|2013-07-11|2016-09-15|国立大学法人 東京大学|Aflatoxin production inhibitor and aflatoxin contamination control method|
    PT3057424T|2013-10-16|2018-10-30|Bayer Cropscience Ag|Active compound combinations comprising a carboxamide derivative and a fungicidal compound|
    UY36432A|2014-12-16|2016-06-30|Bayer Cropscience Ag|COMBINATIONS OF ACTIVE COMPOUNDS THAT INCLUDE A DERIVATIVE OFCARBOXAMIDE AND FUNGICIDE COMPOUND |
    WO2016174042A1|2015-04-27|2016-11-03|BASF Agro B.V.|Pesticidal compositions|
    AR104687A1|2015-05-19|2017-08-09|Bayer Cropscience Ag|METHOD FOR TREATING ROYA COFFEE DISEASES, BLACK MANCHA OF THE CITRUS, SARNA OF THE CITRUS AND SIGATOKA BLACK OF THE BANANA|
    MX2018000212A|2015-07-02|2018-05-23|Valent Usa Llc|Methods for apple scab control.|
    WO2017004334A1|2015-07-02|2017-01-05|Valent U.S.A. Corporation|Compositions for powdery mildew control and methods of their use|
    CN105085075A|2015-09-12|2015-11-25|顾伟|Agricultural composition containing propamidine and foliage fertilizer|
    UY36964A|2015-10-27|2017-05-31|Bayer Cropscience Ag|COMBINATIONS OF ACTIVE PRINCIPLES THAT INCLUDE A DERIVATIVE OFCARBOXAMIDE AND A FUNGUITED COMPOUND|
    WO2017110864A1|2015-12-25|2017-06-29|住友化学株式会社|Plant disease control composition and application for same|
    WO2017194363A1|2016-05-10|2017-11-16|Bayer Cropscience Aktiengesellschaft|Compound combination for controlling phytopathogenic harmful fungi|
    WO2017207368A1|2016-06-02|2017-12-07|BASF Agro B.V.|Fungicidal compositions|
    EP3522716A1|2016-10-10|2019-08-14|Basf Se|Pesticidal mixtures|
    WO2018069110A1|2016-10-10|2018-04-19|Basf Se|Pesticidal mixtures|
    WO2018069109A1|2016-10-10|2018-04-19|Basf Se|Pesticidal mixtures|
    CN106489966B|2016-10-14|2019-05-14|浙江省农药检定管理所|Ternary built fungicide containing Fluoxastrobin and application thereof|
    WO2018109062A1|2016-12-16|2018-06-21|Bayer Cropscience Aktiengesellschaft|Method for the control of plant bacterial diseases using carboxamide derivatives|
    EP3554239A1|2016-12-16|2019-10-23|Bayer CropScience Aktiengesellschaft|Method for the control of plant bacterial diseases using carboxamide derivatives|
    WO2018140458A1|2017-01-24|2018-08-02|Germains Seed Technology, Inc.|Anti-fungal seed treatment formulations, treated seeds, and methods|
    WO2020007646A1|2018-07-02|2020-01-09|Basf Se|Pesticidal mixtures|
    CN109169676A|2018-09-30|2019-01-11|东莞东阳光科研发有限公司|A kind of bactericidal composition containing Isoflucypram and methoxy acrylic bactericide|
    EP3698634A1|2019-02-25|2020-08-26|Basf Se|Pesticidal mixtures|
    CN112616844B|2020-11-27|2021-10-15|浙江威尔达化工有限公司|Bactericide|
    法律状态:
    2018-04-03| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]|
    2018-05-29| B07A| Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]|
    2019-03-12| B07A| Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]|
    2019-04-24| B25A| Requested transfer of rights approved|Owner name: BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) |
    2019-11-05| B06A| Patent application procedure suspended [chapter 6.1 patent gazette]|
    2020-03-10| B06A| Patent application procedure suspended [chapter 6.1 patent gazette]|
    2020-07-07| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|
    2020-12-01| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/04/2012, OBSERVADAS AS CONDICOES LEGAIS. |
    优先权:
    申请号 | 申请日 | 专利标题
    EP11356005.6|2011-04-22|
    EP11356005|2011-04-22|
    US201161486479P| true| 2011-05-16|2011-05-16|
    US61/486,479|2011-05-16|
    PCT/EP2012/001676|WO2012143127A1|2011-04-22|2012-04-18|Active compound combinations comprising a carboxamide derivative and a fungicidal compound|
    [返回顶部]